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Fifteen years. That is the target 
international animal health specialists 
have set themselves to eradicate peste 
des petits ruminants (PPR). This is 
only half the time it took to eradicate 
rinderpest. This is an ambitious yet 
realistic target and will be achieved 
through coordinated joint action by the 
various national, regional and global 
parties involved.
During the past 15 years, PPR has 
spread at an alarming rate, reaching 
regions not previously infected. 
Identified in Côte d’Ivoire in 1942, this 
devastating disease now affects nearly 
70 countries in Africa, the Middle East 
and Asia, which are home to more 
than 80% of the world’s sheep and goat 
populations.
The disease is highly contagious. 
Once introduced, the virus can infect 
up to 90% of a flock, and the disease 
can then kill 30% to 70% of infected 
animals. The economic losses induced 
by PPR strike at the heart of vulnerable 
rural populations, ruining animal 
production at the national and regional 
level. Affected countries have suffered 
cumulative annual losses ranging from 
tens to hundreds of millions of dollars. 
In the absence of any control plan, 
PPR could spread still further, causing 
more devastating socio-economic losses 
and hardship for the millions of poor 
farmers, mostly women, who rely on 
sheep and goats for their livelihoods.
Towards global eradication  
of peste des petits ruminants
This explains why the World 
Organisation for Animal Health 
(OIE) and the Food and Agriculture 
Organization of the United Nations 
(FAO), in a bid to stop the spread of 
the disease and ultimately eradicate it, 
have developed a Global Strategy for 
the Control and Eradication of PPR, 
within the FAO/OIE Global Framework 
for the Control of Transboundary 
Animal Diseases (GF-TADs) Working 
Group.
At the beginning of April, over 
300 high-level representatives from all 
corners of the Earth met in Abidjan, 
Côte d’Ivoire, at an international 
conference organised by the OIE 
and FAO with the aim of adopting 
this global strategy. The Ministerial 
recommendations issued by the 
meeting defined PPR as a top-priority 
disease that should be eradicated in the 
next two decades.
The objective of global control 
and eradication of the disease within 
fifteen years will only be achieved if 
sufficient funding can be obtained 
and if good coordination exists at all 
levels, coupled with a strong political 
commitment.
Fortunately, valuable lessons have 
been learned from the past and show 
the path to success. To date, only 
two diseases have been successfully 
wiped off the face of the planet: 
human smallpox, eradicated under 
the auspices of the World Health 
Organization (WHO), and the much-
feared animal disease rinderpest, 
eradicated under the auspices of the 
OIE and FAO. 
Based on the rinderpest model, 
a gradual, step-by-step method 
has been developed for the global 
control and eradication of PPR. 
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At a national level, the strategy 
is implemented in four stages, the 
ultimate aim being to obtain the status 
of a country officially recognised as 
free from PPR by the World Assembly 
of National Delegates of OIE Member 
Countries. It is also possible for each 
infected country to apply for OIE 
endorsement of its national PPR control 
programme, based on the standards in 
the OIE Terrestrial Code. 
At the global level, a joint 
governance and coordination 
mechanism is being implemented 
within the framework of the GF-TADs 
agreement, established between the 
OIE and FAO in 2004. In addition to 
this, there is a specific mechanism for 
managing the resources allocated to 
PPR eradication by the programme’s 
financial partners. 
It should be emphasised that the 
Global Strategy for the Control and 
Eradication of PPR is not presented as 
a ‘stand-alone’ activity, but rather as 
a combination of three inter-related 
components: namely, the control and 
eradication of PPR, the strengthening 
of Veterinary Services, and the parallel 
prevention and control of other major 
diseases of small ruminants. These 
three pillars form the Global Strategy 
adopted in Abidjan.
Based on these three pillars, the aim 
of global eradication of PPR is also the 
starting point to achieve sustainable 
progress in the performance of national 
animal health systems and, in turn, to 
improve the animal health status for 
other diseases of small ruminants and 
the health status of small village flocks. 
The countries meeting in Abidjan 
thus undertook to strengthen the 
capacities and expertise of their 
Veterinary Services to ensure proper 
implementation of the eradication 
strategy, notably through the 
development of surveillance plans 
for the disease, capacity-building 
programmes for staff, technology 
transfer, public–private partnerships, 
and the use of vaccines that comply 
with OIE intergovernmental standards. 
The global investment needed 
during the next fifteen years will be 
substantial and at the present time 
is difficult to evaluate precisely. 
Nevertheless, the target is achievable 
and will have a significant impact on 
food production, nutrition, incomes 
and the livelihood resilience of more 
than 330 million poor farmers in many 
parts of the world, by improving the 
productivity and profitability of their 
flocks. 
Supporting Veterinary Services by 
helping them to achieve compliance 
with OIE standards of quality will also 
improve the effectiveness of prevention 
and control of all other animal diseases, 
demonstrating even further the cost-
effectiveness of the investment made.
In the current context of globalised 
trade, paving the way for large-scale 
dissemination of pathogens, the 
activities of Veterinary Services and 
the control of transboundary animal 
diseases such as PPR at their source are 
in the interests of all countries, infected 
or otherwise. These activities should, 
more than ever, be considered as global 
public goods. 
The OIE and FAO are continuing to 
implement the Global Foot and Mouth 
Disease Control Strategy adopted at the 
Bangkok Conference in 2012. The OIE, 
WHO and FAO are also continuing 
with the Global Control Programme 
for Canine Rabies. A world conference 
on the subject, organised by WHO, 
the OIE and FAO, is due to be held 
at WHO Headquarters in Geneva in 
December 2015. 
2015 • 22
The objective 
of global control 
and eradication 
of the disease 
within fifteen 
years will only 
be achieved 
if sufficient 
funding can 
be obtained 
and if good 
coordination 
exists at all 
levels, coupled 
with a strong 
political 
commitment
forum
Global 
strategy 
for the 
control and 
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of PPR
Peste des petits ruminants (PPR) is 
one of the most damaging of all animal 
diseases, and around 70 countries have 
either reported the disease to the OIE 
or are suspected of being infected . Of 
these, more than 60% are in Africa, the 
other infected countries being in Asia 
(People’s Republic of China, South Asia, 
Central Asia/West Eurasia, including 
Turkey) and the Near and Middle East . 
Fifty other countries are considered to 
be at risk of PPR .
In the worst situations, PPR-
related morbidity is as high as 100%, 
with a mortality rate that can reach 
90% . In areas where the disease is 
endemic the mortality rate may be 
lower, but the disease has a more 
insidious impact on flock productivity . 
Each year, PPR causes economic 
losses worth an estimated USD 1 .2 to 
1 .7 billion, due to animal deaths, 
reduced production and the cost of 
fighting the disease .
The FAO/OIE Global Framework 
for the Progressive Control of 
Transboundary Animal Diseases 
(GF-TADs) Global Steering Committee 
in 2012, the FAO Council and the 
Committee on Agriculture (COAG), and 
the OIE, in the form of a Resolution 
of the World Assembly of Delegates 
of the OIE in 2014, all recommended 
the development of a Global Strategy 
for the Control and Eradication of PPR 
(hereinafter ‘the Global Strategy’) and 
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expressed a strong willingness to 
address animal health problems 
in a systematic way, dealing with 
horizontal as well as more disease-
specific (i .e . vertical) issues, relating 
to PPR or to other diseases .
The Global Strategy has been 
prepared by the GF-TADs Working 
Group on PPR, in collaboration 
with numerous experts and 
representatives of key countries, 
regional organisations, specialised 
organisations and the private sector .
The overall objective of the 
Global Strategy is a small ruminant 
sector contributing to global food 
security and nutrition, human health 
and economic growth, particularly 
in developing countries, thereby 
alleviating poverty, increasing 
income generation and improving 
the livelihoods of smallholder 
farmers and general human 
wellbeing . The specific objectives 
are the eradication of PPR by 2030, 
while at the same time, through 
reinforcing the Veterinary Services, 
improving animal health globally 
by reducing the impact of other 
major infectious diseases of small 
ruminants .
The experience gained and the 
lessons learned during the Global 
Rinderpest Eradication Programme 
(GREP) are important assets, and 
there are several factors conducive 
to Global Strategy implementation, 
such as the availability of effective 
vaccines, suitable diagnostic 
assays, favourable epidemiological 
conditions and a political context 
that is now quite conducive to 
PPR control and eradication . 
Other factors provide strong 
incentives, such as the possibility 
to strengthen the small ruminant 
sector by combining PPR control 
with control activities for other 
important diseases, and indeed the 
possibility of obtaining official OIE 
recognition of a ‘PPR free’ status 
or endorsement of national PPR 
control programmes .
Nevertheless, Global 
Strategy implementation will 
have to contend with significant 
challenges, such as the level of 
effectiveness of the Veterinary 
Services, the difficulty of finding 
vaccine delivery systems that are 
effective in all locations, even in 
remote or war-torn areas, and also 
the considerable mobility of small 
ruminants .
The Global Strategy has three 
integrated components. While 
eradication of PPR (Component 1) 
is the ultimate goal, it cannot 
be achieved independently of the 
other two components, namely 
strengthening the Veterinary 
Services (Component 2) as a 
country moves towards PPR 
eradication and better prevention 
and control of other priority diseases 
of small ruminants (Component 3) .
At national level, the strategic 
approach is based on four stages, 
beginning with Stage 1, when the 
epidemiological situation is being 
assessed, and culminating with 
Stage 4, when the country can 
provide evidence that there is no 
virus circulation and is ready to 
apply for official OIE recognition of 
the status ‘free from PPR’ .
In addition to the PPR vaccine 
and specific diagnostic assays 
that are already available, a 
variety of tools will be used during 
implementation of the Global 
Strategy, such as the OIE PVS 
Pathway, the PPR Monitoring and 
Assessment Tool (PMAT) and the 
Post-Vaccination Evaluation (PVE) 
tool . The aim of the PMAT is to 
categorise countries according 
to the four stages identified in 
the Global Strategy . The PVE tool 
will enable the effectiveness of 
the vaccination campaign to be 
evaluated . The Global Strategy 
will also establish a Global PPR 
Research and Expertise Network 
(PPR-GREN) .
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The five technical elements that 
characterise each stage are related 
to:
− PPR diagnosis
− surveillance systems
− prevention and control 
systems
− the legal framework in place 
− stakeholder involvement .
The activities will begin by 
controlling the disease in areas 
where it is highly endemic, and 
they will then consolidate these 
efforts by concentrating on zones 
where a low endemic level has been 
achieved . For countries already 
free from PPR, this status will be 
maintained .
At regional level, the emphasis 
is on the need to harmonise 
strategies and activities through 
strong partnerships with the relevant 
regional economic communities 
or other relevant regional 
organisations, such as the African 
Union – Inter-African Bureau for 
Animal Resources (AU-IBAR) 
in Africa, as well as through the 
development of regional networks 
for laboratories and epidemiology . 
The GF-TADs Regional Animal 
Health centres (RAHCs) can play 
an important role at regional level . 
Countries will participate in (sub)-
regional roadmaps that provide for 
evaluation and validation of the 
various stages .
At global level, the GF-TADs 
governing bodies, principles and 
mechanisms will be maintained and 
a new FAO/OIE Global PPR Control 
and Eradication Programme (PPR-
GCEP) will be established, with its 
own FAO/OIE joint global Secretariat. 
FAO/OIE global networks of PPR 
Reference Laboratories/Centres and 
Epidemiology Collaborating Centres 
for PPR will be established .
Monitoring and evaluation are 
key elements of Global Strategy 
implementation and the PPR 
Monitoring and Evaluation Tool 
(PMAT) and Post-Vaccination 
Evaluation tool (PVE) will be used for 
this purpose .
The timelines of the PPR 
Global Strategy foresee three 
five-year phases, with constant 
epidemiological evaluation and 
monitoring and a global evaluation 
of the results in 2020, which will 
provide guidance on the continuation 
or updating of programme activities .
The undiscounted costs for a 
fifteen-year Global Strategy are 
between USD 7 .6 and 9 .1 billion . 
The annual cost during the initial 
five-year period is estimated to be  
in the region of USD 0 .5 billion . 
In the event of a rapid decrease 
in PPR incidence in countries 
employing an effective 
vaccination strategy, the costs 
could be lower than the original 
estimates . In all the scenarios 
tested, vaccination campaigns 
are significant components and 
their cost could well be reduced 
by strong targeting of at-risk 
populations through careful 
epidemiological and economic 
analysis .
The annual direct impact 
of PPR is currently between 
USD 1 .2 and 1 .7 billion, and 
this impact would be reduced to 
zero if the eradication programme 
were successful . It is important 
to realise that without the Global 
Strategy anything between 
USD 4 .0 and 5 .5 billion would 
be spent over a 15-year period 
on poorly targeted vaccination 
campaigns that are unlikely to 
lead to eradication .
Global strategy for the control and 
eradication of peste des petits ruminants:
www.oie.int/eng/PPR2015/Document.html
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OIE news
new OIE publications
Published in English, French and Spanish 
24th edition, 2015
29 .7 x 21 cm
Vol . I: 432 pages
Vol . II: 308 pages
 
ISBN 978-92-9044-970-6 
Price: EUR 60
Terrestrial Animal Health Code 
The aim of the OIE Terrestrial Animal Health Code 
(Terrestrial Code) is to contribute to the improvement of 
terrestrial animal health and welfare and veterinary public 
health worldwide and to assure the sanitary safety of 
international trade in terrestrial animals (mammals, birds 
and bees) and their products .
The standards in the Terrestrial Code are based on 
the most recent scientific and technical information and 
have been formally adopted by the World Assembly of OIE 
Delegates . They are also recognised as the international 
standard for animal health and zoonotic diseases within the 
World Trade Organization Agreement on the Application of 
Sanitary and Phytosanitary Measures .
The Terrestrial Code should be used by the Competent 
Authorities of importing and exporting countries for early 
detection, reporting and control of agents pathogenic 
to terrestrial animals, and, in the case of zoonoses, for 
humans, and to prevent their transfer via international trade 
in terrestrial animals and their products, while avoiding 
unjustified sanitary barriers to trade .
This 24th edition incorporates modifications to the 
Terrestrial Code agreed at the 83rd General Session in 
May 2015 . It includes an updated version of the table 
Order online: http://web.oie.int/boutique/index.php?page=&lang=en
of contents, user’s guide and glossary, as well as three 
new chapters: animal welfare and dairy cattle production 
systems (7 .11 .) (volume I), infection with epizootic 
hemorrhagic disease virus (8 .7 .) (volume II) and infection 
with Taenia solium (15 .3 .) (volume II) .
Additionally, volume I includes revised text in the 
following chapters: procedures for self declaration and for 
official recognition by the OIE, evaluation of Veterinary 
Services, collection and processing of in vivo derived 
embryos from livestock and equids, high health status horse 
subpopulation, general obligations related to certification, 
certification procedures, prevention, detection and control 
of Salmonella in poultry, harmonisation of national 
antimicrobial resistance surveillance and monitoring 
programmes, risk analysis for antimicrobial resistance 
arising from the use of antimicrobial agents in animals, 
animal welfare and broiler chicken production systems .
The following chapters in volume II were also updated: 
infection with bluetongue virus, infection with Brucella 
abortus, B. melitensis and B. suis, infection with foot and 
mouth disease virus, infection with Rift Valley fever virus, 
infection with avian influenza viruses and bovine spongiform 
encephalopathy .
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Published in English, French and Spanish 
18th edition, 2015
29 .7 × 21 cm
298 pages 
ISBN 978-92-9044-977-5 
Price: EUR 45
Aquatic Animal Health Code 
The aim of the OIE Aquatic Animal Health Code (Aquatic Code) is 
to contribute to the improvement of the health of aquatic animals and 
welfare of farmed fish worldwide and to assure the sanitary safety of 
international trade in aquatic animals (amphibians, crustaceans, fish 
and molluscs) and their products . 
The standards in the Aquatic Code are based on the most recent 
scientific and technical information and have been formally adopted 
by the World Assembly of OIE Delegates. They are also recognised as 
the international standard for aquatic animal health within the World 
Trade Organization Agreement on the Application of Sanitary and 
Phytosanitary Measures . 
The Aquatic Code should be used by the Competent Authorities 
of importing and exporting countries for early detection, reporting and 
control of agents pathogenic to aquatic animals, and to prevent their 
transfer via international trade in aquatic animals and their products, 
while avoiding unjustified sanitary barriers to trade .
The 2015 edition includes an updated version of the table of 
contents, user’s guide and glossary, and revised text in the following 
chapters:
− diseases listed by the OIE
− import risk analysis
− control of pathogenic agents in aquatic animal feed
− general obligations related to certification
− certification procedures
− infection with Batrachochytrium dendrobatidis
− infection with ranavirus 
− infection with Perkinsus olseni .
In addition, the text in Articles X .X .7 . and X .X .11 . of 
disease-specific chapters has been merged, and some amendments 
have been made in Articles 10 .4 .4 . and 10 .4 .6 .
This edition also includes two new chapters: Recommendations 
for surface disinfection of salmonid eggs (4 .3 .) and Risk analysis for 
antimicrobial resistance arising from the use of antimicrobial agents in 
aquatic animals (6 .5 .) .
news from 
headquarters
Coordination  
of the World 
Fund 
Ms Sophie Rivière   
Project Officer  
Sophie Rivière joined the Coordination 
Unit of the OIE World Animal Health and 
Welfare Fund in November 2014 as a Project 
Officer. A French citizen who grew up in the 
United States, Sophie brings with her ten 
years of experience in managing international 
development projects, particularly in the 
fields of higher education and research. She 
spent three years working as the Advisor to 
the Director General of 2iE, the International 
Institute for Water and Environmental 
Engineering, an African Centre of Excellence 
based in Burkina Faso that provides high-level 
training to students from over 40 different 
countries. She holds a Master’s Degree in 
Political Science from the Sorbonne in France 
and a Bachelor’s Degree in International 
Development from McGill University in 
Canada.
Arrivals
Order online: http://web.oie.int/boutique/index.php?page=&lang=en Order online: http://web.oie.int/boutique/index.php?page=&lang=en
Staff movements
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Legal  
and Administrative  
Affairs Unit
  
Mr Rodney de Souza 
Head of the Unit  
Rodney de Souza joined the 
OIE on 1 January 2015 as Head 
of the Legal and Administrative 
Affairs Unit, a new unit created 
because of an increasing need for internal legal support 
within the Organisation. He was also appointed acting 
Head of the Human Resources Unit on 28 January. Since 
then, as well as handling human resources matters, 
Rodney has been responsible for drafting contracts 
with international organisations and other third parties; 
monitoring the OIE’s governance and institutional 
relations; and overseeing the internal audit.
Before joining the OIE, Rodney worked as an attorney 
at an international law firm in New York, where he 
represented businesses, institutions, research centres 
and start-up companies involved in biotechnology, 
clean technology, diagnostics, medical devices and 
pharmaceuticals, in various litigations and cross-border 
transactions.
Rodney holds law degrees from Cornell University 
(New York), King’s College (London) and the Sorbonne 
(Paris).
Regional Activities Department 
  
Dr Pablo Belmar von Kretschmann  
Chargé de mission
Dr Pablo Belmar von 
Kretschmann joined the 
staff of OIE Headquarters 
in January 2015, as Chargé 
de mission in the Regional 
Activities Department. His 
responsibilities primarily 
involve activities associated 
with the Performance of 
Veterinary Services Pathway (PVS Pathway), the OIE´s global 
programme which aims to strengthen national Veterinary 
Services. These include: helping to organise OIE assessments 
of the performance of Veterinary Services (PVS Evaluations), 
PVS Gap Analyses, Veterinary Legislation Missions and 
Follow-up Missions; and taking part in the analysis of 
PVS Pathway Mission reports; as well as contributing to 
the activities of the OIE Veterinary Legislation Support 
Programme (VLSP).
Dr Belmar von Kretschmann graduated as a DVM from 
the University of Chile, later gaining an MSc in Food Safety 
from Wageningen University in the Netherlands. He spent 
seven years working as a Veterinary Officer for food/feed 
safety at Chile’s competent authority in the area of aquatic 
animals. Here, he gained experience in applying the WTO 
Agreement on the Application of Sanitary and Phytosanitary 
Measures (SPS Agreement), negotiating animal health and 
food safety requirements with trading partners and the 
inspection and certification of animal products for export. 
He was also responsible for implementing the programme for 
the control of residues of pharmaceutical and environmental 
pollutants in aquaculture fish in Chile.
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Activities of the Communication Unit
This was the 52nd Paris International Agricultural Show, featuring 
several thousand animals and welcoming nearly 700,000 visitors during 
the week .
In partnership with the European Commission’s Directorates General 
for Health and Food Safety (DG SANTE) and Agriculture (DG AGRI), the 
OIE informed visitors to the show about the various stages in the food 
production chain ‘from farm to fork’, and the rules and standards set by 
the European Commission and the OIE to ensure food safety . 
Numerous events, including videos, quizzes and a tasting workshop, 
helped to raise awareness among visitors of all ages of the role played 
by professionals, and especially veterinarians, in ensuring that the rules 
on animal health and welfare are followed and the safety and quality of 
animal products protected .
The OIE’s fact sheets have been updated to give a clear 
overview of topics of interest for the Organisation, such as 
transparency of the world animal health situation, the role of 
Veterinary Services, food safety and animal welfare . Through this 
comprehensive update, the OIE provides a review of its key texts, 
programmes and tools aimed at improving animal health and 
welfare throughout the world .
As well as these updates, the OIE will publish a new fact 
sheet on its intergovernmental standards . The aim is to provide 
information on intergovernmental standard-setting documents, 
which set out the rules that Member Countries can use to protect 
themselves from the introduction of diseases and pathogens 
without setting up unjustified animal health barriers .
What is an OIE standard? Where can one find the OIE’s 
standards? Why are they developed? How and by whom? The new 
OIE fact sheet answers these and many other questions .
The OIE fact sheets can be consulted on the OIE website . They 
are available in English, French and Spanish .
The OIE at the Paris International Agricultural Show 2015 
For the fifth year running, the OIE was present at the Paris International Agricultural Show, held during the week 
of 21 February to 1 March 2015.
The OIE updates its fact sheets and launches a new one  
on intergovernmental standards
Throughout the week, people of all ages were able to discover the central 
role of veterinarians ‘from farm to fork’
©
 O
IE
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The 10 fact sheets already available on-line cover:
− animal welfare
− antimicrobial resistance (currently being updated)
− aquatic animals
− biological threat reduction
− food safety
− good veterinary governance
− official disease status
− prevention and control
− wildlife
− world information on animal diseases
We hope you’ll find them informative!
The OIE fact sheets:
www.oie.int/en/for-the-media/key-documents/fact-sheets/
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Activities of the Communication Unit
The OIE presents the 2015 edition of the Organisation’s 
on-line handbook, the ‘A-Z’ . This essential tool for national and 
international decision-makers in the field of animal health and 
welfare is a collection of key documents, information and data 
designed to inform users about the OIE and familiarise them with 
the way the Organisation functions .
This interactive tool’s user-friendly format makes it ideal 
for rapid reference . Users can navigate the document in several 
different ways .
The chapters are as follows:
− General presentation of the Organisation and the role of the 
representatives of its 180 Member Countries
− Veterinary Services and their role in matters of animal 
health, public health and animal welfare
The OIE launches the 2015 edition of its ‘A-Z’,  
an on-line handbook for a clearer understanding of the OIE
− OIE standards applicable in matters of animal health, 
including zoonoses
− The OIE’s World Animal Health Information System: 
WAHIS/WAHID
− The official disease status of Member Countries with 
respect to several priority animal diseases
− The OIE’s global scientific network, the central core that 
enables the OIE to remain at the forefront of world veterinary 
scientific expertise and successfully carry out its key missions
− OIE Publications, a chapter containing normative 
texts, serial publications and the proceedings of international 
conferences aimed at informing public debate and policy 
development worldwide .
OIE A → Z :
www.oie.int/fileadmin/vademecum/OIE_A-Z_2015.html
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Activities of the Scientific and Technical Department
Summaries of the OIE Specialist Commission,  
Working Group and Ad hoc Group meetings 
January to March 2015 
Specialist Commissions
Biological Standards Commission 
(‘Laboratories Commission’)
OIE Headquarters, Paris, 28–30 January 2015
The Laboratories Commission met at the OIE Headquarters 
under the chairmanship of its President, Prof . Vincenzo Caporale, 
and addressed, among others, the following issues:
1. OIE Reference Centres 
The Commission accepted one request for designation as an 
OIE Reference Laboratory . Following the meeting, this request 
was endorsed by the OIE Council along with two others that had 
been waiting for an answer from the Council to a question from 
the Commission; all will be proposed for adoption by the World 
Assembly of Delegates through a formal resolution at the OIE 
General Session in May 2015 .
Annual reports of activities in 2014 were received from 
most Reference Centres . The new online web-based annual 
report template has been used by the Collaborating Centres for 
the first time . The web-based reporting system makes it easy to 
identify areas for the Commission’s focus . For example, many 
OIE Reference Laboratories produce and supply reference 
materials but few produce and supply OIE-approved reagents . 
The Commission will be able to review its guidelines on the 
preparation, validation and distribution of approved materials 
and encourage participation in its standardisation programme . 
The Commission expressed its ongoing appreciation for the 
enthusiastic support and expert advice given to the OIE by the 
Reference Centres .
2. Ad hoc Groups 
The Commission endorsed the report of the OIE ad hoc 
Group on High Throughput Sequencing, Bioinformatics 
and Computational Genomics (HTS–BCG), held on 13 and 
14 November 2014 (see Bulletin, no . 2015–1, p . 15), and 
encouraged the implementation of the work plan drafted by this 
Group .
The Commission also endorsed the report of the ad hoc Group 
on Biosafety and Biosecurity in Veterinary Laboratories, held on 
26 and 27 January 2015 .
3. Manual of Diagnostic Tests and Vaccines for Terrestrial 
Animals (‘Terrestrial Manual’)
The Commission reviewed and approved the proposals of 
the Enlarged Bureau Group: 18 chapters and the glossary of 
the Terrestrial Manual were approved for circulation to Member 
Countries as the final versions that would be proposed for 
adoption by the Assembly in May 2015 .
4. OFFLU (the Joint OIE–FAO Network of Expertise on Animal 
Influenza) 
An OFFLU strategy meeting was held on 27 and 
28 October 2014 by the combined OFFLU Steering and 
Executive Committees at the OIE Headquarters to discuss and 
recommend strategic directions for OFFLU . In identifying broad 
strategic areas in which OFFLU should be delivering recognised 
outcomes, the group reaffirmed the importance of OFFLU being 
recognised as an authoritative source of information on influenza 
in animals globally and as an effective laboratory network for 
diagnosing influenza in animals . In recognition of significant gaps 
in surveillance for influenza infections in animal populations, 
the meeting agreed that OFFLU should promote and advocate 
for more comprehensive surveillance . In line with developments 
in both the OIE and FAO on the increasingly important role 
of sequence data in animal disease control, OFFLU should 
participate in existing and future international efforts to develop 
more standardised processes for capturing, storing, ensuring 
the quality of and analysing molecular data, together with 
corresponding epidemiological, clinical and other relevant data . 
Current work on the analysis of avian influenza isolates for 
antigenic matching for the purposes of vaccine antigen selection 
in both humans and poultry should be continued, broadened 
and improved, along with the similar work undertaken for equine 
influenza . 
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Scientific Commission for Animal Diseases 
(‘Scientific Commission’)
OIE Headquarters, Paris, 9–13 February 2015
The Scientific Commission met at the OIE Headquarters 
under the chairmanship of its President, Dr Gideon Brückner, 
and addressed, among others, the following issues:
1 . Endorsement of the reports of the OIE ad hoc Groups 
convened for:
− evaluation of the foot and mouth disease (FMD) status 
of Member Countries and revision of the amended Terrestrial 
Animal Health Code (Terrestrial Code) chapter on FMD 
− evaluation of the contagious bovine pleuropneumonia 
status of Member Countries
− evaluation of the classical swine fever status of Member 
Countries
− evaluation of the bovine spongiform encephalopathy 
(BSE) risk status of Member Countries 
− evaluation of the peste des petits ruminants (PPR) status 
of Member Countries
− evaluation of the African horse sickness disease status of 
Member Countries 
− developing a global database on the use of antimicrobial 
agents in animals and the revision of the relevant amended 
Terrestrial Code chapters
− revision of the notification of animal diseases procedure 
and of the disease-listing criteria for pathogenic agents .
2. Endorsement of the report of the Wildlife Working Group.
3 . Comments from Member Countries on the new and 
amended draft chapters of the Terrestrial Code on:
− high health status horses, including the draft model 
veterinary certificate for the international movement for not 
more than 90 days of a high-health, high-performance (HHP) 
horse for competitions or races
− porcine respiratory and reproductive syndrome
− glanders .
4 . Liaison with the Biological Standards Commission on 
issues raised during previous Scientific Commission meetings 
on the diagnostic strategies and proposed amendments of the 
Terrestrial Manual .
5 . Evaluation of the request of a Member Country to be 
designated as a Collaborating Centre for Training Veterinary 
Officials and Diagnosing Infectious Animal Diseases and 
Zoonosis in Tropical Africa .
Activities of the Scientific and Technical Department
6 . Evaluation of the twinning project proposal between the 
USDA–APHIS1–Veterinary Services (USA) and the Department of 
Agriculture, Forestry and Fisheries (South Africa), in partnership 
with the Epidemiology Unit of the Faculty of Veterinary Science, 
University of Pretoria, South Africa .
7 . A review of the outcomes of the OIE expert missions 
conducted since September 2014 and discussion on the expert 
missions scheduled for 2015 and 2016 .
8 . Prioritisation of the future work of the Scientific 
Commission, including the new planned Ad hoc Groups .
The Scientific Commission was updated on specific disease 
issues, such as the procedure for designating holding facilities 
for material containing rinderpest virus and on the state of play 
of the Global Control Strategy for FMD, including the post-
vaccination monitoring guidelines, and of the Global Control 
Strategy for PPR . The Commission was informed on the main 
outcomes of scientific meetings relevant to OIE activities and on 
progress in organising the OIE Global Conference on Biological 
Threat Reduction (30 June – 2 July 2015) and the Global 
Conference on Rabies (December 2015) .
Additionally, the Scientific Commission and the Terrestrial 
Animal Health Standards Commission held a joint meeting 
chaired by the OIE Deputy Director General to coordinate the 
working programmes of both Commissions . Several important 
cross-cutting items were discussed, including the finalisation 
of the amended chapter on FMD; the progression of the 
development of Chapter 4 .16 . for the high health status 
horse subpopulation movements for international equestrian 
competitions and the model certificate; the progress of work 
on antimicrobial resistance; and the impact of atypical BSE 
on official status recognition . Both Commissions emphasised 
the importance of documenting Commission decisions when 
communicating with Member Countries .
1 USDA–APHIS: United States Department of Agriculture – Animal and Plant Health 
Inspection Service
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Ad hoc Groups
Evaluation of African horse sickness (AHS) 
status of Member Countries
OIE Headquarters, Paris, 14–15 January 2015
The Group evaluated two applications for freedom from AHS 
in accordance with the Terrestrial Code, one for AHS-free country 
status and the other for an AHS-free zone .
The Group was also informed of the status of harmonisation 
of the Terrestrial Code chapters on bluetongue (Chapter 8 .3 .), 
AHS (Chapter 12 .1 .) and epizootic haemorrhagic disease (draft 
chapter), and considered additional comments from two Member 
Countries on the AHS chapter, as tasked by the Scientific 
Commission . 
Biosafety and Biosecurity in Veterinary 
Laboratories
OIE Headquarters, Paris, 26–27 January 2015
Although the 180 Member Countries adopted Terrestrial 
Manual Chapter 1 .1 .3a ., ‘Standard for managing biorisk in the 
veterinary laboratory and animal facilities’, at the OIE General 
Session in May 2014, some Member Countries expressed 
concerns about the chapter’s approach to biosafety and 
biosecurity in veterinary laboratories, based only on a biological 
risk analysis .
The Group took note of these comments and decided to 
reassess the information and approaches in Chapters 1 .1 .3 ., 
‘Biosafety and biosecurity in the veterinary diagnostic 
microbiology laboratory and animal facilities’, and 1 .1 .3a ., for 
the purposes of developing an approach that would meet the 
requirements of Member Countries and also realistically deliver 
those standards for the management of biological risks associated 
with laboratories and animal facilities needed by the international 
community .
The Group merged the current Chapters 1 .1 .3 . and 1 .1 .3a . 
of the Terrestrial Manual, and developed a new Chapter 1 .1 .3 ., 
‘Biosafety and biosecurity: standard for managing biological risk 
in veterinary laboratory and animal facilities’ .
Foot and Mouth Disease (FMD)
OIE Headquarters, Paris, 27–28 January 2015
The Group finalised the evaluation of three dossiers from 
Member Countries for the recognition of an FMD-free zone and 
for the endorsement of official FMD control programmes . 
The Group was also asked to conduct an overall review of the 
revised version of the new chapter on FMD in the Terrestrial Code 
and Member Countries’ comments . 
International Horse Movement  
for Equestrian Sport
OIE Headquarters, Paris, 3–5 March 2015
The Group met for the fifth and last time . It was informed of 
Member Countries’ comments received by the Terrestrial Animal 
Health Standards Commission at its February meeting (see 
next page) on the draft revised Terrestrial Code, Chapter 4 .16 ., 
and on the draft model high-health, high-performance (HHP) 
health certificate . The Group discussed the supporting guidance 
documents for the practical implementation of the HHP concept 
(biosecurity guidelines, management guidelines) and for the 
establishment of equine-disease-free zones (EDFZ) . It was agreed 
that further expert sub-group meetings would be needed to 
finalise the HHP guidelines .
The Group was also updated on the progress made with 
this project since its last meeting in June 2014 . It approved a 
2015–2019 work plan, co-funded by the Federation Equestre 
Internationale (FEI) and the International Federation of 
Horseracing Authorities (IFHA), which includes the development 
of joint OIE–industry communication activities to promote the 
HHP initiative, as well as funding for research programmes on 
the prevention and diagnosis of priority diseases .
Activities of the Scientific and Technical Department
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Activities of the International Trade Department
Summaries of the OIE Specialist Commission,  
Working Group and Ad hoc Group meetings 
January to March 2015 
Ad hoc Groups
Disaster management and risk reduction  
in relation to animal health and welfare  
and veterinary public health
OIE Headquarters, Paris, 27–29 January 2015
The Group, chaired by Dr Gary Vroegindewey, thoroughly 
discussed the report of the first meeting and finalised the 
draft Guidelines on disaster management and risk reduction 
in relation to animal health and welfare and veterinary public 
health (Guidelines for National Veterinary Services), and also 
developed some guiding principles for the OIE in this field, 
as it engages with this new area of work . The draft guidelines 
were presented for Member Countries’ consideration in the 
report of the February 2015 meeting of the Terrestrial Animal 
Health Standards Commission (‘the Code Commission’) . The 
Group also drew up a proposed strategy to facilitate the use of 
the guidelines by Veterinary Services and their partners .
A final meeting of the Group, if needed, will be held after 
the September 2015 meeting of the Code Commission .
Susceptibility of crustacean species to 
infection with OIE-listed diseases 
OIE Headquarters, Paris, 10–12 February 2015
The Group held its first meeting from 10 to 12 February 
2015 . This was convened to review the list of species 
susceptible to infection with OIE-listed crustacean diseases, 
in accordance with the recently adopted new Aquatic Animal 
Health Code Chapter 1 .5 ., ‘Criteria for listing species as 
susceptible to infection with a specific pathogen’ . The Group 
reviewed the relevant scientific literature and developed a 
list of species susceptible to infection with yellow head virus 
to be considered for inclusion in the relevant chapters of the 
Aquatic Animal Health Code and the Manual of Diagnostic 
Tests for Aquatic Animals .
The Group report was sent to the Aquatic Animal Health 
Standards Commission for its consideration at the March 
2015 meeting . 
Specialist Commissions
Terrestrial Animal Health Standards 
Commission (‘Code Commission’)
OIE Headquarters, Paris, 10–19 February 2015
The Terrestrial Animal Health Standards Commission 
reviewed Member Countries’ comments on the texts circulated 
after the Commission meeting in September 2014, together with 
the reports of the OIE ad hoc Groups on ‘Salmonella in cattle’, 
‘Notification of animal diseases and pathogenic agents’ and 
‘Animal welfare and disaster management’; and the report of the 
OIE Working Group on Animal Production Food Safety. 
The Commission also reviewed several new or revised draft 
chapters received from the Scientific Commission for Animal 
Diseases .
The Commission will propose the following new or revised 
chapters for adoption in the Terrestrial Animal Health Code at the 
83rd OIE General Session in May 2015:
− the user’s guide 
− the glossary 
− The evaluation of Veterinary Services 
− Collection and processing of in vivo-derived embryos from 
livestock and equids 
− General obligations related to certification 
− Certification procedures 
− The prevention, detection and control of Salmonella in 
poultry 
− Animal welfare and dairy cattle production systems 
− Animal welfare and broiler chicken production systems 
− Slaughter of animals 
− Infection with epizootic haemorrhagic disease virus 
− Infection with bluetongue virus 
− Infection with Taenia solium 
− Infection with foot and mouth disease virus and 
procedures for self-declaration and official recognition by the OIE 
− Infection with Rift Valley fever virus
− Infection with Brucella abortus, B. melitensis and B. suis 
− Infection with avian influenza viruses 
− The high health status horse subpopulation
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− Bovine spongiform encephalopathy 
− Harmonisation of national antimicrobial resistance 
surveillance and monitoring programmes and risk analysis for 
antimicrobial resistance arising from the use of antimicrobial 
agents in animals .
The Commission also decided to circulate the following 
revised chapters and documents for Member Countries’ 
comments: 
− the glossary 
− notification of diseases, infections and infestations,  
and provision of epidemiological information 
− criteria for the inclusion of diseases, infections and 
infestations in the OIE list 
− infection with African swine fever virus 
− a model veterinary certificate for the international 
movement of not more than 90 days of a high-health, 
high-performance horse for competition or racing
− draft guidelines on disaster management and risk 
reduction in relation to animal health and welfare and veterinary 
public health .
Member Country comments on these texts will be reviewed 
at the Commission’s next meeting in September 2015 .
Aquatic Animal Health Standards 
Commission (‘Aquatic Animals Commission’)
OIE Headquarters, Paris, 2–6 March 2015
The Aquatic Animal Health Standards Commission (Aquatic 
Animals Commission) addressed Member Country comments 
on texts circulated as part of the Commission’s report on its 
September 2014 meeting and the work of the OIE ad hoc 
Groups on ‘Susceptibility of crustacean species to infection with 
OIE-listed diseases’ and ‘Notification of animal diseases and 
pathogenic agents’ .
The Aquatic Animals Commission will propose amended 
texts for adoption in the Aquatic Code at the 83rd General 
Session in May 2015 on: 
− the glossary 
− the user’s guide 
− Diseases listed by the OIE (Chapter 1 .3 .)
− Import risk analysis (Chapter 2 .1 .)
− Recommendations for disinfection of salmonid eggs  
(new Chapter 4 .X .)
− Control of hazards in aquatic animal feed (Chapter 4 .7 .)
− General obligations related to certification (Chapter 5 .1 .)
− Certification procedures (Chapter 5 .2 .)
− Risk analysis for antimicrobial resistance arising from 
the use of antimicrobial agents in aquatic animals (new 
Chapterr 6 .5 .)
− Infection with Batrachochytrium dendrobatidis 
(Chapter 8 .1 .)
− Infection with ranavirus (Chapter 8 .2 .)
− Articles X .X .7 . and X .X .11 . of disease-specific chapters
− Articles 10 .4 .4 . and 10 .4 .6 .
− Infection with Perkinsus olseni (Article 11 .6 .2 .) .
The Aquatic Animals Commission will propose amended 
texts for adoption in the Aquatic Manual at the 83rd General 
Session in May 2015 on: 
− Infectious hypodermal and haematopoietic necrosis 
(Chapter 2 .2 .2 .)
− Necrotising hepatopancreatitis (Chapter 2 .2 .4 .)
− Taura syndrome (Chapter 2 .2 .5 .)
− yellow head disease (Chapter 2 .2 .8 .)
− Infection with Perkinsus olseni (Chapter 2 .4 .7 .) .
The Aquatic Animals Commission also circulated the 
following chapters for Member Countries’ comments in the 
Aquatic Code:
− Notification of diseases and epidemiological information 
(Chapter 1 .1 .)
− Criteria for listing (Chapter 1 .2 .) 
− Infection with yellow head virus (Chapter 9 .2 .)
and the Aquatic Manual:
− Acute hepatopancreatic necrosis disease (new draft 
Chapter X .X .X .) .
The Aquatic Animals Commission discussed the outcomes 
and recommendations of the OIE Global Conference on Aquatic 
Animal Health, held in Ho Chi Minh City, Vietnam, from 20 to 
22 January 2015 (see p . 103) .
The Commission agreed that one of the objectives of the 
conference – to set priorities for the future work of the Aquatic 
Animals Commission – was achieved and noted a number of 
work items that should be considered when formulating the 
Commission’s work plan at its next meeting in September 2015 .
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The OIE is one of the three international standard-setting 
organisations recognised in the WTO Agreement on the 
Application of Sanitary and Phytosanitary Measures (the SPS 
Agreement) . To this end, the OIE provides guidance on the 
use and application of the OIE standards on its website . 
This article concerns a document entitled Devising 
import health measures for animal commodities, which has 
recently been revised and updated to address the adoption of 
the new WTO Trade Facilitation Agreement [1] in 2014.
National Customs Agencies are the leaders in the 
implementation of the new Trade Facilitation Agreement . 
Facilitating safe trade
by using the Terrestrial Animal Health Code to set health measures 
for trade in terrestrial animals and products 
In addition to providing measures for the prevention and control of animal diseases, the OIE sets standards for preventing the spread 
of animal diseases and zoonoses via the international movement of animals and animal products; standards that are central to the 
World Trade Organization (WTO) rules-based framework for trade.
These agencies do not usually have a mandate to safeguard 
health; rather, this is one of the roles of national Veterinary 
Services . The OIE saw a need for guidance on how 
Veterinary Services can contribute to the objectives of the 
WTO Trade Facilitation Agreement without compromising 
health . The OIE document, ‘Facilitating safe trade: how 
to use the Terrestrial Code to set health measures for 
trade in terrestrial animals and products’ [2] provides this 
guidance .
The revised document addresses the goal of facilitating 
safe trade, which involves preventing the introduction and 
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spread of animal diseases and zoonoses while avoiding 
the imposition of unjustified trade barriers . The document 
focuses on the Terrestrial Animal Health Code and three 
commonly traded commodities: beef, pork and poultry 
meat . It provides information on key topics, such as the 
identification of hazards, including the use of the World 
Animal Health Information System (WAHIS). It explains 
how to comply with disciplines included in the SPS 
Agreement, such as harmonisation and regionalisation, 
when setting import measures. With an emphasis on 
practical information, the document includes three tables 
that summarise the Terrestrial Code’s provisions on trade 
in beef, pork and poultry meat .
This document may be useful in training and for 
discussions between national Veterinary Services and 
other government agencies or stakeholders . Together with 
the other guidance provided by the OIE, this document 
is relevant to the negotiation of market access and the 
conduct of import risk analyses . The OIE encourages 
members of the Veterinary Services, especially those 
OIE portal on international standard-setting:
www.oie.int/en/international-standard-setting/overview/
working in import/export, to provide feedback to the OIE 
International Trade Department .
If requested by Member Countries, the OIE will provide 
guidance on commodities other than meat, as well as on 
aquatic animals and their products . 
References
1. World Trade Organization (WTO). – Trade Facilitation Agreement. Available at: www.wto.org/english/tratop_e/tradfa_e/tradfa_e.htm 
(accessed on 21 March 2015) .
2. World Organisation for Animal Health (OIE). – Facilitating safe trade: how to use the Terrestrial Code to set health measures for 
trade in terrestrial animals and products. Available at: www.oie.int/en/international-standard-setting/overview/facilitating-safe-trade/ 
(accessed on 21 March 2015) .
Facilitating safe trade: how to use the Terrestrial Code to set health measures for trade in terrestrial animals and products:
www.oie.int/en/international-standard-setting/overview/facilitating-safe-trade/
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Staff movements
Africa
regional activities
Arrival
OIE Regional Representation for Africa
Dr Karim Tounkara   
Dr Karim Tounkara was born in Bamako, Mali. He graduated 
as a DVM from the Moscow Veterinary Academy (Former Soviet 
Union) in 1978, and obtained a PhD in microbiology in 1982. 
He also obtained certificates in epidemiology, virology, serology 
and molecular biology from the University of Reading (United 
Kingdom), Washington State University (United States of America) 
and the International Atomic Energy Agency (IAEA).
Dr Tounkara has more than 30 years’ working experience at 
the national and international level in the field of animal disease 
control: he was Head of Diagnosis and Research at the Central 
Veterinary Laboratory of Bamako, and has been a consultant for 
the FAO and IAEA on many assignments in Africa and Asia. He 
worked at the IAEA as an international consultant and member 
of staff for five years (2001–2006). He then worked at the African 
Union – Interafrican Bureau for Animal Resources (AU-IBAR) as 
a Regional Expert in Animal Disease Control, on the Pan African 
Programme for the Control of Epizootics (PACE) and Quality 
Assurance for Southern African Development Community (SADC) 
countries. He provided technical support to the Veterinary Services 
of many AU Member States in the process of eradicating rinderpest.
In June 2006, Dr Tounkara joined the African Union 
as a Director of the Pan African Veterinary Vaccine Centre 
(AU-PANVAC), in Debre Zeit, Ethiopia, within the Department 
of Rural Economy and Agriculture. During his tenure in office, 
AU-PANVAC became an OIE Collaborating Centre in Quality 
Control of Veterinary Vaccine. Dr Tounkara successfully managed 
the OIE sub-grant to AU-PANVAC to strengthen the capacity of the 
Centre to guarantee the quality of vaccines against peste des petits 
ruminants in Africa. He left the African Union in November 2014 
and joined the OIE as Deputy Regional Representative for Africa in 
early 2015.
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Departure
OIE Regional 
Representation for Asia 
and the Pacific 
Dr Chantanee Buranathai   
Dr Chantanee Buranathai, 
who has been working as a 
Regional Project Coordinator at 
the OIE Regional Representation 
for Asia and the Pacific, Tokyo, left the OIE at the 
end of January 2015, having completed her four-year 
secondment from the Ministry of Agriculture and 
Cooperatives, Royal Government of Thailand.
Dr Buranathai first joined the OIE in February 2011, 
as Officer in Charge of the FAO/OIE Regional Steering 
Committee of GF-TADs1 for Asia and the Pacific, 
attached to the Permanent Secretariat. She also worked 
on the implementation of the OIE/Japan Trust Fund 
Project on Foot and Mouth Disease Control in Asia, a 
project which established an FMD Roadmap for East 
Asia and saw the implementation of FMD field studies 
and vaccination campaigns in Laos, Myanmar and 
Mongolia.
Dr Buranathai has returned to Thailand to 
resume her position in the Department of Livestock 
Development in Bangkok.
The OIE wishes her all the best in her new 
endeavours.
Asia – Pacific
1 GF-TADs: FAO/OIE Global Framework for the Progressive Control of 
Transboundary Animal Diseases
Meetings
Seminar on the development of  
public–private partnerships to support 
Veterinary Services  
Rabat, Morocco, 16 February 2015
A one-day seminar for African National Delegates to 
the OIE on the development of public–private partnerships 
to support Veterinary Services was held on 16 February 
2015 in Rabat . It was held back to back with the 
21st Conference of the OIE Regional Commission for 
Africa, which took place at the same venue .
The seminar was attended by 88 participants, 
comprising OIE Delegates from 36 Member Countries 
and senior officials from six international and regional 
organisations, including the Interafrican Bureau for 
Animal Resources of the African Union (AU–IBAR), the 
Intergovernmental Authority on Development (IGAD) 
and the West African Economic and Monetary Union 
(WAEMU). It was co-financed by the Bill and Melinda 
Gates Foundation and facilitated by OIE experts . 
In its commitment to assisting its Members to meet 
the intergovernmental standards for national Veterinary 
Services as embodied in the OIE Terrestrial Animal 
Health Code and Aquatic Animal Health Code, and 
recognising that government Veterinary Services face 
enormous challenges in meeting their mandates due to 
declining budgets, the OIE organised this seminar to 
promote public–private partnerships between official 
Veterinary Services and organisations and actors in the 
private sector; most notably, veterinarians and veterinary 
para-professionals in private practice .
The seminar was divided into four sessions, covering: 
− intergovernmental standards on the quality and 
responsibilities of Veterinary Services
− an overview of the OIE’s services to Members 
through the Performance of Veterinary Services (PVS) 
Pathway
− information on and examples of partnerships 
between official Veterinary Services and private 
veterinarians
− public–private partnerships involving Veterinary 
Services and livestock owners working together .
Africa
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21st Conference of the OIE Regional Commission for Africa
Rabat, Morocco, 17–20 February 2015
Several case studies were presented 
to display examples of success stories in 
the context of public–private partnership . 
For example, the Delegate of Uganda 
described his country’s participation 
in the Veterinary Legislation Support 
Programme (VLSP) and how this has 
led to the drafting of new legislation 
to establish a veterinary statutory body 
for the regulation of veterinarians and 
veterinary para-professionals in Uganda 
as a basis for establishing animal 
health mandates . The Delegate of 
Morocco reported his country’s success 
in dramatically improving vaccination 
coverage for national disease control 
programmes in small ruminants through 
the use of private veterinary practitioners 
under animal health mandate contracts . 
Outside Africa, Afghanistan was the 
subject of a case study by Dr David 
Sherman in which the establishment of 
a national network of community-based 
veterinary para-professionals, working 
in the private sector to provide basic 
veterinary services to farmers, gradually 
led to the cooperation of these same 
veterinary para-professionals with the 
government Veterinary Services through 
animal health mandates to provide 
disease reporting, disease surveillance 
and disease control activities . The 
Afghanistan story provided an interesting 
model for the re-establishment of 
veterinary services in post-conflict 
situations, which also exist within Africa .
Participants understood the 
importance of public–private 
partnerships to more effectively and 
efficiently meet their domestic and 
global obligations for animal and human 
health . The main challenge arising 
from this is the fact that, to have a 
productive and successful public–
private partnership in the veterinary 
domain, any official veterinary services 
provided on behalf of the government 
by the private sector must be properly 
regulated . This requires the development 
and enactment of quality veterinary 
legislation that allows for the delegation 
of official responsibilities, and which 
sets clear, enforceable standards for 
those performing such responsibilities . 
To address this concern, the OIE has 
developed the PVS Pathway and the 
VLSP to build capacity within countries 
to prepare meaningful legislation, 
establish and manage effective veterinary 
statutory bodies, and enforce standards 
of practice .
On the kind invitation of the government of Morocco, the 
21st Conference of the OIE Regional Commission for Africa 
was held in Rabat from 17 to 20 February 2015 .
A total of 120 participants, comprising OIE Delegates 
and/or nominees of 36 Member Countries, three observer 
countries and senior officers from 12 regional and 
international organisations, attended the conference . 
The opening ceremony was chaired by Dr Abderrahman 
El Abrak, Delegate of Morocco to the OIE, accompanied by 
Mr Ahmed Bentouhami, Director of the Moroccan National 
Office for Food Safety (ONSSA), who gave a speech on 
behalf of Mr Aziz Akhannouch, Minister of Agriculture and 
Marine Fisheries of Morocco . Participants were welcomed 
by Dr Marosi Molomo, President of the OIE Regional 
Commission for Africa; Dr yacouba Samaké, OIE Regional 
Representative for Africa; Dr Karin Schwabenbauer, President 
of the OIE World Assembly of Delegates;  
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Dr Awilo Ochieng-Pernet, President of the Codex 
Alimentarius Commission; and Dr Bernard Vallat, Director 
General of the OIE, while also in attendance were 
Dr Monique Eloit, OIE Deputy Director General; Dr Gideon 
Brückner, President of the OIE Scientific Commission for 
Animal Diseases; and Dr Franck Berthe, President of the 
OIE Aquatic Animal Health Standards Commission . 
The conference had a very full agenda which made for 
some fruitful discussion .
Two Technical Items of interest for the region were 
presented and lead to the adoption of two recommendations 
that will be submitted to the World Assembly of Delegates 
of the OIE for approval in May 2015 . Once these have 
been endorsed by the Assembly, they will provide important 
guidelines for the 54 Member Countries of the OIE Regional 
Commission for Africa .
Technical Item I, based on the answers of Member 
Countries to a questionnaire, addressed the ‘Impact of 
animal diseases on animal productivity and public health in 
Africa’, and was presented by Dr Delia Grace, Programme 
Manager, Food Safety and Zoonoses, at the International 
Livestock Research Institute (ILRI) .
Technical item II concerned the ‘Cross-border 
movements of animals and animal products and their 
relevance to the epidemiology of animal diseases in Africa’, 
and was presented by Prof . Mohammed Bouslikhane from 
the Institute of Agronomy and Veterinary Medicine  
Hassan II from Rabat .
The agenda also covered, among other items:
− the OIE’s activities and vision for the 
21st Century,
− challenges for animal health from antimicrobial 
resistance,
− OIE perspectives on tsetse-transmitted 
trypanosomosis,
− the One Health concept: OIE approaches and 
collaboration with FAO and WHO, particularly towards 
rabies control,
− lessons learned from the Regional Animal 
Welfare Strategy (RAWS) in other regions, and 
− the animal health situation of Member Countries 
in the region .
Dr Monique Eloit, OIE Deputy Director General, 
in collaboration with Dr Botlhe Michael Modisane, 
Delegate of South Africa and Vice-President of the OIE 
World Assembly of Delegates, presented a review of 
regional perspectives on the OIE Sixth Strategic Plan 
(2016–2020), with particular emphasis on the main 
challenges facing the OIE, such as sanitary concerns, 
and societal and environmental issues . She stressed 
the need for modernised governance of the OIE to 
ensure that the Organisation’s statutory organs were 
ready to face these challenges .
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A workshop was held in Panama 
City, from 10 to 12 March 2015, to 
train Veterinary Service officials from 
OIE Member Countries in the Americas 
on current procedures for obtaining OIE 
official recognition of their classical 
swine fever and bovine spongiform 
encephalopathy status . The event was 
made possible by the financial support 
of the Spanish Agency for International 
Development Cooperation (AECID) .
A further aim was to improve the 
quality of applications for OIE official 
recognition of the disease status of 
Member Countries in the Americas, to 
help avoid the most common difficulties 
and problems observed in preparing 
applications .
The workshop was attended by 
45 Veterinary Service officials from 
24 countries in charge of prevention 
and/or control programmes for the two 
diseases, including Dr Marvin Vega, 
representing the Delegate of Panama; 
Dr Mark Trotman, Delegate of Barbados; 
and Dr Nimia Lissette Gómez, 
Delegate of the Dominican Republic . 
The workshop was also attended 
by representatives of the Food and 
Agriculture Organization of the United 
Nations (FAO), Inter-American Institute 
for Cooperation on Agriculture (IICA) 
and the International Organisation for 
Plant Protection and Animal Health 
(Organismo Internacional Regional de 
Sanidad Agropecuaria – OIRSA), who 
shared their views about opportunities 
for coordinating activities in the 
Americas .
Participants were divided into two 
groups, one for each disease . Group 
activities included an analysis of the 
recent epidemiological situation, as well 
as a review of disease status recognition 
procedures and the relevant OIE 
international standards . 
Each group discussed a sample 
case study of a fictitious application for 
OIE official recognition, analysing the 
critical points and the most common 
mistakes made when preparing these 
applications .
The OIE presented real-life 
experiences of country disease status 
recognition . Dr Germán Cáceres Garrido, 
from Spain’s Ministry of Agriculture, 
Food and Environment (MAGRAMA), 
pointed to the support his country had 
provided, adding that the initiative 
would help to improve the region’s 
animal health status .
Dr John Pasick and Dr Javier 
Blanco Viera expressed the views of OIE 
Reference Laboratories, stressing the 
importance of the interactions between 
Veterinary Service laboratories and the 
laboratory twinning projects offered by 
the OIE .
As the workshop coincided with 
the meeting of the Bureau of the OIE 
Regional Commission for the Americas, 
Delegates attending that meeting were 
able to participate in the closing of the 
workshop . Dr Guilherme Figueiredo 
Marques, Delegate of Brazil to the OIE 
and President of the Commission, said 
that the exercise would do much to 
help countries to secure OIE official 
recognition for their disease status .
Americas
Workshop on the OIE procedure for official recognition of country status  
with respect to classical swine fever and bovine spongiform encephalopathy 
Panama City, Panama, 10–12 March 2015
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The 12th Meeting of the Upper Mekong Working Group on 
Foot and Mouth Disease (FMD) Zoning and Animal Movement 
Management (UMWG) was organised from 4 to 6 February 
2015 in Vinh Phuc, Vietnam, by the OIE Sub-Regional 
Representation for South-East Asia (OIE SRR–SEA), in 
cooperation with the Vietnamese Department of Animal Health . 
Twenty-four representatives (17 men and 7 women) from the 
Veterinary Services of the People’s Republic of China, Laos, 
Myanmar, Thailand and Vietnam were in attendance, as well as 
partners from the FAO Regional Office for Asia and the Pacific 
(FAO–RAP), and the OIE Regional Representation for Asia and 
the Pacific (OIE RR–AP) . The meeting was also attended by 
observers from the Department of Animal Health of Vietnam, 
OIE Special Advisor Dr Gardner Murray, and Dr Stéphane 
Forman of the World Bank Group.
The 12th UMWG meeting provided a forum for Member 
Countries and partners to share experiences and information on 
the current status of FMD in the region, and to provide updates 
on past and continuing initiatives for prevention and control . 
In particular, participants provided updates on FMD control 
activities in the Upper Mekong Zone, with inputs from the OIE 
RR–AP and the FAO–RAP on activities in the region . Technical 
presentations reviewed the importance of animal movement 
management and monitoring vaccination programmes, and 
highlighted the ways in which participatory epidemiology (PE) 
could be used to support these endeavours . Plenary discussions 
focused on the progress made on recommendations from 
previous meetings, and refined future recommendations for 
12th meeting of the Upper Mekong Working Group on FMD Zoning  
and Animal Movement Management 
Vinh Phuc, Vietnam, 4–6 February 2015
Asia – Pacific
Group photo at the Huu Nghi International Border Gate
priority action for the South-East Asia and China Foot-and-
Mouth Disease Campaign (SEACFMD) and Member Countries 
over the coming year . 
Facilitated workshops were conducted on the first 
and second days, starting with discussions of potential 
applications of PE to improve FMD control in the region . 
Members outlined current practices for animal movement 
management and vaccination and post-vaccination 
monitoring, and recorded country-specific benchmarks . These 
workshops in turn provided an opportunity for participants to 
suggest and develop regionally relevant strategies to improve 
FMD investigations, movement management and vaccination 
monitoring in the Upper Mekong Zone . 
A field trip on day three gave participants the chance to 
view the facilities and management procedures for cross-
border animal movement at the Huu Nghi International Border 
Gate in Lang Son, Vietnam .
Over all, the 12th UMWG meeting enabled participants to 
share information, interact, network, plan together and discuss 
options and complementarities for FMD plans and activities . 
Key recommendations included an agreement to develop 
cross-border animal movement guidelines and conduct pilot 
PE outbreak investigation studies with a view to developing PE 
guidelines for the whole region . The enthusiastic discussions, 
resulting recommendations and positive feedback on the 
event pointed to a successful step forward on the way to FMD 
control in the Upper Mekong Zone .
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The Ninth Meeting of the Regional 
Animal Welfare Strategy (RAWS) – 
Asia, the Far East and Oceania (AFEO) 
Coordination Group (CG) – was held in 
Kuala Lumpur on 26 and 27 March 
2015 to:
− allow members to report on and 
review the progress of RAWS
− examine the nature and format of 
the current Action Plan and identify key 
developments since RAWS CG 8  
(see Bulletin, no . 2015-1, p . 35)
− discuss future governance and 
organisational options for RAWS
− recommend small project/meeting 
options to support RAWS, should funding 
be available .
The RAWS CG reported significant 
and continuing progress on animal 
welfare, made by those countries and 
organisations that are members of the 
CG, as well as the observer countries 
and organisations that attended the 
meeting . As requested in past meetings, 
it is important that Member Countries of 
9th meeting of the Regional Animal Welfare Strategy Coordination Group 
Kuala Lumpur, Malaysia, 26–27 March 2015
the OIE provide short annual summaries 
of animal welfare activities so that 
the implementation of RAWS can be 
assessed . 
The RAWS CG updated the 
Action Plan and made a number of 
recommendations on its nature, format 
and modus operandi, to improve clarity 
as well as regional coordination . This will 
provide useful support documentation for 
future RAWS arrangements. Given the 
importance of this issue, a small drafting 
group comprising the OIE, Malaysia 
and the non-governmental organisation, 
World Animal Protection, will revise the 
Action Plan and provide advice on how 
the programme can be improved .
The RAWS CG reinforced the 
importance of RAWS and the need to 
have a system in place to provide advice 
and to help drive its implementation . 
It was decided that the OIE Regional 
Commission for Asia, the Far East and 
Oceania should assume responsibility 
for ongoing RAWS activities and that an 
advisory group or equivalent 
should also be established to 
provide recommendations .  
If funds became available,  
it was agreed that a workshop 
should be held for selected 
participants to consider 
future and transitional 
arrangements for RAWS.  
A number of potential small 
projects were also identified 
to help support RAWS.
Dr Gardner Murray, 
Chairman of the RAWS CG, 
pointed out that the animal 
welfare strategy was an innovative 
and significant global initiative, which 
provided a solid framework for the 
implementation of OIE and other relevant 
animal welfare standards . He thanked 
all those who have been involved over 
the years in developing the Strategy 
and providing advice to the Regional 
Commission and the OIE on RAWS’ 
progress . He also thanked the Australian 
Government for funding the RAWS 
Initiative, a model that has been used 
in other OIE regions to improve animal 
welfare .
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The OIE Scientific and Technical Department, 
the Regional Representation in Moscow and the OIE 
Sub-Regional Foot-and-Mouth-Disease (FMD) Coordination 
Unit Office in Astana, with the support of the Kazakh 
government, organised a Workshop on the OIE Procedure for 
Official Recognition of Member Countries’ Disease Status and 
for the Endorsement of Official National Control Programmes 
with regard to FMD, in Astana, Kazakhstan, from 26 to 
27 March 2015 .
The workshop was attended by 22 participants from 
11 countries and 31 observers from the host country, 
Kazakhstan . There were more than 53 attendees in total, and 
the workshop was publicised by the media of Kazakhstan .
Prof . Kazimieras Lukauskas, OIE Regional Representative 
in Moscow, opened the workshop by emphasising the 
importance of implementing the OIE procedure for the official 
recognition of Member Countries’ disease status and for the 
endorsement of official national control programmes . He 
stressed that the OIE procedure for the official recognition of 
a Member Country’s freedom from, or risk status in relation 
to, certain diseases is of growing interest to many countries in 
the world, particularly in the case of FMD in this region .
Ms Gulmira Issayeva, Vice-Minister of Agriculture of 
Kazakhstan, welcomed participants on behalf of her country 
and affirmed Kazakhstan’s willingness to support and 
contribute to future OIE activities . 
Workshop on the OIE procedure for the official recognition of Member Countries’ disease status 
and for the endorsement of their official national control programmes with regard to FMD  
Astana, Kazakhstan, 26–27 March 2015
Left to right: Ms Gulmira Issayeva (Kazakhstan), Prof. Kazimieras Lukauskas  
(OIE Moscow), Dr Min Kyung Park (OIE Paris), Dr Laure Weber-Vintzel (OIE Paris), 
Dr Mereke Taitubayev (OIE Astana)
Europe
General presentations 
were given on the OIE, with 
an emphasis on Veterinary 
Services and on development, 
as well as on the current 
FMD situation . The Head of 
the OIE Sub-Regional FMD 
Coordination Unit Office in Astana, Dr Mereke Taitubayev, 
introduced the role of this new Office and participants were 
updated on the OIE PVS Pathway status . Dr Samat Tyulegenov, 
Delegate of Kazakhstan to the OIE, shared his country’s 
experiences and the efforts being made to control FMD .
Dr Laure Weber-Vintzel, Officer in Charge of the Recognition 
of Countries’ Status, together with Dr Min Kyung Park from the 
OIE Scientific and Technical Department, presented 
− the ‘standard operating procedures’ for official 
recognition of disease and for the endorsement of official control 
programmes; 
− the general requirements of the FMD Terrestrial Animal 
Health Code (‘Terrestrial Code’) chapter for official recognition 
and endorsement of a national official control programme; and 
− a description of the questionnaire(s) and feedback on 
the most common shortcomings found by the evaluating ad hoc 
groups in dossiers submitted so far . 
Prof . Trevor Drew, an OIE Expert, presented the Terrestrial 
Code requirements for FMD surveillance and zoning . 
Significant time was allocated for the participants to work in 
groups on practical exercises . During this session, participants 
worked on quizzes covering the important points from the 
topics presented, and put together fictitious dossiers for official 
recognition of FMD-free status and for the endorsement of 
a national control programme for FMD . At the end of the 
workshop, time was allowed to share opinions and suggestions .
On the whole, participants expressed their satisfaction 
with the workshop and some countries noted their interest in 
applying for future OIE endorsement of their national official 
control programme for FMD . Some participants also expressed 
interest in receiving additional training focusing on specific 
technical points involved in structuring a national control 
programme . There was also discussion on the need for a regional 
vaccine bank . 
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Belarus
Dr Vasili Pivavar
Deputy Minister, Chief of the Department of 
Veterinary and Food Surveillance, Chief State 
Veterinary Officer of the Republic of Belarus, 
Department of Veterinary and Food Surveillance, 
Ministry of Agriculture and Food
1 November 2014
Albania
Dr Edi Fero
Director, Veterinary Directorate, Ministry of 
Agriculture, Rural Development and Water 
Administration
1 January 2015
Cyprus
Dr Penelope Stylianou
Acting Director, Veterinary Services, Ministry of 
Agriculture, Natural Resources and Environment
2 February 2015
Ghana
Dr Ben Aniwa
Deputy Director, Veterinary Services Department, 
Ministry of Food and Agriculture
17 February 2015
Oman
Dr Hadi Mohsin Al-Lawati
Director for Animal Health Department, Ministry 
of Agriculture and Fisheries
27 February 2015
Laos
Dr Syseng Khounsy
Deputy Director General, Department 
of Livestock and Fisheries, Ministry of 
Agriculture and Forestry
28 February 2015
India
Mr Ashok Kumar Angurana
Secretary, Department of Animal 
Husbandry, Dairying and Fisheries, 
Ministry of Agriculture
5 March 2015
Gambia
Dr Duto Sainy Fofana
Acting Director General, Department 
of Livestock Services, Ministry of 
Agriculture
30 March 2015
Georgia
Mr Zaza Dolidze
Directeur de l’Agence nationale de 
l’alimentation, Ministère de l’agriculture
31 March 2015
Chile
Dr José Ignacio Gómez Meza
Jefe de la División de Protección 
Pecuaria del Servicio Agricola y 
Ganadero (SAG), Ministerio de 
Agricultura
1 April 2015
Turkmenistan
Mr Dovlet Nuriyev
Acting Chief Veterinary Officer, 
Veterinarian Union of Turkmenistan
official acts
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Appointment of permanent Delegates
7 April 2015
Moldova
Dr Vitalie Caraus
Head, Sanitary and Veterinary Surveillance 
Division, National Food Safety Agency
9 April 2015
Romania
Dr Marius Grigore
Director, National Sanitary Veterinary 
and Food Safety Authority, Ministry of 
Agriculture and Food
13 April 2015
Somalia
Dr Ahmed Gedi
Director of Animal Health, Ministry of 
Livestock, Forestry and Range
23 April 2015
Bahrain
Dr Abdalla Fadlalla Azrug
Animal Health Director, Ministry of 
Works, Municipalities Affairs and Urban 
Planning
1 May 2015
France
Dr Loïc Evain
Inspecteur général de la santé publique 
vétérinaire, Directeur général adjoint 
de l’alimentation et CVO, Ministère de 
l’agriculture, de l’agroalimentaire et de la 
forêt
5 May 2015
Tajikistan
Dr Sherali Vazirov
Chief of the State Veterinary Inspection 
Service, Ministry of Agriculture
6 May 2015
Lebanon
Dr Elias Ibrahim
Director of Animal Resources, Ministry 
of Agriculture
12 May 2015
Trinidad and Tobago
Dr Simone Titus
Director, Animal Production and Health 
Division, Ministry of Food Production
13 May 2015
Bulgaria
Dr Damyan Iliev
Chief Veterinary Officer & Deputy 
Executive Director of the Bulgarian 
Food Safety Agency, Ministry of 
Agriculture and Food
1 June 2015
Finland
Dr Taina Aaltonen
Chief Veterinary Officer and Deputy 
Director General in the Ministry of 
Agriculture and Forestry
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PVS Evaluation missions
State of Play – as at 22 June 2015
OIE Region OIE Members
Requests 
received
Missions 
completed
Reports available  
for distribution to donors 
and partners
Africa 54 53 51 42
Americas 29 25 23 19
Asia and the Pacific 32 24 22 11
Europe 53 18 17 11
Middle East 12 13 11 6
Total 180 133 124 89
PVS Evaluation mission requests
• Africa (53)
Algeria, Angola, Benin, Botswana, Burkina Faso, 
Burundi, Cameroon, Cape Verde, Central African 
Rep., Chad, Comoros, Rep. of the Congo,  
Dem. Rep. of the Congo, Côte d’Ivoire, Djibouti, 
Egypt, Equatorial Guinea, Eritrea, Ethiopia, Gabon, 
Gambia, Ghana, Guinea, Guinea-Bissau, Kenya, 
Lesotho, Liberia, Libya, Madagascar, Malawi, Mali, 
Mauritania, Mauritius, Morocco, Mozambique, 
Namibia, Niger, Nigeria, Rwanda, São Tomé and 
Principe, Senegal, Seychelles, Sierra Leone, Somalia, 
South Africa, Sudan, Swaziland, Tanzania, Togo, 
Tunisia, Uganda, Zambia, Zimbabwe.
• Americas (25) 
Argentina, Barbados, Belize, Bolivia, Brazil, Chile, 
Colombia, Costa Rica, Dominican Rep., Ecuador, 
El Salvador, Guatemala, Guyana, Haiti, Honduras, 
Jamaica, Mexico, Nicaragua, Panama, Paraguay, 
Peru, Suriname, Trinidad and Tobago, Uruguay, 
Venezuela.
• Asia-Pacific (24)
Australia, Bangladesh, Bhutan, Brunei, Cambodia, 
Fiji, Indonesia, Iran, Dem. People’s Rep. of Korea, 
Laos, Malaysia, Maldives, Mongolia, Myanmar, 
Nepal, New Caledonia, Pakistan, Papua New Guinea, 
Philippines, Sri Lanka, Thailand, Timor Leste, 
Vanuatu, Vietnam.
• Europe (18)
Albania, Armenia, Azerbaijan, Bosnia and 
Herzegovina, Bulgaria, Georgia, Iceland, Israel, 
Kazakhstan, Kyrgyzstan, Former Yug. Rep. of 
Macedonia, Romania, Serbia, Tajikistan, Turkey, 
Turkmenistan, Ukraine, Uzbekistan.   
• Middle East (13)
Afghanistan, Bahrain, Iraq, Jordan, Kuwait, 
Lebanon, Oman, Palestinian N.A. (observer), Qatar, 
Saudi Arabia, Syria, United Arab Emirates, Yemen.
In red: completed missions
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Veterinary Services
PVS Gap Analysis missions
State of Play – as at 22 June 2015
OIE Region OIE Members
Requests 
received
Missions  
completed
Reports available for 
distribution to donors 
and partners
Africa 54 46 43 26
Americas 29 16 12 9
Asia and the Pacific 32 18 13 7
Europe 53 9 8 3
Middle East 12 8 4 0
Total 180 97 80 45
PVS Gap Analysis mission requests
• Africa (46)
Algeria, Angola, Benin, Botswana, 
Burkina Faso, Burundi, Cameroon, 
Central African (Rep.), Chad, Comoros, 
Dem. Rep. of the Congo, Côte d’Ivoire, 
Djibouti, Egypt, Eritrea, Ethiopia, 
Gabon, Gambia, Ghana, Guinea, 
Guinea-Bissau, Kenya, Lesotho, 
Libya, Madagascar, Mali, Mauritania, 
Mauritius, Morocco, Mozambique, 
Namibia, Niger, Nigeria, Rwanda, 
Senegal, Seychelles,  
Sierra Leone, South Africa, Sudan, 
Swaziland, Tanzania, Togo, Tunisia, 
Uganda, Zambia, Zimbabwe.
• Americas (16)
Barbados, Belize, Bolivia, Brazil,  
Costa Rica, Dominican Republic, 
Ecuador,  El Salvador, Guatemala, 
Haiti, Honduras, Jamaica, Nicaragua, 
Panama, Paraguay, Suriname.
• Asia-Pacific (18)
Bangladesh, Bhutan, Brunei, 
Cambodia, Fiji, Indonesia, Iran,  
Dem. People’s Rep. of Korea, Laos, 
Mongolia, Myanmar, Nepal, Philippines,   
Sri Lanka, Thailand, Timor Leste, 
Vanuatu, Vietnam.
• Europe (9)
Armenia, Azerbaijan, Bosnia and 
Herzegovina, Israel,Kazakhstan, 
Kyrgyzstan, Serbia, Tajikistan, Turkey.
• Middle East  (8)
Afghanistan, Kuwait, Lebanon, Oman, 
Palestinian N.A. (observer), Syria, 
United Arab Emirates, Yemen.
In red: completed missions
Legislation mission 
requests 
• Africa (40)
Angola, Benin, Botswana, Burkina Faso, 
Burundi, Cameroon, Central African (Rep.), 
Chad, Comoros, Dem. Rep. of the Congo, 
Côte d’Ivoire, Djibouti, Eritrea, Ethiopia, 
Gabon, Gambia, Ghana, Guinea,  
Guinea-Bissau, Kenya, Lesotho, Libya, 
Madagascar, Malawi, Mali, Mauritania, 
Mauritius, Mozambique, Niger, Nigeria, 
Rwanda, Senegal, Seychelles, Sudan, 
Tanzania, Togo, Tunisia, Uganda, Zambia, 
Zimbabwe.
• Americas (7)
Barbados, Bolivia, Dominican Rep., 
Guatemala, Haiti, Honduras, Paraguay.
• Asia/Pacific (6)
Bhutan, Cambodia, Laos, Mongolia,  
Papua New Guinea, Vietnam.
• Europe (5)
Armenia, Georgia, Israel, Kazakhstan, 
Kyrgyzstan.
• Middle East (4)
Afghanistan, Kuwait, Lebanon,  
United Arab Emirates.
In red: completed missions
Legislation missions
State of Play – as at 22 June 2015
OIE Region OIE Members
Requests 
received
Missions  
completed
Africa 54 40 24
Americas 29 7 6
Asia and the 
Pacific
32 6 6
Europe 53 5 4
Middle East 12 4 4
Total 180 62 44
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OIE Regional Workshops 
for focal points and Information Seminars for new Delegates
Workshop on the World Animal Health Information System (WAHIS) for newly appointed 
National Focal Points for Animal Disease Notification to the OIE
OIE Headquarters, Paris, 20–22 January 2015
The OIE World Animal Health Information and Analysis 
Department organised a training workshop on the World 
Animal Health Information System (WAHIS) and its public 
interface (WAHID) in collaboration with the Regional 
Activities Department . The workshop was held at the 
OIE Headquarters from 20 to 22 January 2015 . It was 
intended for National Focal Points for Animal Disease 
Notification to the OIE that had recently been appointed or 
had not previously received specific training .
Training was given by staff of the World Animal Health 
Information and Analysis Department and was designed to 
train Focal Points in the use WAHIS and WAHID, based on 
presentations and real-life practical exercises . Exercises 
on entering information in the various types of reports, 
checking reports and identifying the most common errors 
gave participants a better grasp of the different aspects of 
notifying animal health information to the OIE . Participants 
examined the latest six-monthly report submitted to the 
OIE by their country, enabling them to put these skills into 
practice in a real-life situation . Participants also practised 
conducting information searches in WAHID and uploading 
CSV files – uploading information in this way is a useful 
option for notifying a large number of disease outbreaks in 
follow-up reports, monthly reports and six-monthly reports .
Nineteen (19) participants took part in the training, 
representing 18 countries, namely Australia, Bhutan, 
Brazil, Chad, Chile, Dominican Republic, El Salvador, 
Ghana, Honduras, Indonesia, Iran, Iraq, Republic of Korea, 
Namibia, Niger, Saudi Arabia, South Sudan and Sweden . 
For the benefit of participants, a team of interpreters 
relayed the training in three languages (English, French 
and Spanish) .
At the end of training, participants were asked 
to complete an evaluation questionnaire . Questions 
were scored from 1 to 4 (1: dissatisfied; 4: completely 
satisfied) . The results of the workshop evaluation showed 
that participant appreciated the practical exercises on data 
entry in WAHIS, which obtained a mean score of 3.84, 
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Asia – Pacific
Regional Seminar for OIE National Focal Points for Aquatic Animals
Ho Chi Minh City, Vietnam, 22–23 January 2015
OIE Regional Workshops for focal points and Information Seminars for new Delegates
This Regional Seminar for OIE 
National Focal Points for Aquatic 
Animals, which was held on 22 and 
23 January 2015 in Ho Chi Minh 
City, Vietnam, was attended by 
35 participants, including 16 assigned 
Focal Points and seven proxies from 
23 Regional Member Countries, two 
members of the Aquatic Animals 
Commission, two experts on emergency 
disease response, a representative from 
the Network of Aquaculture Centres 
for Asia–Pacific, and staff of the OIE . 
Since this was the third seminar in 
the region, the one-and-a-half-day 
programme focused on emerging 
diseases and emergency response, 
both vital aspects of aquatic animal 
health management . Each topic 
was introduced by short informative 
presentations, followed by a group 
work exercise . 
The first working group session 
was a facilitated discussion on 
and the module on identifying the most common errors 
made by Focal Points in reports submitted to the OIE, 
which obtained a mean score of 3 .65 . The mean score for 
training organisation and content was 3 .87 .
The participants unanimously agreed that after the 
training they considered themselves capable of submitting 
the various types of notification reports to the OIE . 
Indeed, shortly after the workshop, the OIE began to 
receive animal heath reports from Focal Points who had 
taken part in the workshop .
Lastly, the participants were highly appreciative of the 
exchanges they had had with other participants and with 
workshop facilitators, at both a professional and a human 
level . Some participants felt that the workshop was too 
short given the density of the content and wished that in 
future it could be increased in length .
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assessing emergency response 
capability . Participants individually 
measured their country’s progress 
against ten critical competencies 
from the Aquatic PVS Tool  that 
related to emergency response, 
and also examined the adequacy of 
the OIE standards in these areas . 
Most countries reported strengths 
in laboratory capacity, international 
export procedures, surveillance and 
transparency on sharing disease 
information . In contrast, weaknesses 
included: no specific national 
funding for an emergency response, 
difficulties in applying the principle 
of zoning in aquaculture because of 
the local landscape and small-scale 
farming, and differences in disease 
reporting between epidemiological 
units in various countries . 
The second working group 
session aimed to help participants 
to apply such knowledge in an 
OIE Regional Workshops for focal points and Information Seminars for new Delegates
OIE PVS Tool: Aquatic:
www.oie.int/fileadmin/Home/eng/Support_to_OIE_Members/pdf/A_PVS_Tool_aquatic_animals.pdf
emergency response scenario . They 
worked in small groups to consider 
the elements required for an effective 
emergency response against a new or 
emerging disease outbreak, with very 
high and rapid mortality in a semi-
closed system and no indication of the 
causal agent of concern . Each group 
reported back on what information they 
would provide to the Chief Veterinary 
Officer or Fisheries Director in such 
a situation: e .g . reporting the disease 
situation to the relevant Competent 
Authorities, setting up a task force, 
conducting surveillance, removing 
infected animals and water, movement 
controls, raising public awareness, 
improving communication with farmers 
and continuing laboratory diagnosis 
until the pathogen was identified . 
Participants discussed additional 
comments and suggestions on the 
mitigation and control of emergency 
diseases . 
The seminar highlighted the fact that 
emerging diseases and disease outbreaks 
are a major threat to the sustainability 
of aquaculture − due to the diversity 
of aquatic animal species and changes 
in relationships between the host, 
pathogen and environment, as well as 
host switching of pathogens in modern 
aquatic animal production settings .
The Focal Points also attended the 
Third OIE Global Conference on Aquatic 
Animal Health (see p . 103), where they 
were able to promote awareness of the 
importance of aquatic animal health 
and of building a worldwide framework 
to improve the management, prevention 
and control of aquatic animal diseases . 
1 PVS: OIE Tool for the Evaluation of Performance of Veterinary Services and/or Aquatic Animal Health Services
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meetings and visits
Names and positions of OIE permanent staff who participated in meetings or visits  
from January to March 2015
OIE Headquarters
General Directorate
Bernard Vallat Director General
Alex Thiermann Adviser to the Director General 
and President of the OIE Terrestrial 
Animal Health Standards 
Commission
Catherine Bertrand-Ferrandis Head of the Communication Unit
Marina Domingo Monsonís Chargée de mission
Yael Farhi Chargée de mission
Monique Eloit Deputy Director General 
(Administration, Management, 
Human Resources and Regional 
Activities)
Alain Dehove Coordinator of the World Animal 
Health and Welfare Fund
Julie Macé Project Officer (World Fund)
Emily Tagliaro Project Officer (World Fund)
Victoria Wong Project Officer (World Fund)
Sophie Rivière Project Officer (World Fund)
Rodney De Souza Head of the Legal and 
Administrative Affairs Unit
Alix Weng Head of the Budget and Financial 
Unit
Jean-Pierre Croiziers Head of the Human Resources Unit
Gilles Seigneurin Head of the Accounts Unit
Brian Evans Deputy Director General (Animal 
Health, Veterinary Public Health and 
International Standards)
Administration, Logistics and Publications Department
Daniel Chaisemartin Head of Department
Bertrand Flahault 1st Deputy Head of Department and 
Head of the Systems Management 
and Events Unit
Ingrid Contreras Arias Trilingual Conference Coordinator
Elisabeth Boucaud Conference Coordinator
Annie Souyri 2nd Deputy Head of Department and 
Head of the Publications Unit
Tamara Benicasa Marketing and Sales Manager
World Animal Health Information and Analysis Department
Paula Cáceres Soto Head of Department
Neo Mapitse Deputy Head of Department
Marija Popovic Chargée de mission
Lina Awada Veterinary Epidemiologist
Paolo Tizzani Veterinary Epidemiologist
Patrícia Pozzetti Chargée de mission
Aziza Yassin Mustafa Chargée de mission
International Trade Department
Derek Belton Head of Department
Gillian Mylrea Deputy Head of Department
Rastislav Kolesar Animal Welfare Coordinator
Tomasz Grudnik Chargé de mission
Leopoldo Humberto Stuardo Escobar Chargé de mission
Jae Myong Lee Chargé de mission
Scientific and Technical Department
Brian Evans Head of Department
Elisabeth Erlacher-Vindel Deputy Head of Department
Joseph Domenech Adviser
Susanne Münstermann Project Officer
Morgane Dominguez Project Officer
François Diaz Chargé de mission
Keith Hamilton Officer in charge of the Reduction of 
Biological Threats
Laure Weber-Vintzel Officer in charge of the Recognition 
of Countries’ Animal Disease Status
Jennifer Lasley Project Coordinator
Mariano Ramos Chargé de mission
Gounalan Pavade OFFLU Technical Assistant
Dietrich Rassow Veterinarian Adviser
Min Kyung Park Chargée de mission
Dawid Visser Biosecurity Officer
Barbara Freischem Chargée de mission
Simona Forcella Chargée de mission
Gregorio José Torres Peñalver Chargé de mission
Kazutoshi Matsuo Chargé de mission
Regional Activities Department
François Caya Head of Department
Mara Elma González Ortiz Deputy Head of Department
Nathaly Monsalve Conference Coordinator/Trilingual 
Secretary
Sylvie Pupulin Chargée de mission
Valentyna Sharandak Chargée de mission
David Sherman Chargé de mission
Martial Petitclerc Chargé de mission
Pablo Andrés Belmar von 
Kretschmann
Chargé de mission
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OIE Regional and Sub-Regional Representations
Africa
Yacouba Samaké Regional Representative for Africa 
(Bamako, Mali)
Karim Tounkara Deputy Head of the Regional 
Representative for Africa (Bamako, Mali)
Daniel Bourzat Adviser to the Regional Representative for 
Africa (Bamako, Mali)
Abdramane Sanogo Accountant (Bamako, Mali)
Aïssata Bagayoko Secretary (Bamako, Mali)
Alou Sangaré Administrative Assistant (Bamako, Mali)
Moetapele Letshwenyo Sub-Regional Representative for Southern 
Africa (Gaborone, Botswana)
Mpho Mantsho Administrative and Financial Assistant 
(Gaborone, Botswana)
Nomsa Thekiso Secretary (Gaborone, Botswana)
Rachid Bouguedour Sub-Regional Representative for North 
Africa (Tunis, Tunisia)
Alessandro Ripani Programme Officer (Tunis, Tunisia)
Jocelyn Mérot Programme Officer (Tunis, Tunisia)
Ines Guitouni Administrative and Financial Assistant 
(Tunis, Tunisia)
Walter Masiga Sub-Regional Representative for Eastern 
Africa and the Horn of Africa (Nairobi, 
Kenya)
Patrick Bastiaensen Programme Officer (Nairobi, Kenya)
Grace Omwega Administrative and Financial Assistant 
(Nairobi, Kenya)
Loise Ndungu Secretary (Nairobi, Kenya)
Americas
Luis Osvaldo Barcos Regional Representative for the Americas 
(Buenos Aires, Argentina)
Martín Minassian Technical Assistant (Buenos Aires, 
Argentina)
Alina Gutiérrez Camacho Secretary (Buenos Aires, Argentina)
Leandro Barcos Administrative Assistant (Buenos Aires, 
Argentina)
Montserrat Arroyo Kuribreña Sub-Regional Representative for Central 
America (Panama City, Panama)
Baldomero Molina Flores Project Officer (Panama City, Panama)
Manuel Gonzalez Cano Consultant (Panama City, Panama)
Lexy Castro de Ceballos Secretary (Panama City, Panama)
Asia and the Pacific
Hirofumi Kugita Regional Representative for Asia and the 
Pacific (Tokyo, Japan)
Chantanee Buranathai Regional Project Coordinator (Tokyo, 
Japan) (until 30 January 2015)
Tikiri Wijayathilaka Regional Project Coordinator (Tokyo, 
Japan)
Hnin Thidar Myint Regional Project Coordinator (Tokyo, 
Japan)
Yooni Oh Regional Veterinary Officer (Tokyo, Japan)
Yoko Aoyama Regional Veterinary Officer (Tokyo, Japan)
Lushi Liu Secondment Officer (Tokyo, Japan)
Takako Hasegawa Administrative Officer (Tokyo, Japan)
Kanako Koike Accounting Officer (Tokyo, Japan)
Izumi Goto Administrative Officer (Tokyo, Japan)
Ronello Abila Sub-Regional Representative for South-
East Asia (Bangkok, Thailand)
Phillip Widders Programme Coordinator (STANDZ) 
(Bangkok, Thailand)
Mary Joy Gordoncillo Science and One Health Coordinator 
(Bangkok, Thailand)
Pennapa Matayompong STRIVES Coordinator (Bangkok, Thailand)
Cecilia Dy M&E Coordinator and Communication 
Officer (Bangkok, Thailand)
Karan Kukreja Project Officer (Bangkok, Thailand)
Corissa Miller Project Officer (STANDZ) (Bangkok, 
Thailand)
Scott Zaari Project Officer (Bangkok, Thailand)
Melada Ruengjumroonnath Financial Officer (Bangkok, Thailand)
Preechaya Srithep Administrative Officer (Bangkok, Thailand)
Onsiri Benjavejbhaisan Administrative Officer (Bangkok, Thailand)
Europe
Nikola T. Belev Regional Representative for Eastern 
Europe (Sofia, Bulgaria)
Aleksandra Miteva Technical Assistant (Sofia, Bulgaria)
Rina Kostova Secretary (Sofia, Bulgaria)
Kazimieras Lukauskas Regional Representative in Moscow 
(Russia)
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Hassan Abdel Aziz Aidaros Member of the OIE Scientific Commission for Animal Diseases
Ali Abdullah Al-Sahmi Member of the OIE Council and Delegate of Oman to the OIE (until 16 February 2015)
Marc Artois Member of the OIE Working Group on Wildlife (Marcy-l’Étoile, France)
Franck Berthe President of the OIE Aquatic Animal Health Standards Commission
Francisco Javier Blanco Viera OIE Expert, OIE Reference Laboratory for Bovine Spongiform Encephalopathy and Scrapie (Buenos Aires, Argentina)
Etienne Bonbon Vice-President of the OIE Terrestrial Animal Health Standards Commission
Gideon Brückner President of the OIE Scientific Commission for Animal Diseases
German Caceres Expert on Classical Swine Fever
John Clifford Member of the OIE Council and Delegate of the United States of America to the OIE
Susan Corning OIE Consultant
Carlos A. Correa Messuti Past President of the World Assembly of OIE Delegates and Delegate of Uruguay to the OIE
Trevor Drew OIE Expert, OIE Reference Laboratory for Bovine Viral Diarrhea and Classical Swine Fever  
(Weybridge, United Kingdom)
Nicholas Kauta Member of the OIE Council and Delegate of Uganda to the OIE
Toshiro Kawashima Member of the OIE Council and Delegate of Japan to the OIE
Geneviève Libeau OIE Expert, OIE Reference Laboratory for Rinderpest and Peste des petits ruminants (Montpellier, France)
Botlhe Michael Modisane Vice-President of the OIE Council and Delegate of South Africa to the OIE
Gérard Moulin OIE Expert, OIE Collaborating Centre for Veterinary Medicinal Products (Fougères, France)
Gardner Murray OIE Special Adviser
Evgeny Nepoklonov Member of the OIE Council and Delegate of Russia to the OIE
Jean-Pierre Orand OIE Expert, OIE Collaborating Centre for Veterinary Medicinal Products (Fougères, France)
Ekaterina Panina Technical and Administrative Assistant 
(Moscow, Russia)
Nadège Leboucq Sub-Regional Representative in Brussels 
(Belgium)
Stéphane de La Rocque Chargé de mission – Veterinary Public 
Health (Brussels, Belgium)
Stanislav Ralchev Technical Assistant (Brussels, Belgium)
Mereke Taitubayev Head of the Sub-Regional FMD 
Coordination Unit (Astana, Kazakhstan)
Assylbek Kozhumratov Technical Assistant (Astana, Kazakhstan)
Middle East
Ghazi Yehia Regional Representative for the Middle 
East (Beirut, Lebanon)
Mustapha Mestom Consultant (Beirut, Lebanon)
Xavier Pacholek Technical Assistant (Beirut, Lebanon)
Ali El Romeh Technical Assistant (Beirut, Lebanon)
Rita Rizk Trilingual Secretary (Beirut, Lebanon)
Khodr Rejeili Assistant (Beirut, Lebanon)
Tony Atallah Assistant (Beirut, Lebanon)
Names and positions of experts who represented the OIE in meetings  
or visits from January to March 2015
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List of abbreviations
AAVMC 
Association of American Veterinary  
Medical Colleges
AEGCD 
ASEAN Expert Group on Communicable  
Diseases
AFD 
French Development Agency
AGISAR 
Advisory Group on Integrated Surveillance of 
Antimicrobial Resistance
ASEAN 
Association of South-East Asian Nations
ASF 
African swine fever
ASWGL 
ASEAN Sectoral Working Group on Livestock
AU-IBAR 
African Union-Interafrican Bureau for Animal 
Resources
BSE 
bovine spongiform encephalopathy
CDC 
Centers for Disease Control and Prevention
CIC 
International Council for Game and Wildlife 
Conservation
CIRAD 
French Agricultural Research Centre for 
International Development
CIS 
Commonwealth of Independent States
CMC-AH 
Crisis Management Centre – Animal Health
CSF 
Classical swine fever
CVOs 
Chief Veterinary Officers
DG DEVCO 
European Commission’s Directorate General for 
International Cooperation and Development
DG SANCO 
European Commission’s Directorate General for 
Health and Consumers
EFFORT 
Ecology from Farm to Fork Of microbial drug 
Resistance and Transmission (project co-funded 
by the European Union)
EFSA 
European Food Safety Authority
ESVAC 
European Surveillance of Veterinary Antimicrobial 
Consumption
EU 
European Union
EWDA 
European Wildlife Disease Association
FAO 
Food and Agriculture Organization of the United 
Nations
FEI 
International Equestrian Federation
FMD 
Foot and mouth disease
FVE 
Federation of Veterinarians of Europe
GALVMed 
Global Alliance for Livestock Veterinary Medicines
GARC 
Global Alliance for Rabies Control
GCC 
Gulf Cooperation Council
GF-TADs 
FAO/OIE Global Framework for the Progressive 
Control of Transboundary Animal Diseases
GHSA 
Global Health Security Agenda
GLEWS 
Global Early Warning System
HHP 
High-Health High-Performance (FEI concept  
for horses)
John Pasick OIE Expert, OIE Reference Laboratory for Classical Swine Fever and Highly and Low Pathogenic Avian Influenza 
(poultry) (Winnipeg, Canada)
Paul-Pierre Pastoret Scientific Adviser
Mark Schipp Member of the OIE Council and Delegate of Australia to the OIE
Karin Schwabenbauer President of the World Assembly of OIE Delegates and Delegate of Germany to the OIE
François Thiaucourt OIE Expert, OIE Reference Laboratory for Contagious Bovine Pleuropneumonia and Contagious Caprine 
Pleuropneumonia (Montpellier, France)
Michel Thibier OIE Expert
Blesilda Verin Project Officer, Northern Laos FMD Project
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List of abbreviations (contd)
IETS 
International Embryo Transfer Society
IFAH 
International Federation for Animal Health
ILRI 
International Livestock Research Institute
M&E 
Monitoring & Evaluation
MAN-IMAL 
First training in France based on the concept 
‘One World, One Health’ (programme receiving 
financial support from French State managed  
by the French National Agency for Research)
MERS-CoV 
Middle East Respiratory Syndrome Coronavirus
NRPCP 
National Rabies Prevention and Control Program 
(the Philippines)
OFFLU 
Joint OIE/FAO worldwide scientific network for the 
control of animal influenzas
OIE 
World Organisation for Animal Health
PAN-SPSO 
Participation of African Nations in Sanitary and 
Phytosanitary Standard-setting Organisations
PVMA 
Philippine Veterinary Medical Association
RAWS 
Regional Animal Welfare Strategy
REMESA 
Mediterranean Animal Health Network
RISKSUR 
Risk-Based Animal Health Surveillance Systems 
(European Union-funded project)
SADC 
Southern African Development Community
SCAR 
Standing Committee on Agricultural Research
SEACFMD 
South-East Asia and China Foot and Mouth 
Disease Campaign
SPS 
Sanitary and phytosanitary measures
STANDZ 
Stop Transboundary Animal Diseases and 
Zoonoses
STAR-IDAZ 
Global Strategic Alliances for the Coordination 
of Research on the Major Infectious Diseases of 
Animals and Zoonoses
STDF 
Standards and Trade Development Facility
STRIVES 
Strengthening Initiative for Veterinary Services
TAIEX 
Technical Assistance and Information Exchange 
Instrument of the European Commission
TASW 
Towards a Safer World
UMA 
Arab Maghreb Union
US 
United States
VETGOV 
Reinforcing Veterinary Governance in Africa  
(EU-funded project implemented by AU-IBAR  
in partnership with OIE and FAO)
VICH 
International Cooperation on Harmonisation 
of Technical Requirements for Registration of 
Veterinary Medicinal Products
VIV Asia 
International platform of trade shows  
for the Feed to Meat industry in Asia
WAHIS 
OIE World Animal Health Information System
WCO 
World Customs Organization
WHO 
World Health Organization
WTO 
World Trade Organization
WVA 
World Veterinary Association
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January 2015 (contd)
Title of the event Place Date Participants
Concertation meeting for the organisation  
of the FAO/OIE International Conference for the Control 
and Eradication of Peste des Petits Ruminants (PPR), 
to be held in Abidjan, Côte d’Ivoire, from 31 March  
to 2 April 2015
FAO Headquarters, 
Rome, Italy
8 January Dr D. Chaisemartin
1st EFFORT Annual Meeting Madrid, Spain 8–9 January Dr E. Erlacher-Vindel
Workshop on ‘Research priorities in Animal Influenza’ EFSA Headquarters, 
Parma, Italy
8–9 January Dr G. Pavade
IETS Preconference Symposium: ‘Safe International 
Trade in Embryos’
OIE Headquarters, 
Paris, France
10 January Dr B. Vallat, Dr A. Thiermann, Dr D. Belton 
& Prof. M. Thibier
41st IETS Annual Conference Versailles, France 11–13 January Prof. M. Thibier
Workshop on Monitoring and Evaluation  
for the STANDZ-funded Rabies Project in the 
Philippines
Manila, the Philippines 12 January Dr M.J. Gordoncillo & Ms C. Dy
Rinderpest Holding Facility Site Inspection Debre Zeit, Ethiopia 12–16 January Dr K. Hamilton
Visit of students from the French National School  
of Veterinary Services (ENSV)
OIE Headquarters, 
Paris, France
13 January Dr P. Cáceres Soto,  
Dr C. Bertrand-Ferrandis,  
Dr D. Chaisemartin
5th Meeting of the ISO/TC 212 Working Group on 
Laboratory Biorisk Management
London,  
United Kingdom
13–14 January Dr F. Diaz
WHO Workshop on Strengthening Integrated 
Surveillance of Foodborne Diseases and Antimicrobial 
Resistance in the Caribbean and Antimicrobial 
Resistance Awareness Seminar
Saint Augustine, 
Trinidad and Tobago
13–16 January Dr M. Arroyo Kuribreña
GLEWS Task Force Meeting OIE Headquarters, 
Paris, France
14 January Dr D. Chaisemartin, Dr P. Cáceres Soto  
& Dr M. Popovic
Ebola Virus Disease Preparedness for High Risk 
Countries in Africa
Geneva, Switzerland 14–16 January Dr S. de La Rocque
High-Level Meeting with the Secretary General  
of the WCO, Mr Kunio Mikuriya, to consider 
strengthening the existing cooperation between 
the OIE and the WCO in the context of the recent 
ratification of the WTO Trade Facilitation Agreement 
and the increase in the traffic of counterfeit 
medicines
WCO Headquarters, 
Brussels, Belgium
15 January Dr B. Vallat, Dr D. Belton, Dr N. Leboucq 
& Dr E. Bonbon
Consultative Meeting on Surveillance, Preparedness, 
and Response for Important Zoonotic Influenza in 
Myanmar
Naypyidaw, Myanmar 15 January Dr H. Thidar Myint
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meetings and visits
January 2015 (contd)
Title of the event Place Date Participants
VETGOV Post Mid-Term Review (MTR) Retreat, 
organised by AU-IBAR, to coordinate the revision 
of the logframe and the budget in line with the 
recommendations of the MTR Report
Naivasha, Kenya 15–16 January Dr P. Bastiaensen
Risk Assessment Orientation Workshop for Avian 
Influenza A (H7N9) in Myanmar
Naypyidaw, Myanmar 16 January Dr H. Thidar Myint
International Green Week 2015 Berlin, Germany 16–25 January Dr K. Schwabenbauer,  
Dr C. Bertrand-Ferrandis, Dr Y. Farhi,  
Ms E. Boucaud & Dr S. Münstermann
Preparation Workshop for FMD Vaccination Campaign 
in Central Myanmar
Mandalay, Myanmar 19–22 January Dr P. Widders & Dr C. Miller
Animal Rabies Communication Planning Workshop Tagaytay City, the 
Philippines
19–22 January Ms C. Dy
Meeting between OIE and FVE OIE Headquarters, 
Paris, France
20 January Dr B. Vallat & Ms M. Domingo Monsonís
GHSA teleconference on ‘Workforce’ (‘Detect-5’)  
Action Package
Rome, Italy 20 January Dr S. Corning
Preparatory meeting of the Organising Committee for 
the 7th International Symposium on Emerging and 
Re-Emerging Pig Diseases, to be held in Kyoto, Japan, 
from 21 to 24 June 2015
Kyoto, Japan 20–21 January Dr Y. Aoyama
3rd OIE Global Conference on Aquatic Animal Health: 
‘Riding the wave to the future’
Ho Chi Minh City, 
Vietnam
20–22 January Dr K. Schwabenbauer, Dr B. Vallat,  
Dr D. Chaisemartin,  
Ms I. Contreras Arias, Dr G. Mylrea,  
Dr D. Bourzat, Dr M. Letshwenyo,  
Dr A. Ripani, Dr P. Bastiaensen,  
Dr M. Arroyo Kuribreña, Dr H. Kugita,  
Dr H. Thidar Myint, Dr R. Abila,  
Ms M. Ruengjumroonnath,  
Prof. K. Lukauskas, Dr N. Leboucq  
& Dr G. Yehia
OIE Training Workshop on WAHIS for Recently 
Appointed National Focal Points for Animal Disease 
Notification to the OIE
OIE Headquarters, 
Paris, France
20–22 January Dr P. Cáceres Soto & Dr N. Mapitse
OIE Training Course on: ‘Livestock vaccines:  
concepts, developments, regulations and 
applications’
Zaragoza, Spain 21 January Dr B. Freischem
GHSA teleconference on ‘Nationwide Laboratory 
Systems’ (‘Detect-1’) Action Package
Rome, Italy 21 January Dr S. Corning
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January 2015 (contd)
Title of the event Place Date Participants
Meetings with writing team members to update  
the Cambodia National FMD Plan
Phnom Penh, Cambodia 21–22 January Dr K. Kukreja
3rd Regional Seminar for OIE National Focal Points  
for Aquatic Animals for Asia and the Pacific
Ho Chi Minh City, 
Vietnam
22–23 January Dr G. Mylrea, Dr H. Kugita,  
Dr H. Thidar Myint, Dr R. Abila,  
Dr P. Widders, Dr C. Miller  
& Ms M. Ruengjumroonnath
STAR-IDAZ Network Management  
Board Meeting
Bogota, Colombia 23 January Dr B. Freischem
1st GHSA Steering Committee Meeting Geneva, Switzerland 24 January Dr A. Dehove, Dr B. Evans & Dr S. Corning
Special session on the response to Ebola  
in West Africa
Geneva, Switzerland 25 January Dr B. Evans
Antimicrobial Resistance Prevention Strategy 
Workshop, organised by GCC
Riyadh, Saudi Arabia 25–27 January Dr E. Erlacher-Vindel
136th Session of the WHO Executive Board Geneva, Switzerland 26–31 January Dr B. Evans & Dr S. de La Rocque
CMC-AH mission on avian influenza West Bank, Palestinian 
Autonomous Territories
26 January – 
2 February
Dr G. Pavade
Rinderpest Holding Facility Site Inspection Tokyo, Japan 26 January – 
2 February
Dr D. Visser
Meeting between OIE and WVA OIE Headquarters, 
Paris, France
27 January Dr B. Vallat, Dr C. Bertrand-Ferrandis  
& Dr Y. Farhi
Launch of an ILRI book: Food Safety and Informal 
Markets: Animal Products in Sub-Saharan Africa, 
edited by Kristina Roesel and Delia Grace
Kabete, Kenya 27 January Dr P. Bastiaensen
Preparatory meeting for the organisation  
of the FAO/OIE International Conference for the Control 
and Eradication of Peste des Petits Ruminants (PPR), 
to be held in Abidjan, Côte d’Ivoire, from 31 March  
to 2 April 2015
Abidjan, Côte d’Ivoire 27–29 January Dr D. Chaisemartin & Dr Y. Samaké
Preparatory meeting for the GHSA meeting on 
workforce development, national laboratory system 
strengthening and antimicrobial resistance in East 
Asia Pacific Region
Bangkok, Thailand 29 January Dr M.J. Gordoncillo, Dr P. Matayompong  
& Dr S. Zaari
Meeting of the SCAR Collaborative Working Group  
on Animal Health and Welfare Research  
and meeting of the SCAR Foresight  
and Programming Unit
Rome, Italy 30 January Dr B. Freischem
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meetings and visits
February  2015 (contd)
Title of the event Place Date Participants
Meeting with Professor Louis Nel, Executive Director 
of the GARC
OIE Headquarters, 
Paris, France
3 February Dr B. Vallat & Dr A. Dehove
Meeting with the Department of Animal Health  
of Vietnam
Hanoi, Vietnam 3 February Dr R. Abila, Dr P. Widders & Dr G. Murray
SADC Livestock Technical Committee Meeting Pretoria, South Africa 4–5 February Dr M. Letshwenyo
Joint Georgia–Azerbaijan–Kazakhstan Electronic 
Integrated Disease Surveillance System (EIDSS) 
Best Practices and Regional Disease Surveillance 
Cooperation Meeting
Baku, Azerbaijan 4–6 February Dr S. Corning
12th Meeting of the Upper Mekong Working Group  
on FMD Zoning and Animal Movement Management
Vinh Phuc, Vietnam 4–6 February Dr Y. Oh, Dr R. Abila, Dr P. Widders,  
Dr K. Kukreja, Dr C. Miller,  
Ms O. Benjavejbhaisan & Dr G. Murray
SADC Sanitary and Phytosanitary Coordinating 
Committee Meeting
Pretoria, South Africa 5 February Dr M. Letshwenyo
2nd Steering Committee Meeting of the 
Epidemiological Surveillance and Emergency 
Response Management (SEGA) Network of the Indian 
Ocean Commission (IOC)
Saint-Gilles-les-Bains, 
Reunion, France
5–6 February Dr P. Bastiaensen
World Bank Mission on H5N1 Abuja, Nigeria 5–7 February Dr J. Domenech
4th International Symposium on the Global 
Harmonisation for Animal Epidemic Prevention 
Strategies
Tokyo, Japan 6 February Dr H. Kugita, Dr H. Thidar Myint,  
Dr Y. Aoyama & Dr L. Liu
2nd Coordination Committee Meeting of the Northern 
Laos FMD Project
Luang Prabang, Laos 9 February Dr R. Abila, Dr P. Widders & Dr G. Murray
Opening Ceremony of the OIE Veterinary Education 
Twinning Programme between the Royal Veterinary 
College (United Kingdom) and the Jordan University  
of Science and Technology
Irbid, Jordan 9 February Dr G. Yehia
2nd Advisory Group Meeting of the Northern Laos  
FMD Project
Luang Prabang, Laos 10 February Dr R. Abila, Dr P. Widders & Dr G. Murray
21st FAO/OIE/WHO Tripartite Annual Executive 
Coordination Meeting
OIE Headquarters, 
Paris, France
10–11 February Dr B. Vallat, Dr C. Bertrand-Ferrandis,  
Dr M. Eloit, Dr A. Dehove,  
Ms E. Tagliaro, Dr D. Chaisemartin,  
Dr P. Cáceres Soto, Dr G. Mylrea,  
Dr B. Evans, Dr E. Erlacher-Vindel,  
Dr J. Domenech, Dr K. Hamilton,  
Dr G. Pavade, Dr G.J. Torres Peñalver  
& Dr S. de La Rocque
GHSA teleconference on ‘Antimicrobial Resistance’ 
(‘Prevent-1’) Action Package
Rome, Italy 11 February Dr S. Corning
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February  2015 (contd)
Title of the event Place Date Participants
2nd Meeting of the Standing Group of Experts on ASF 
in the Baltic and Eastern Europe Region, under the 
GF-TADs Umbrella
Tallinn, Estonia 11–12 February Prof. K. Lukauskas & Dr N. Leboucq
STDF Policy Committee Meeting OIE Headquarters, 
Paris, France
12 February Dr B. Vallat, Dr A. Thiermann  
& Dr B. Evans
GF-TADs Management Committee Meeting OIE Headquarters, 
Paris, France
12 February Dr M. Eloit, Dr D. Chaisemartin  
& Dr F. Caya
Meeting with the Bulgarian Union of Hunters and 
Anglers in relation with the 62nd CIC General 
Assembly, to be held in Pravets, Bulgaria,  
from 23 to 25 April 2015
Sofia, Bulgaria 12 February Prof. N.T. Belev
Preparation of an OIE twinning project on small 
ruminant diseases (CIRAD, France and Central 
Veterinary Laboratory, Kuwait)
Kuwait City, Kuwait 15–17 February Dr G. Yehia, Dr F. Thiaucourt  
& Dr G. Libeau
Seminar for OIE African National Delegates on the 
development of public–private partnerships  
to support Veterinary Services
Rabat, Morocco 16 February Dr K. Schwabenbauer, Dr B.M. Modisane, 
Dr B. Vallat, Dr M. Eloit, Dr N. Mapitse,  
Dr E. Erlacher-Vindel, Dr J. Domenech,  
Dr F. Caya, Ms N. Monsalve,  
Dr D. Sherman, Dr M. Petitclerc,  
Dr Y. Samaké, Dr K. Tounkara,  
Dr D. Bourzat, Ms A. Bagayoko,  
Dr M. Letshwenyo, Dr R. Bouguedour,  
Dr A. Ripani, Dr J. Mérot, Ms I. Guitouni, 
Dr P. Bastiaensen, Dr S. de La Rocque,  
Dr N. Kauta, Dr G. Brückner & Dr F. Berthe
Inception workshop of the TCP/CMB/3505 
(‘Curriculum Development for the new Faculty 
of Veterinary Medicine of the Royal University of 
Agriculture (RUA)’)
Phnom Penh, Cambodia 16–17 February Dr P. Matayompong
21st Conference of the OIE Regional Commission  
for Africa
Rabat, Morocco 17–20 February Dr K. Schwabenbauer, Dr B.M. Modisane, 
Dr B. Vallat, Dr M. Eloit, Dr N. Mapitse,  
Dr E. Erlacher-Vindel, Dr J. Domenech,  
Dr F. Caya, Ms N. Monsalve,  
Dr D. Sherman, Dr M. Petitclerc,  
Dr Y. Samaké, Dr K. Tounkara,  
Dr D. Bourzat, Ms A. Bagayoko,  
Dr M. Letshwenyo, Dr R. Bouguedour,  
Dr A. Ripani, Dr J. Mérot, Ms I. Guitouni, 
Dr P. Bastiaensen, Dr S. de La Rocque,  
Dr N. Kauta, Dr G. Brückner & Dr F. Berthe
Regional Rabies Coordinators’ Meeting Cebu, the Philippines 17 February Dr R. Abila & Dr M.J. Gordoncillo
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February  2015 (contd)
Title of the event Place Date Participants
Workshop on Effective Inter-agency Interoperability 
and Coordinated Communication in case of Chemical 
and/or Biological Attacks, organised by the United 
Nations Counter-Terrorism Implementation Task Force 
(UN-CTITF)
The Hague,  
the Netherlands
18–20 February Dr K. Hamilton & Dr D. Visser
WHO/FAO/OIE Joint Technical Mission on MERS-CoV Riyadh, Saudi Arabia 18–20 February Dr G. Yehia
82nd PVMA Scientific Conference and Annual 
Convention
Cebu, the Philippines 18–20 February Dr R. Abila & Dr M.J. Gordoncillo
Meeting of the CIS Intergovernmental Council  
for Cooperation in Veterinary Field between CVOs  
of CIS countries
Sochi, Russia 19–20 February Dr M. Taitubayev & Dr A. Kozhumratov
GHSA teleconference of Action Package leaders Rome, Italy 20 February Dr S. Corning
Multidisciplinary Symposium: ‘Ebola: how far have we 
come, where do we go from here?’, organised by the 
Royal Academy of Medicine of Belgium
Brussels, Belgium 21 February Prof. P.-P. Pastoret
52nd International Exhibition of Agriculture 2015 Paris, France 21 February – 
1 March
Dr C. Bertrand-Ferrandis,  
Ms M. Domingo Monsonís, Dr Y. Farhi,  
Ms T. Benicasa, Dr L. Awada  
& Dr M. Dominguez
Vet Youth Summit Japan 2015: ‘International 
cooperation in the veterinary industry’
Osaka, Japan 23 February Dr H. Kugita
Launch of the Central Myanmar FMD Vaccination 
Campaign
Mandalay, Myanmar 23–24 February Dr C. Miller
31st VICH Steering Committee Meeting and 5th VICH 
Outreach Forum Meeting
Washington, DC,  
United States
23–26 February Dr B. Freischem & Dr J.-P. Orand
Rinderpest Holding Facility Site Inspection Plum Island,  
United States
23–26 February Dr K. Hamilton
4th WHO Strategic and Technical Advisory Group 
Meeting on Antimicrobial Resistance
WHO Headquarters, 
Geneva, Switzerland
24–25 February Dr J. Domenech & Dr S. Corning
Workshop on alternatives to pig castration Brussels, Belgium 25 February Dr T. Grudnik
Implementing Partners Technical Coordination 
Meeting of the PAN-SPSO Project Consolidation Phase
Nairobi, Kenya 25 February Dr P. Bastiaensen
CIRAD-AFD Round table on One Health at the 52nd 
International Exhibition of Agriculture
Paris, France 25 February Dr S. de La Rocque
Seminar within the Master Programme ‘Veterinary 
Administration’, at the Thracian University, Stara 
Zagora
Stara Zagora, Bulgaria 25 February Prof. N.T. Belev
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February  2015 (contd)
Title of the event Place Date Participants
1st Asia Regional Workshop on Rabies Elimination Bangkok, Thailand 25–26 February Dr R. Abila, Dr M.J. Gordoncillo,  
Ms C. Dy & Dr S. Zaari
OIE Council’s Meeting OIE Headquarters, 
Paris, France
25–27 February Dr K. Schwabenbauer, Dr B.M. Modisane, 
Dr C.A. Correa Messuti, Dr B. Vallat,  
Dr M. Eloit, Dr B. Evans,  
Dr A. Thiermann, Ms A. Weng,  
Dr M. Schipp, Dr E. Nepoklonov,  
Dr N. Kauta, Dr T. Kawashima,  
Dr J. Clifford & Dr A.A. Al-Sahmi
5th Steering Committee Meeting of the PAN-SPSO 
Project Consolidation Phase (Phase 2)
Nairobi, Kenya 26 February Dr P. Bastiaensen
5th AU-IBAR Advisory Committee Meeting AU-IBAR Headquarters, 
Nairobi, Kenya
27 February Dr P. Bastiaensen
Preparatory meeting for the organisation of the 2015 
Regional Rabies Scientific Conference, to be held in 
Wuhan, P.R. China, from 16 to 17 April 2015
Beijing, P.R. China 28 February – 
2 March
Dr Y. Oh
meetings and visits
March  2015 (contd)
Title of the event Place Date Participants
Assessment of laboratory equipment and supplies and 
to conduct hands-on training on laboratory diagnosis 
to national FMD laboratory staff for the Northern Laos 
FMD Project post vaccination monitoring field samples 
in the National Animal Health Laboratory of the 
Department of Livestock and Fisheries
Vientiane, Laos 1–7 March Dr B. Verin
Meeting with the FVE Working Group on Animal 
Welfare
Brussels, Belgium 2 March Dr N. Leboucq
High-Level Meeting with Dr Thomas Frieden, 
CDC Director, accompanied by its senior staff 
representatives in order to pursue and strengthen 
efficient cooperation between the two organisations
CDC Headquarters, 
Atlanta, United States
2–3 March Dr B. Vallat & Dr A. Dehove
Meeting of the Technical Working Group on 
multinational case study of MERS-CoV control
Riyadh, Saudi Arabia 2–3 March Dr G. Pavade
ESVAC Annual Stakeholders Meeting 2015 London,  
United Kingdom
3 March Dr F. Diaz, Dr B. Freischem  
& Dr G. Moulin
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March  2015 (contd)
Title of the event Place Date Participants
ESVAC Annual Network Meeting 2015 London,  
United Kingdom
3–4 March Dr F. Diaz, Dr B. Freischem  
& Dr G. Moulin
2nd International Conference on Dog Population 
Management: ‘Inter-sectorial collaboration, innovation 
and evidence-based solutions for dog population 
management’
Istanbul, Turkey 3–5 March Dr L.H. Stuardo Escobar  
& Dr N. Leboucq
Regional workshop on highly pathogenic avian 
influenza
Yogyakarta, Indonesia 3–6 March Dr H. Thidar Myint
GHSA teleconference on ‘Biosafety and Biosecurity’ 
(‘Prevent-3’) Action Package
Rome, Italy 4 March Dr S. Corning
International Livestock Congress (ILC): ‘Providing 
Animal Protein to the World’
Houston, United States 4–5 March Dr B. Vallat & Dr A. Dehove
Conference on policies for competitive smallholder 
livestock production, organised by ILRI
Gaborone, Botswana 4–5 March Dr M. Letshwenyo
Kick-off meeting of the DG DEVCO One  
Health project
Brussels, Belgium 5 March Ms E. Tagliaro & Dr S. de La Rocque
Livestock Global Alliance (LGA) Meeting Houston, United States 5–6 March Dr B. Vallat & Dr A. Dehove
NRPCP Medium Term Plan Writing Workshop Manila, the Philippines 5–6 March Dr M.J. Gordoncillo
OIE Information Seminar for Veterinary Educational 
Establishments
Bangkok, Thailand 6 March Dr P. Matayompong & Dr S. Zaari
National Rabies Awareness Month Kick-off Manila, the Philippines 7 March Dr M.J. Gordoncillo & Ms C. Dy
Steering Committee Meeting of the OIE 
Sub-Commission for SEACFMD Campaign  
and Rabies Steering Committee Meeting
Manila, the Philippines 9 March Dr M. Eloit, Ms E. Tagliaro,  
Dr J. Domenech, Dr H. Kugita,  
Dr Y. Oh, Dr R. Abila, Dr P. Widders,  
Dr M.J. Gordoncillo, Dr K. Kukreja,  
Dr C. Miller, Ms M. Ruengjumroonnath,  
Dr G. Murray & Dr B. Verin
Visit to the Pirbright Institute and presentation made 
on the OIE HHP concept 
Pirbright,  
United Kingdom
9 March Dr S. Münstermann & Dr M. Dominguez
Meeting of the DG SANCO Animal Health Advisory 
Committee
Brussels, Belgium 9 March Dr N. Leboucq
Workshop to improve welfare practices during 
transport and at the time of slaughter in some Middle 
East countries, organised by TAIEX
Beirut, Lebanon 9–10 March Dr L.H. Stuardo Escobar, Dr G. Yehia,  
Dr X. Pacholek, Dr A. El Romeh  
& Prof. H.A.A. Aidaros
Expert Inspection of the Pirbright Facilities  
to be approved by FAO/OIE as Rinderpest Holding 
Facility
London,  
United Kingdom
9–12 March Dr D. Visser
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March  2015 (contd)
Title of the event Place Date Participants
High-Level Meeting on Pastoralism at the French 
Ministry of Foreign Affairs
Paris, France 10 March Dr B. Vallat & Dr A. Dehove
STANDZ Steering Committee Meeting Manila, the Philippines 10 March Dr R. Abila, Dr P. Widders, Dr M.J. 
Gordoncillo & Ms C. Dy
Workshop on the OIE procedure for the official 
recognition of Member Countries’ disease status with 
regard to CSF and BSE risk for the Americas
Panama City, Panama 10–12 March Dr L. Weber-Vintzel, Dr D. Rassow,  
Dr M.K. Park, Dr L.O. Barcos,  
Dr M. Minassian, Dr M. Arroyo Kuribreña, 
Dr B. Molina Flores, Dr M. Gonzalez Cano, 
Ms L. Castro de Ceballos, Dr J. Pasick,  
Dr F.J. Blanco Viera & Dr G. Caceres
21st Meeting of the OIE Sub-Commission for 
SEACFMD Campaign
Manila, the Philippines 10–13 March Dr M. Eloit, Ms E. Tagliaro,  
Dr J. Domenech, Dr H. Kugita, Dr Y. Oh,  
Dr R. Abila, Dr P. Widders, Dr K. Kukreja, 
Dr C. Miller, Ms M. Ruengjumroonnath,  
Dr G. Murray & Dr B. Verin
4th Regional workshop of the regional task force 
on pastoralism of the Regional Sahel Pastoralism 
Support Project (PRAPS)
Dakar, Senegal 10–14 March Dr K. Tounkara & Dr D. Bourzat
OIE/GALVMed/SADC Meeting on the Harmonization  
of Veterinary Drugs Registration
Gaborone, Botswana 11 March Dr M. Letshwenyo
9th Maghreb Permanent Veterinary Committee 
Meeting (UMA’s Secretariat General)
Rabat, Morocco 11–12 March Dr R. Bouguedour
VIV Asia 2015 Bangkok, Thailand 12 March Dr M.J. Gordoncillo,  
Dr P. Matayompong, Dr S. Zaari,  
Ms P. Srithep  
& Ms O. Benjavejbhaisan
Preparatory meeting for the GHSA meeting on 
workforce development, national laboratory system 
strengthening and antimicrobial resistance in East 
Asia Pacific Region
Bangkok, Thailand 12 March Dr M.J. Gordoncillo, Dr P. Matayompong  
& Dr S. Zaari
2015 AAVMC Annual Conference: ‘Recruiting and 
Selecting for the Future of Veterinary Medicine’ and 
Meeting with the US Department of State
Washington, DC,  
United States
13 March Ms V. Wong
Working Session for the TASW Network Sendai, Japan 13 March Dr H. Thidar Myint
Wilton Park Workshop on: ‘Antimicrobial Resistance 
in humans and animals in low and middle income 
countries: How can knowledge be strengthened at 
national level?’
Wiston House, Steyning, 
United Kingdom
13–15 March Dr B. Freischem
3rd United Nations World Conference on Disaster  
Risk Reduction
Sendai, Japan 14–17 March Dr H. Kugita, Dr T. Wijayathilaka  
& Dr H. Thidar Myint
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March  2015 (contd)
Title of the event Place Date Participants
3rd International ‘One Health’ Congress:  
‘Prevention at the Source’
Amsterdam, the 
Netherlands
15–18 March Dr S. Corning
Public forum: ‘Testing successful solutions: a 
collaborative approach to reducing animal losses 
from disasters’
Sendai, Japan 16 March Dr H. Kugita, Dr T. Wijayathilaka  
& Dr H. Thidar Myint
10th REMESA Joint Permanent Committee Meeting Heraklion, Crete island, 
Greece
16–17 March Dr M. Eloit, Dr R. Bouguedour,  
Dr A. Ripani, Dr J. Mérot, Dr X. Pacholek  
& Dr A. El Romeh
WCO Regional (Asia-Pacific) Workshop on Strategic 
Initiatives for Trade Facilitation
Jakarta, Indonesia 16–18 March Dr R. Abila
National Strategy for Rabies Control and Elimination 
Workshop
Phnom Penh, Cambodia 16–20 March Dr M.J. Gordoncillo
Inception Workshop of the WHO-AGISAR Pilot  
Project on Integrated Surveillance of Antimicrobial 
Resistance in Uganda
Kampala, Uganda 17 March Dr P. Bastiaensen
IFAH Board Meeting Brussels, Belgium 17–18 March Dr B. Vallat & Dr N. Leboucq
Eggs Production and Marketing Congress,  
organised by the Paulista Poultry Association
Ribeirão Preto, Brazil 17–19 March Dr L.O. Barcos
1st Session of the OIE ‘Train the Trainers’  
Regional Workshop on animal welfare during  
transport and slaughter
Tbilisi, Georgia 17–20 March Dr R. Kolesar & Dr S. Ralchev
MAN-IMAL Colloquium 2015 on: ‘One World,  
One Health’
Nantes, France 18 March Dr E. Erlacher-Vindel
Engaging Intergovernmental Organizations 
Programme (EIO 2015) from the University  
of Minnesota, United States of America
OIE Headquarters, 
Paris, France
23 March Dr B. Vallat, Dr A. Thiermann, Dr Y. Farhi, 
Ms E. Tagliaro, Dr L. Awada,  
Dr L.H. Stuardo Escobar, Dr G. Pavade  
& Dr G.J. Torres Peñalver
One-day think-tank: ‘One Health: Impacts,  
Measures and Metrics’
Nairobi, Kenya 23 March Dr P. Bastiaensen
WTO-STDF Working Group Meeting WTO Headquarters, 
Geneva, Switzerland
23–25 March Dr D. Belton
Monitoring mission of the Central Myanmar FMD 
Vaccination Campaign
Mandalay, Myanmar 23–25 March Dr P. Widders & Dr C. Miller
4th Meeting of the Collaborative Arrangement  
for the Prevention and Management of Public Health 
Events in Civil Aviation (CAPSCA)
Amsterdam, the 
Netherlands
23–25 March Dr N. Leboucq
FMD Outbreak Investigation and Management 
Training
Battambang, Cambodia 23–27 March Ms C. Dy
meetings and visits
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March  2015 (contd)
Title of the event Place Date Participants
Symposium: ‘Animal Health Surveillance 2.0’, 
organised by the RISKSUR consortium
Ghent, Belgium 24 March Dr G.J. Torres Peñalver
27th Congress of the Veterinary Association of 
Malaysia: ‘Providing Holistic Solutions to Changing 
Global Challenges: Threats and Opportunities for 
Veterinarians’
Kuala Lumpur, Malaysia 24–25 March Dr R. Abila
OIE Veterinary Legislation Support Programme (VLSP) 
Training Seminar
OIE Headquarters, 
Paris, France
24–26 March Dr B. Vallat, Dr M. Eloit, Dr A. Dehove,  
Dr G. Mylrea, Dr F. Diaz, Dr F. Caya,  
Dr M.E. González Ortiz, Dr S. Pupulin,  
Dr V. Sharandak, Dr D. Sherman,  
Dr M. Petitclerc,  
Dr P.A. Belmar von Kretschmann,  
Dr J. Mérot, Dr M. Arroyo Kuribreña  
& Dr X. Pacholek
Engaging Intergovernmental Organizations 
Programme (EIO 2015) from the University of 
Minnesota, United States of America
WTO and WHO 
Headquarters, Geneva, 
Switzerland
24–26 March Dr Y. Farhi
Training for Caribbean Veterinary Services on Animal 
Disease Recognition and Response
Port of Spain, Trinidad 
and Tobago
24–26 March Dr K. Hamilton
9th Regional workshop on animal welfare for 
veterinary practitioners
Stara Zagora, Bulgaria 25–26 March Prof. N.T. Belev
62nd WTO SPS Committee Meeting and two informal 
meetings
Geneva, Switzerland 25–27 March Dr D. Belton
1st Consultation Meeting with Partners and 
Stakeholders of the OIE Platform on Animal Welfare 
for Europe 
OIE Headquarters, 
Paris, France
26 March Dr N. Leboucq
High-Level Technical Meeting: ‘Overcoming Gaps  
in Research and Development on Antimicrobial Drug 
Resistance’, co-organised by WHO and the Ministry  
of Health of Brazil
Brasilia, Brazil 26–27 March Dr B. Freischem & Dr M. Minassian
Workshop on the OIE procedure for the official 
recognition of Member Countries’ disease  
status and for the endorsement of their official 
national control programmes with regard to FMD  
for Eastern Europe
Astana, Kazakhstan 26–27 March Dr L. Weber-Vintzel, Dr M.K. Park,  
Prof. K. Lukauskas, Dr M. Taitubayev,  
Dr A. Kozhumratov & Prof. T. Drew
9th RAWS Coordination Group Meeting Kuala Lumpur, Malaysia 26–27 March Dr L.H. Stuardo Escobar, Dr H. Kugita,  
Dr Y. Oh, Dr R. Abila, Dr P. Matayompong 
& Dr G. Murray
Final Workshop Laboratory Twinning Project  
between the Istituto Zooprofilattico Sperimentale  
delle Venezie and the Central Vietnam  
Veterinary Institute
Nha Trang, Vietnam 26–27 March Dr S. Zaari
meetings and visitsO
IE
 n
ew
s
2015 • 248
March  2015 (contd)
Title of the event Place Date Participants
Engaging Intergovernmental Organizations 
Programme (EIO 2015) from the University  
of Minnesota, United States of America
FAO Headquarters, 
Rome, Italy
27 March Dr Y. Farhi
6th EWDA Student Workshop: ‘Human drivers  
of emerging diseases’
Veyrier-du-Lac, France 27–29 March Dr F. Diaz & Prof. M. Artois
1st AEGCD-ASWGL Joint Consultative Workshop  
on Development of Action Plan to implement the 
ASEAN Rabies Elimination Strategy
Chiang Mai, Thailand 30–31 March Dr H. Kugita, Dr H. Thidar Myint,  
Dr Y. Aoyama, Dr R. Abila  
& Dr M.J. Gordoncillo
GHSA teleconference on ‘Real-time Biosurveillance’ 
(‘Detect-2/3’) Action Package
OIE Headquarters, 
Paris, France
31 March Dr P. Cáceres Soto, Dr L. Awada  
& Dr P. Tizzani
2nd FAO/OIE Sub-Regional Meeting on GF-TADs  
for ASEAN Member Countries
Chiang Mai, Thailand 31 March Dr H. Kugita, Dr H. Thidar Myint,  
Dr Y. Aoyama, Dr R. Abila  
& Dr M.J. Gordoncillo
FAO/OIE International Conference for the Control  
and Eradication of Peste des Petits Ruminants (PPR)
Abidjan, Côte d’Ivoire 31 March –  
2 April
Dr B. Vallat, Dr C. Bertrand-Ferrandis,  
Dr D. Chaisemartin,  
Ms I. Contreras Arias,  
Dr N. Mapitse, Dr J. Domenech,  
Dr S. Münstermann, Dr D. Sherman,  
Dr Y. Samaké, Dr K. Tounkara,  
Dr D. Bourzat, Dr M. Letshwenyo,  
Dr R. Bouguedour, Dr A. Ripani,  
Dr J. Mérot, Dr P. Bastiaensen,  
Dr N. Leboucq, Dr X. Pacholek  
& Dr N. Kauta
Meeting with the Minister of Livestock  
of Somalia
Abidjan, Côte d’Ivoire 1 April Dr B. Vallat & Dr Y. Samaké
Meeting with the Adviser in charge of animal 
production to the Ministry of Agriculture of the 
Democratic Republic of Congo
Abidjan, Côte d’Ivoire 1 April Dr B. Vallat & Dr Y. Samaké
Meeting with the Minister of Livestock  
of Mauritania
Abidjan, Côte d’Ivoire 2 April Dr B. Vallat & Dr Y. Samaké
Hearing with His Excellency Mr Alassane Ouattara, 
President of the Republic of Côte d’Ivoire
Abidjan, Côte d’Ivoire 3 April Dr B. Vallat & Dr Y. Samaké
Hearing with the Prime Minister of Côte d’Ivoire Abidjan, Côte d’Ivoire 3 April Dr B. Vallat & Dr Y. Samaké
Meeting with the Minister of Livestock and Fishery 
Resources of Côte d’Ivoire
Abidjan, Côte d’Ivoire 3 April Dr B. Vallat & Dr Y. Samaké
meetings and visits
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the OIE 
and its partners
Official procedure for PPR disease status
Introduction
Peste des petits ruminants 
(PPR) is an acute, contagious 
viral disease affecting sheep and 
goats and, occasionally, wild small 
ruminants. It represents one of 
the most economically important 
diseases affecting the livelihoods 
of smallholders who rely on small 
ruminants. 
First described in Côte d’Ivoire 
in 1942, the distribution of PPR 
has steadily expanded from West 
Africa to the Middle East and South 
and Central Asia. The disease has 
recently spread to North Africa and 
to the People’s Republic of China 
and has been reported to be moving 
southwards in Africa (see map on 
p. 56).
The importance of PPR is 
recognised by the OIE World 
Assembly of Delegates (the 
Assembly). During the 81st General 
Session, the Assembly adopted two 
resolutions in this regard: 
− Resolution No. 29, which 
amended the chapter of the Terrestrial 
Animal Health Code (Terrestrial Code) 
on PPR1
epidemiology & animal disease 
control programmes
− Resolution No. 30, which 
included PPR in the procedure by 
which the OIE officially recognises 
the disease status of countries2. 
From this time, Member 
Countries could request the 
Assembly to officially recognise 
their freedom from PPR for their 
whole country or for a zone, and 
also to endorse their national control 
programme for PPR.
Member Countries with an officially 
recognised PPR-free status or a national 
control programme endorsed by the OIE
The procedure for official 
recognition of disease status was 
first developed in 1994, as a result 
of Member Countries’ requests 
concerning foot and mouth disease 
(FMD), and then progressively 
extended to other diseases, according 
to the Assembly’s prerogative. 
The procedure currently includes 
the official recognition of disease 
status for African horse sickness, 
classical swine fever, contagious 
bovine pleuropneumonia (CBPP), 
rinderpest, PPR and bovine 
spongiform encephalopathy risk 
status, as well as the endorsement of 
official control programmes for FMD, 
CBPP and PPR. 
A Member Country wishing to 
be officially recognised by the OIE as 
free from one of the diseases listed 
above, or asking for endorsement 
of its official control programme by 
the OIE, should submit its request 
to the Director General of the 
OIE, accompanied by the relevant 
questionnaire laid out in Chapter 1.6. 
of the Terrestrial Code and any other 
relevant information, in compliance 
with the specific chapter of the 
Terrestrial Code.
Chapter 14.7. and Article 1.6.9. 
of the Terrestrial Code lay down the 
specific requirements that must be 
fulfilled by a Member Country to 
be included in the list of PPR-free 
Member Countries. Article 1.6.12. is 
concerned with Member Countries 
wishing to have their official control 
programme for PPR endorsed by the 
OIE.
In autumn 2013, Member 
Countries could, for the first time, 
submit an application to be officially 
recognised as free from PPR. 
1 See Bulletin, no. 2013–4, pp. 44–46
2 See Bulletin, no. 2013–4, pp. 46–49
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Table I
OIE Member Countries’ Official Disease-free Status for Peste des Petits Ruminants, as of May 2014
Region Member Country
Africa
Mauritius
South Africa
Americas
Argentina
Bolivia
Brazil
Canada
Chile
Colombia
Ecuador
Paraguay
United States of America
Asia and the 
Pacific
Australia 
Chinese Taipei
Korea (Rep. of)
Myanmar
New Caledonia 
New Zealand 
Singapore
Thailand
Region Member Country
Europe
Austria
Belgium
Bosnia and Herzegovina
Cyprus
Denmark
Estonia
Finland
France
Germany
Greece
Hungary
Iceland
Ireland
Italy
Liechtenstein
Lithuania
Luxembourg
Malta
Norway
Poland
Portugal
Romania
Slovakia
Slovenia
Spain
Sweden
Switzerland
The Netherlands
United Kingdom
Since it considers that adjusted 
surveillance to substantiate 
historical freedom from the disease, 
in accordance with the provisions 
in Article 1.4.6.(1), is valid for 
PPR, the Scientific Commission 
for Animal Diseases offered 
Member Countries that have 
historically been free from PPR 
the opportunity to apply through 
a shorter process that would be 
valid for one year. A modified 
and shortened questionnaire was 
developed for these countries.
The first list of PPR-free 
Member Countries officially 
recognised by the OIE was adopted 
by the Assembly in Resolution 
No. 20 during the 82nd General 
Session in May 2014 and included 
48 countries, as shown in Table I.
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Countries has applied for 
endorsement of its official PPR 
control programme. However, 
the OIE is expecting several 
applications, in line with the recent 
official implementation of the 
Global Control and Eradication 
Strategy for PPR.
included in the list of Member 
Countries free from PPR and the 
zone of Namibia located south of 
the Veterinary Cordon Fence was 
recognised as a zone free from PPR 
(Fig. 1).
Despite the offered procedure, 
to date none of the OIE Member 
Five additional Member Countries 
were proposed for official recognition 
by the Assembly during the 83rd 
General Session in May 2015, in 
accordance with the provisions 
of Article 14.7.3. of the Terrestrial 
Code: the Czech Republic, Mexico, 
the Philippines and Swaziland were 
Fig. 1
Map of OIE Member Countries’ official peste des petits ruminants (PPR) status, May 2015
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Member Countries and zones recognised as free from PPR
Countries without OIE official status for PPR
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Equine influenza activity in 2014 
During 2014, individual animal cases and 
outbreaks of equine influenza were reported by 
France, Germany, Ireland, Sweden, the United 
Kingdom (UK) and the United States of America 
(USA).
Sources of equine influenza viruses characterised  
Equine influenza A (H3N8) viruses were isolated 
and/or characterised from outbreaks in all the 
countries listed above.
Field data
Equine influenza virus infections were confirmed 
in both vaccinated and unvaccinated horses. 
In 2014 there was an increase in influenza 
activity in Europe particularly in the UK and 
Ireland with cases confirmed on 31 and 18 premises 
respectively. The majority of the clinically 
affected horses were unvaccinated or of unknown 
vaccination history, but vaccination breakdown was 
recorded in several racing yards in Ireland. 
Equine influenza outbreaks were confirmed on 
28 premises in 19 states in the USA. The vaccination 
history was unknown in the majority of cases but 
vaccination breakdown was recorded in a boarding 
facility in Tennessee. 
Characterisation of viruses identified  
in 2014 
Viruses isolated/identified from outbreaks in 
France, Germany, Ireland, Sweden, the UK and the 
USA were genetically characterised by sequencing 
the haemagglutinin (HA) gene. The sequences of the 
neuraminidase (NA) genes for several virus isolates 
from Ireland, Sweden, the UK and the USA were 
determined. 
Equine influenza vaccine 
composition
Conclusions and recommendations  
of the OIE Expert Surveillance Panel  
on Equine Influenza Vaccine Composition 
meeting held at OIE Headquarters,  
Paris, on 6 March 2015
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Viruses isolated in Ireland, the UK and the USA were 
also characterised antigenically by the haemagglutination 
inhibition (HI) assay, using post-infection ferret antisera 
and chicken red blood cells. 
Genetic characterisation
All HA sequences obtained from viruses were of the 
American lineage (Florida sublineage). 
The viruses detected in the USA were characterised as 
clade 1 viruses. 
The viruses detected in France, Germany, Ireland, 
Sweden and the UK were characterised as clade 2 viruses. 
Two subpopulations of clade 2 viruses have been 
identified with amino acid substitutions in HA1 at either 
position 144 or position 179. The majority of 2014 
viruses characterised had a valine at position 144 and an 
isoleucine at position 179. No equine influenza viruses 
were identified in Asia in 2014, but clade 2 viruses from 
Asia are distinguishable from those circulating in Europe.
The NA gene sequences of viruses from clade 1 and 
clade 2 were clearly distinguishable.
Representative sequences for HA and NA are available 
on GenBank and the Global Initiative on Sharing All 
Influenza Data (GISAID).
Antigenic characteristics
Haemagglutination inhibition data available for 
viruses isolated in 2014, and antigenic cartography 
analyses of these same data, show that the two clades of 
the Florida sublineage continue to co-circulate and evolve 
but currently remain closely related antigenically to the 
recommended vaccine viruses of that lineage.
Conclusions 
No Eurasian viruses were detected in 2014. Those 
viruses that were isolated and characterised came from 
clades 1 and 2 of the Florida sublineage. Viruses of both 
clades were associated with vaccination breakdown. 
Level of surveillance and updating of vaccines 
The OIE Expert Surveillance Panel on Equine 
Influenza Vaccine Composition continues to emphasise 
the importance of increased surveillance and further 
investigation of vaccination breakdown in different 
countries. 
Increased surveillance in Asia has been facilitated by 
the OIE laboratory twinning programme. 
The rapid submission of viruses to Reference 
Laboratories is essential if antigenic and genetic drift is to 
be monitored effectively on a global basis.
Although some vaccines have been updated to 
include a virus from clade 2, in accordance with the 
recommendations of 2010 to 2014, the majority of the 
current vaccines contain outdated strains.
Updating vaccines with epidemiologically relevant 
viruses is necessary for optimum protection. The OIE 
Expert Surveillance Panel welcomes the replacement 
of the European Medicines Agency (EMA) note for 
guidance on the harmonisation of requirements for 
equine influenza vaccines (EMEA/CVMP/112/98-
FINAL) by the Guideline on data requirements for changes 
to the strain composition of authorised equine influenza 
vaccines in line with OIE recommendations (EMA/CVMP/
IWP/97961/2013)1 and any amendments to regulatory 
procedures that allow equine influenza vaccines to be 
updated as speedily as possible without compromising 
safety and efficacy.
Recommendations (March 2015)
These are unchanged from those made in March 2014.
It is not necessary to include an H7N7 virus or an 
H3N8 virus of the Eurasian lineage in vaccines as these 
viruses have not been detected in the course of the most 
recent surveillance and are therefore presumed not to be 
circulating.
Vaccines for the international market should 
contain both clade 1 and clade 2 viruses of the Florida 
sublineage:
− Clade 1 is represented by A/eq/South 
Africa/4/2003-like or A/eq/Ohio/2003-like viruses. 
Recent clade 1 viruses are available from the OIE 
Reference Laboratories.
− Clade 2 is represented by A/eq/
Richmond/1/2007-like viruses. Recent clade 2 viruses 
are available from the OIE Reference Laboratories.
1 Available at: www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/11/WC500177527.pdf
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Manufacturers producing vaccines for a strictly 
national market are encouraged to liaise with 
Reference Laboratories. The selected viruses should 
induce responses which are immunogenically 
relevant to the equine influenza viruses circulating 
nationally. A sequence determination of both HAs 
and NAs should be completed before use.
Reference reagents
Freeze-dried post-infection equine antisera to 
A/eq/Newmarket/1/93 (American lineage H3N8) 
and A/eq/South Africa/4/2003 (Florida clade 1, 
sublineage of the American lineage) are available 
from the European Directorate for the Quality of 
Medicines (EDQM). These sera have been assigned 
single radial haemolysis (SRH) values through an 
international collaborative study and can be used 
as primary reference sera for the assay. 
There is no SRH reference serum currently 
available for A/eq/Richmond/1/2007, representative 
of Florida clade 2. The need for such a reference 
serum is recognised by the panel.
There is currently a shortage of standardised 
antigen for the purpose of quantifying HA. Single 
radial diffusion (SRD) reagents will no longer be 
produced by the National Institute for Biological 
Standards and Control (NIBSC), the UK. Vaccine 
companies should inform the OIE if there is a need 
for updated SRD reagents or other standards.
Recent virus strains, including suitable vaccine 
candidates for clades 1 and 2, are available from 
the OIE Reference Laboratories. In the event 
that an OIE Reference Laboratory cannot supply 
suitable vaccine candidates for both clades, it will 
assist the vaccine company to source the viruses 
from an alternative OIE Reference Laboratory.
Small quantities of ferret antisera for antigenic 
characterisation are available from the OIE 
Reference Laboratories in Ireland and the UK.
OIE Reference Laboratories  
for equine influenza
Dr Armando Damiani 
Institute of Virology
Department of Veterinary Medicine
Free University of Berlin
Robert-von-Ostertag-Str. 7-13
14163 Berlin
Germany
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Prof. Ann Cullinane  
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Dr Debra Elton 
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Centre for Preventive Medicine
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Tel. +44-1638 75 10 00 
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Dr Thomas M. Chambers  
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Department of Veterinary Science
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Tel. +1-859 257 47 57 
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Peste des petits ruminants (PPR) is the most serious disease 
among small domestic ruminants, affecting an estimated 30 million 
animals every year globally. PPR is contagious, transboundary, 
and has severe negative socio-economic impacts on the income 
of livestock farmers and, in particular, the livelihoods and food 
security of the most vulnerable rural livestock farmers, notably of 
women.
The geographical distribution of PPR has expanded 
considerably over the past ten years.  It now affects a large number 
of countries in Africa, the Middle East, and Asia (Fig. 1). This has 
devastating consequences on families, communities and countries. 
Mortality can affect 90% of animals in flocks and morbidity can 
range from 50 to 100%, which results in production losses of 
20% or higher (due to weight loss, reduced fertility, reduced milk 
production…).
Piloting solutions to best inform  
and shape the Global Strategy for the control 
and eradication of PPR
Fig. 1
Current global PPR situation and occurrence of outbreaks between 2007 and 2014
Source: OIE WAHIS and FAO EMPRES-i
DISEASE STATUS (OIE)
■ Present
■ Absent
OUTBREAKS
● Year 2007
● Year 2008
● Year 2010
● December 2013
●  January 2014
■ Suspected
■ Unknown/N.A.
● February 2014
● March–April 2014
● May–July 2014
● August 2014–
 February 2015
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The benefits and profits accrued from controlling the disease 
may result in improved productivity, food security, income 
generation and social empowerment. The elimination of PPR is key 
to poverty reduction. The need to tackle this disease as a priority 
has also been recognised by the Bill & Melinda Gates Foundation in 
the Agricultural Development, Livestock Overview and Approach 
published in April 2012.
In October 2012, the Bill & Melinda Gates Foundation 
provided funding to the OIE to implement a two-year programme 
to tackle PPR in two donor-selected countries (Burkina Faso and 
Ghana) through the Vaccine Standards and Pilot Approach to PPR 
Control in Africa (VSPA) programme. 
The VSPA programme was composed of the following three 
complementary and interrelated components:
Component 1: Establishment of an OIE PPR Vaccine Bank  
 for Africa
Component 2: Strengthening of the capacities of AU-PANVAC1
Component 3: Development of a pilot strategy to  
 progressively control/eradicate PPR  
 in 2–3 countries.
Establishment of an OIE PPR Vaccine Bank for Africa  
With relation to Component 1, and based on the OIE 
experiences in the establishment of vaccine banks (see p. 61), the 
OIE launched an international call for tenders for the establishment 
of a vaccine bank to control PPR in Africa. Following a selection 
process involving independent international experts, the OIE 
negotiated a contract with an Africa-based vaccine supplier and 
provided a total of 14 million doses of PPR vaccine (and the 
respective diluent) to supply vaccines to a total of four African 
countries.
This programme has underlined that the availability of high 
quality and OIE compliant PPR vaccine is of paramount importance 
for implementing effective vaccination campaigns and that OIE 
regional vaccine banks play a key role for the delivery of such 
quality vaccines. 
Strengthening of the capacities of AU-PANVAC  
Component 2 provided an opportunity for the OIE and 
AU-PANVAC to reinforce an existing partnership and build on new 
strengths and responsibilities2. 
1 AU-PANVAC: African Union Pan-African Veterinary Vaccine Centre
2 At the 81st General Session of the World Assembly of Delegates to the OIE (May 2013) and through Resolution no. 32, AU-PANVAC was recognised 
as an OIE Collaborating Centre for Quality Control of Veterinary Vaccines
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Key outputs of this component included the development of a 
Quality control strategy for PPR vaccines produced in Africa as well as a 
comprehensive analysis of PPR vaccine production capacities in Africa; these 
two documents have been used in the development of the Global Strategy 
for the control and eradication of PPR. 
Thanks to the support provided by ANSES3, Colorado State University, 
CIRAD4, IAEA5 and OVI6, a series of training courses were organised for 
both African PPR vaccine producers and AU-PANVAC staff (more than 
35 individuals trained). The efforts made and accomplishments achieved 
through this component will positively contribute and shape future 
continental efforts to eradicate PPR.
Development of a pilot strategy
Using an array of techniques and in close strong partnership with the 
national Veterinary Services, CIRAD and other relevant actors, the OIE 
conducted a pilot study to define a control strategy which would offer the 
most complete vaccination coverage possible to progressively reduce and 
control PPR in Burkina Faso and Ghana (Component 3). 
The vaccination delivery scenarios tested were: 
–  No vaccination: non treated area (control group).
–  Scenario 1: vaccines provided free of charge to the Veterinary 
Services without additional support.
–  Scenario 2: vaccines provided free of charge, as well as contributing 
to a portion of the operational costs sustained by the Veterinary 
Services for the vaccination campaigns.
–  Scenario 3: vaccines provided free of charge, as well as a portion 
of the operational costs linked to the vaccination campaigns, and 
correlated incentives, such as the free distribution of anthelmintic.
With the collaboration and support of the National Veterinary Services 
and CIRAD, the following specific activities were undertaken:
–  Pre-vaccination participatory disease searching (PDS) surveys to 
estimate pre- and post-vaccination PPR clinical incidence at village 
level. The PDS surveys and serological results clearly demonstrated 
that PPR was widespread in the pilot study areas, thereby 
enabling the assumption that the post-vaccination differences in 
seroprevalence rates, PPR clinical incidence rates and small ruminant 
productivity were related to different vaccine delivery scenarios 
tested.
–  Field training of Veterinary Services in various topics and subject 
matter, including participatory epidemiology, sociological research 
techniques, vaccination techniques, etc.
3 ANSES: Agence nationale de sécurité sanitaire de l’alimentation, de l’environnement et du travail 
(French Agency for Food, Environmental and Occupational Health & Safety)
4 CIRAD: Centre de coopération internationale en recherche agronomique pour le développement  
(French Agricultural Research Centre for International Development)
5 IAEA: International Atomic Energy Agency
6 OVI: Onderstepoort Veterinary Institute, South Africa
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–  Using the vaccines from the OIE PPR Vaccine Bank for Africa, 
vaccination campaigns were conducted in both Burkina Faso and 
Ghana using the vaccination delivery scenarios. 
–  Sero-epidemiological surveys were conducted to cross-check the 
results of PDS surveys, estimate the post-vaccination serological 
prevalence rate and provide an estimate of post-vaccination 
immunity coverage.
–  Animal productivity surveys to estimate animal and financial herd 
productivity on the basis of PPR-infected compared to non-infected 
animals. Productivity indexes were used to make an indicative 
and preliminary cost–benefit analysis of the different vaccination 
strategies implemented in the VSPA programme. 
–  Sociological surveys to identify how socio-technical animal-health 
networks negatively impact and influence the PPR vaccination 
campaign, and to assess farmers and vaccinators perception of 
vaccination and vaccine delivery.
A great detail of data and many lessons were learnt through this pilot 
study and will be used to define the national programmes for PPR control 
in both Burkina Faso and Ghana.
Among key lessons learned, this pilot strategy has demonstrated that:
1. effective collaboration, communication and coordination with all 
relevant national actors are fundamental, particularly with farmers at 
farm level and private veterinarians;
2. flexibility and capacity to adapt the vaccination delivery systems to 
the different farming systems are critical;
3. vaccination periods must be carefully selected to ensure an 
efficacious campaign notably according to the climate seasons, 
flock movements, parturition peak and agricultural calendar and 
availability of the farmers;
4. monitoring and evaluation of the vaccination campaign are key 
and should use a range of diverse yet complementary methods 
(conventional surveillance, laboratory investigations, participatory 
and sociological methods, etc.).
The VSPA has been a largely successful programme and has, to a 
large extent, better informed the development of the Global Strategy 
for the control and eradication of PPR presented and supported by the 
international community at the FAO/OIE International Conference for 
the Control and Eradication of PPR held in Abidjan, Côte d’Ivoire, from 
31 March to 2 April 2015.
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Top five accomplishments:
1. Rapidity and efficacy in establishing the OIE PPR 
Vaccine Bank for Africa, including the cost and quality 
of the vaccine.
2. Significant leverage effect created by direct purchases 
from the OIE PPR Vaccine Bank for Africa by countries 
through funds provided by the World Bank.
3. Extensive and comprehensive field operations in two 
priority countries, Burkina Faso and Ghana, using an 
array of techniques and successfully implemented 
in partnership with National Veterinary Services and 
animal health networks of both countries with the 
support of OIE Collaborating Centre, CIRAD.
4. The lessons learned and data produced by this 
programme have contributed to and supported the 
definition of the Global Strategy for the control and 
eradication of PPR.
5. The project has generated global interest from donors 
and partners on PPR and supported the disease being 
targeted as the next disease for global eradication.
OIE portal on PPR:
www.oie.int/en/animal-health-in-the-world/official-disease-status/
peste-des-petits-ruminants/technical-disease-cards/
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Peste des petits ruminants (PPR) is a highly contagious disease of sheep and 
goats caused by a Morbillivirus closely related to the rinderpest virus and is 
considered to be one of the most damaging livestock diseases in Africa, the Middle 
East and Asia.
Lessons learned from the Global Rinderpest Eradication Programme 
demonstrate that the use of a highly efficacious rinderpest vaccine capable of 
immunising animals against all rinderpest virus strains was a vital contributor to 
the campaign’s success. A similar tool also exists for the prevention and control of 
PPR; efficient live attenuated PPR vaccines are available and can induce life-long 
protective immunity in vaccinated animals.
Vaccination is thus one of the key tools to controlling PPR and has been 
identified as the main option in Stage 2 ‘Control’ and Stage 3 ‘Eradication’ 
(Fig. 1), of the Global Strategy for the control and eradication of PPR presented 
and supported by the international community at the FAO/OIE International 
Conference for the Control and Eradication of PPR held in Abidjan, Côte d’Ivoire, 
from 31 March to 2 April 2015.
OIE PPR vaccine bank for Africa
Fig. 1 
The progressive step-wise approach for the prevention and control of peste des petits ruminants (PPR)
Recognising that PPR can be eradicated and that vaccination is central to the 
achievement of this much-needed endeavour, in 2012 and in the framework of the 
Vaccine Standards and Pilot Approach to PPR control in Africa (VSPA) programme 
financed by the Bill & Melinda Gates Foundation1, the OIE established a PPR 
vaccine bank for Africa (pilot programme in West Africa, at the donor’s request2).
No data
available
Assessment
Stage
Control
Stage
Eradication
Stage
Post Eradication
Stage
OIE Free
Status
BELOW
STAGE
1
STAGE
1
STAGE
2
STAGE
3
STAGE
4
BEYOND
STAGE 
4
1 See article on pp. 56–60 of this Bulletin for detailed information on the VSPA programme
2 See article on pp. 78-85 of this Bulletin for detailed information on the pilot programme
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Based on previous OIE experiences in the establishment of vaccine banks (avian 
influenza, foot-and mouth disease and rabies3), the OIE launched an international 
call for tenders for the establishment of a vaccine bank to control PPR in Africa. 
Following a selection process involving independent international experts and 
AU-PANVAC4, the OIE negotiated a contract with an Africa-based vaccine supplier for 
an initial period of 20 months (extended until September 2015) to supply vaccines 
(and the respective diluent). 
As an outcome of the selection process, the PPR vaccine bank mechanism 
allows high-quality vaccines complying with OIE intergovernmental standards to 
be delivered in batches of 500,000 doses or more (in multi-dose vials5), with two 
delivery speed options and scheduled production of batches of 2 million doses. The 
rolling mechanism of this vaccine bank ensures that the purchased vaccines are 
produced upon request, thereby extending the expiry date of vaccines delivered to the 
country. It also helps limit the multiplication of procurement procedures in countries, 
and enables economies of scale through the reduction of purchase costs per vaccine.
As of March 2015 and in the framework of the VSPA programme, the OIE has 
already delivered a total of 10 million doses of high-quality vaccines complying 
with OIE intergovernmental standards to African countries infected with PPR. An 
additional 4 million doses of PPR vaccine were purchased directly from the OIE PPR 
vaccine bank for Africa and delivered to an Africa country further to a loan received 
from the World Bank. In order to establish this mechanism, the OIE procurement 
procedure for the establishment of the PPR vaccine bank was analysed and evaluated 
by World Bank procurement experts. During the VSPA programme’s closing 
meeting conducted at OIE Headquarters on 2 and 3 October 2014, the World Bank 
representative stated that ‘OIE vaccine banks are an excellent mechanism and we are 
confident when supporting purchases from these banks as the focus is on the quality at an 
incomparable price’.
The OIE is exploring opportunities to sustain and expand its PPR vaccine bank 
in order to continue to provide its Member Countries with access to high quality 
vaccines at a highly competitive rate in the future. This is clearly in line with 
the FAO/OIE International Conference for the Control and Eradication of PPR 
recommendation no. 16, which states that ‘regional PPR vaccine banks [should] be 
established using OIE successful experiences to respond to emergencies and improve 
quality controlled vaccine delivery in countries on a competitive process based on quality 
and price’.
3 See Bulletin, No. 2014-3, pp. 9–11, for an overview of OIE vaccine banks
4 AU-PANVAC: African Union Pan-African Veterinary Vaccine Centre
5 Based on the size of vials offered by the supplier selected through the competitive call for tenders process
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Benefits of the OIE PPR vaccine bank
•	 Quality-related	incentives:
− vaccines supplied to countries are of high quality and comply with OIE 
intergovernmental standards
− vaccines are delivered with required flexibility and based on request/availability 
of the country
− a reduction in the risks associated with storing large quantities of formulated 
vaccine in potentially sub-optimal conditions
− virtual stock/replenishment mechanisms ensure that purchased vaccines do not 
expire before use.
•	 Fluid	logistics:
− timely dispatch of emergency stocks in line with field needs
− possible delivery of relatively small quantities
− easy procurement and delivery systems, limiting possible costs associated with 
the multiplication of local registration and vaccine purchases
− easy customs clearance (international aid)
− virtual stocks, production on demand
− the burden of storage lies with the selected vaccine supplier(s), rather than with 
the purchasing countries
− possible management of a multi-supplier supply chain
− multi-supplier approach available.
•	 Cost	incentives:
− contract foresees sophisticated financial mechanisms with clauses for direct 
purchase by countries 
− economies of scale
− a cost reduction per vaccine unit (one call for tender and contract for large 
quantities resulting in a reduced fixed cost)
− management of multi-donor financial support allows earmarking of funds 
(eligible countries/activities): low overheads, economies of scale and very low 
fixed costs
− synergies and leverage effects.
•	 Better	coordination:
− harmonisation and coordination of regional control programmes
− implementation of global control strategies
− support for multi-party vaccination campaigns
− public–private partnerships
− country incentives to become engaged.
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1. Introduction
Peste des Petits ruminants (PPR), also called rinderpest 
of small ruminants, is an acute contagious disease of sheep 
and goats which causes a devastating plague with morbidity 
and mortality rates as high as 100% and 90% respectively . 
PPR is an OIE listed disease because of the morbidity 
and mortality it causes and of its economic importance 
as a transboundary viral disease that constitutes a threat 
to livestock production in many developing countries, 
particularly in West Africa, East Africa, the Arabian 
Peninsula and South-East Asia . The control of PPR is 
considered a priority for poverty alleviation as it is a major 
constraint in augmenting the productivity of small ruminants 
in developing countries and particularly severely affects poor 
farmers’ economy .
Following the rinderpest eradication celebrations of the 
OIE in May 2011 and the FAO1 in June 2011, attention 
suddenly turned to other transboundary animal diseases . 
The OIE and FAO have recognised PPR as one of the most 
economically important animal diseases and also its huge 
impact on production; and, given its many similarities with 
cattle rinderpest, have considered it a strong candidate for 
eradication .
Several technical factors were taken into consideration 
to work towards achieving global eradication of the PPR 
virus . In addition to the fact that the causal agents of both 
diseases are closely related and belong to the Morbillivirus 
genus [2], these include: availability of low-cost safe 
attenuated vaccines [1, 5] conferring life-long immunity 
with a single shot; availability of diagnostic tests for sero-
monitoring vaccination programmes and virus detection; 
effective sero-conversion achieved with sub-minimal doses of 
the vaccine (100 .8 TCID50) [5].
On the basis of this knowledge, the international 
community consensually selected PPR as one of the next 
animal diseases to be eradicated and this gave rise to 
the development of a global strategy for the control and 
eradication of the disease by the OIE and the FAO .
Drawing on the lessons learned from the role played by 
the African Union (AU) Pan African Veterinary Vaccine Centre 
(PANVAC) in ensuring the quality of the vaccines used in the 
rinderpest eradication campaign, the quality of PPR vaccines 
to be used was considered a key element especially given 
the enormous challenges faced by the majority of developing 
countries in producing and distributing PPR vaccine .
2. Role of AU-PANVAC 
AU-PANVAC is the only organisation mandated by the 
AU Member States to provide the quality assurance of all 
veterinary vaccines either produced or imported into Africa . 
The subsequent Institutionalisation of PANVAC under the 
AU as an AU Technical Centre of Excellence was made in 
recognition of PANVAC’s contribution to the success of the 
Pan African Rinderpest Campaign (PARC) . It was also based 
1 FAO: Food and Agriculture Organization of the United Nations
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Quality control of PPR vaccines  
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on that recognition that the AU-PANVAC mandate was 
eventually expanded to include the quality control of all 
veterinary vaccines and the production of basic diagnostic 
reagents . Thus AU-PANVAC was founded on the belief 
that livestock health in Africa, especially with regards to 
major infectious vaccine-preventable diseases, can be 
substantially improved by the use of good quality vaccines 
and good laboratory diagnostic support .
The AU-PANVAC mandates include: 
− provision of international independent quality control 
of veterinary vaccines produced in Africa and imported to 
Africa; 
− production and distribution of essential biological 
reagents for animal disease diagnosis and surveillance; 
− facilitating the standardisation of veterinary vaccines 
production and harmonisation of their quality control 
techniques in Africa; 
− promoting the transfer of appropriate vaccine production 
technologies in Africa; and 
− providing training and technical support services 
to veterinary vaccine production and quality control 
laboratories .
2.1. Certification of veterinary vaccines on the 
continent
AU-PANVAC continues to ensure that laboratory 
networks throughout Africa are supported to achieve 
high performance standard by promoting the adoption of 
improved methods for the production and quality control 
of priority vaccines . Providing International Independent 
quality of all veterinary vaccines used in Africa has been 
a major activity of the AU-PANVAC since its inception in 
1986 . This has resulted in significant improvements in 
the quality of vaccines produced and used on the African 
continent, which is a clear demonstration of the importance 
of an independent and secondary level quality testing [3]. 
Roll-out of this service was most extensive in Africa 
between 1988 and 1993, when PANVAC tested a total of 
694 batches of rinderpest vaccine used in PARC [4]. In the 
last five years alone, AU-PANVAC has tested more than four 
times the number of batches and the quality improvement 
rate of vaccines from African laboratories has now exceeds 
90% compared to about 30% in the early days . The 
responsibilities of AU-PANVAC continue to increase with 
regards to animal disease control, along with stakeholders’ 
appreciation and recognition of its performance . A number 
of evaluation and review teams reported that PANVAC’s 
activities in the rinderpest eradication campaign have 
resulted in a significant improvement in the quality of 
rinderpest vaccine produced in Africa, thereby contributing 
to the success of the PARC . One review team noted that 
‘The success of the PARC and the Pan African Programme 
for the Control of Epizootics (PACE) clearly demonstrated 
that no amount of vehicles, syringes, trained personnel, 
communication materials, would have eliminated rinderpest 
if the vaccine batches used had been of poor quality. 
The secondary and independent level of quality control 
assessment assured by PANVAC played a major role for this 
success and at the same time led to sustained improvement 
in the quality of vaccines against rinderpest and contagious 
bovine pleuropneumonia produced in Africa’ . The then 
OAU Council of Ministers decided to elevate PANVAC to the 
level of an OAU Specialised Agency in 1998 and eventually 
institutionalised it under the African Union as AU-PANVAC 
in 2003 with a view to sustaining this achievement in the 
interests of Africa .
2.2. Transfer of new vaccine production technologies
In addition to ensuring the quality of vaccines produced, 
and providing training to technicians from National 
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Vaccine Production Laboratories in Africa, PANVAC 
has also been involved with the transfer of new vaccine 
production technologies to Africa and the improvement 
of existing technologies . Accordingly, PANVAC pioneered 
the development of an alternative method for preparing 
thermo-tolerant vaccines known as the Xerovac process 
which demonstrated that the vaccine was capable of 
withstanding 45 °C for a period of 14 days with minimal 
loss of potency and with the distinct advantage of a 
shorter, cheaper and simpler process compared to other 
‘thermostable’ vaccines [11].
This technology ensures that the vaccine will maintain 
the minimum titre required when it reaches the field . The 
minimum requirement for attenuated PPR vaccine dose is 
102 .5 TCID50 per ml . The recommended value for the field 
efficacy should be 1 to 2 log higher than the minimum 
protective dose . This technology has been transferred to 
several vaccine-producing laboratories in Africa . 
2.3. Recognition of AU-PANVAC by the OIE
AU-PANVAC has collaborated with the OIE and has 
participated actively in its activities since inception . 
AU-PANVAC has taken part in the OIE Working Group 
on Veterinary Drug Registration and the FAO/AU-IBAR2/
OIE/IAEA3 Consultative Group on Contagious Bovine 
Pleuropneumonia (CBPP) for several years . It has also 
been invited annually to attend the General Session 
of the OIE which takes place in May . In recognition of 
the key role AU-PANVAC has played in animal disease 
control by providing quality control of vaccines produced 
in Africa, and the expertise it has gained through the 
years, AU-PANVAC was officially designated as an OIE 
Collaborating Centre for Quality Control of Veterinary 
Vaccines by the OIE World Assembly of Delegates  
in May 2013 .
2.4. Maintaining Africa free from rinderpest 
During the ‘Declaration of global eradication of 
rinderpest and the follow-up measures to maintain the 
world free of rinderpest’, the OIE World Assembly of 
Delegates through Resolution No . 18 of its 79th General 
Session in 2011 [7], requested the Director of the 
OIE to approve facilities where material containing the 
rinderpest virus can be held, and to conduct regular site 
visits of those facilities to verify whether their biosafety/
biosecurity conditions are adequate . Furthermore, 
the Assembly urged Member States to ‘destroy, under 
the supervision of the Veterinary Authority, rinderpest 
virus-containing materials or assure the storage or use 
of these materials in a biosecure facility in their country 
or, where applicable, assure the safe transfer to an 
approved laboratory in another country in agreement 
with the Veterinary Authority of the receiving country 
and complying with the standards of the OIE Manual of 
Diagnostic Tests and Vaccines for Terrestrial Animals  
(the Terrestrial Manual) [10] and the Guidelines 
elaborated by the Joint FAO/OIE Committee on Global 
Rinderpest Eradication’ . It is in compliance with the 
general framework of the global eradication of rinderpest 
and specifically in order to maintain Africa free of 
the disease, that the Ministers responsible for Animal 
Resources in Africa during their 8th Conference held in 
Entebbe, Uganda, in May 2010 recommended Member 
States of the AU to destroy all rinderpest virus strains 
held in Africa and to hand over what is deemed necessary 
to AU-PANVAC for safe storage . This Recommendation 
was subsequently endorsed by all the Heads of State of 
the AU during their January Summit of 2011 .
In Resolution No . 23 of the 82nd General Session of 
the World Assembly of Delegates in 2014 [9], the OIE 
established procedures for designating and approving 
facilities holding material containing rinderpest virus 
to maintain global freedom from rinderpest, and in 
2 AU-IBAR: African Union – Inter-African Bureau of Animal Resources
3 IAEA: International Atomic Energy Agency
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collaboration with FAO to ensure the full implementation of 
the activities of the Joint Rinderpest Advisory Committee 
to provide technical advice and oversee post-rinderpest 
eradication activities .
To pursue its actions, the AU Commission made 
available adequate resources to AU-PANVAC to acquire 
bio-safety level 3 required by the international veterinary 
community for the following:
− safekeeping rinderpest vaccine seed stocks; 
− safekeeping of emergency preparedness rinderpest 
vaccine stock (1 .5 million doses); and 
− maintain laboratory diagnostic capacity for rinderpest . 
In recognition and support of the major role played by 
AU-PANVAC in maintaining Africa free of rinderpest, the 
FAO made a grant of 166,800 USD to AU-PANVAC in 2011 
through a letter of agreement to strengthen its capacity for 
the sequestering rinderpest virus in its level 3 bio-safety 
laboratory . The FAO also jointly organised a workshop with 
AU-PANVAC on bio-safety, sequestration and risk analysis 
for laboratories holding rinderpest virus in Debre Zeit, 
Ethiopia, in July 2011 . In view of the need for transparency 
on information about remaining stocks of virus and the 
importance of reducing the existing rinderpest virus stocks, 
the OIE World Assembly of Delegates recommended in its 
Resolutions nos. 33 (2012) [8] and 23 (2014) [9] that 
respectively appointed a limited number of OIE Reference 
Laboratories as ‘rinderpest holding facilities’ and urged 
Member Countries to ensure that the remaining stocks of all 
material containing rinderpest virus to be safely transferred 
to one of the designated rinderpest holding facilities .
On the basis of these recommendations and those of 
the Ministers responsible for animal resources in Africa, the 
OIE/FAO Joint Advisory Committee on Rinderpest indicated 
and assessed AU-PANVAC for rinderpest holding capacity . 
The Committee recommended that AU-PANVAC facility 
should be considered for holding rinderpest virus material 
subject to the implementation of a number of corrective 
actions that AU-PANVAC has subsequently implemented . 
AU-PANVAC will ensure full compliance with the corrective 
actions recommended by the Committee within the 
stipulated time . 
3. The OIE Sub-grant and the Pan African 
Quality Control Strategy for PPR vaccines 
3.1. OIE Sub-grant to AU-PANVAC  
After the eradication of rinderpest, scientists’ 
attention turned to PPR which has been devastating 
small ruminant production in Africa and some parts 
of Asia . On account of the role played by AU-PANVAC 
in the eradication of rinderpest, it was considered to 
strengthen AU-PANVAC to ensure the use of good quality 
vaccines during the PPR eradication campaign . In line 
with this, a sub-grant of USD 1 million was given by the 
OIE to AU-PANVAC for three years to establish capacity 
for AU-PANVAC [6]. This project was awarded within the 
framework of a Bill & Melinda Gates Foundation funded 
grant to the OIE ‘Vaccine Standards and Pilot Approach 
to PPR Control in Africa’ (VSPA) .
The sub-grant project aimed to build capacity for 
PPR quality control at AU-PANVAC, develop the capacity 
of PPR vaccine-producing laboratories to produce good 
quality PPR vaccine, develop a quality control strategy for 
ensuring the use of good quality PPR vaccines in Africa 
and contribute to the definition of a sound scientific PPR 
reduction programme in Africa . Under the terms of this 
project, which was implemented in collaboration with 
and under the responsibility of the OIE, AU-PANVAC 
monitored the PPR vaccine cold chain in the field and 
the quality of the vaccines used in a pilot PPR reduction 
programme implemented by the OIE in West Africa. 
A Pan African quality control strategy was developed 
in collaboration with all the major stakeholders and 
capacities for quality control and good manufacturing 
practices were built in all PPR vaccine-producing 
laboratories . Finally, the PANVAC role and the continental 
strategy for quality control of PPR vaccines produced 
and used in Africa were used to support the regional and 
continental initiatives for the control/eradication of PPR 
in Africa .
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3.2. The Pan African Quality Control Strategy  
As part of the implementation of activity 8 of the 
OIE Sub-grant, AU-PANVAC and the OIE in collaboration 
with consultants/experts defined a PPR vaccine quality 
control strategy, to ensure the production of good quality 
PPR vaccines in Africa . Activity 8 of OIE Sub-grant 
to AU-PANVAC – ‘Define a quality control strategy for 
PPR vaccines produced in Africa’ – was one of the 
11 activities relating to VSPA . The two consultants 
recruited by AU-PANVAC to develop the Pan African 
Quality Control Strategy in collaboration with the OIE 
were Geneviève Libeau, Head of the OIE Reference 
Laboratory for PPR, CIRAD, and Pierrette Mefomdjo, an 
expert with several years’ experience as head of vaccine 
quality control in Africa . During the implementation 
phase of this activity, several meetings were organised 
by the OIE and AU-PANVAC in collaboration with the 
consultants, including one which was held at the OIE 
Headquarters in Paris . The strategy developed and 
provided a general framework for PPR vaccine quality 
control with a view to promoting the use of good quality 
PPR vaccines in Africa . The strategy also determined 
the roles and responsibilities of PPR vaccine-producing 
laboratories, PPR vaccine importers, National Veterinary 
Services and AU-IBAR, National Veterinary Institute of 
Ethiopia (AU-PANVAC Host Institute) and AU-PANVAC 
in a PPR eradication campaign . This strategy will enable 
AU-PANVAC to perform its core mandate of international 
independent quality control and also support other PPR 
disease control activities in full .
The key elements of the strategy include:
− general considerations for vaccine quality 
certification; 
− defining the procedures to be followed by PPR 
vaccine producers for vaccine shipments to AU-PANVAC; 
− defining the role of National Veterinary Services 
and AU-IBAR in ensuring the exclusive use of quality-
certified PPR vaccine in the field; 
− defining the procedures to be followed by PPR 
vaccine importers for requesting AU-PANVAC to 
undertake quality control on imports of PPR vaccine 
batches; 
− defining the role of National Veterinary Institute of Ethiopia 
for the purpose of facilitating the rapid clearance of PPR 
vaccine samples from Ethiopian Customs; and
− defining the tests to be undertaken by AU-PANVAC for PPR 
vaccine quality certification and developing their standard 
operating procedures .
The major issues considered necessary within the strategy 
for enhanced and efficient implementation of quality control 
of vaccines in Africa include:
− ensuring that there is adequate expertise to implement the 
independent quality control of all PPR vaccines produced and 
delivered in a sustainable manner; 
− promoting the harmonisation of quality assurance for 
veterinary vaccine manufacture; 
− AU-PANVAC playing a leading role in facilitating the 
harmonisation of veterinary vaccine registration on the African 
continent; 
− strengthening vaccine manufacturing capacity in Africa to 
meet national and regional vaccine supply needs; 
− AU-PANVAC support of the vaccine delivery network by 
ensuring that transportation, storage and distribution are 
implemented through an appropriate cold-chain, at national 
and regional levels; and 
− support for the implementation of post-vaccination 
monitoring by AU Member States . 
3.3. Responsibility of AU-PANVAC  
in the PPR control strategy 
3.3.1. Ensuring that adequate expertise exists to implement  
the independent quality control of all PPR vaccines produced and 
delivered sustainably
As an OIE Collaborating Centre for quality control of 
vaccines, AU-PANVAC will continue to ensure that all methods 
implemented for ensuring PPR vaccine Quality certification 
are consistent with OIE requirements and standards . The OIE 
is the world organisation responsible for the development 
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and promotion of international animal health standards, 
guidelines, and recommendations affecting trade in 
live animals and animal products . The OIE provides a 
normative framework for laboratory diagnosis and for 
production and control of vaccines and other biological 
products through the Terrestrial Manual that comprises 
internationally-agreed methods .
The methods currently used by AU-PANVAC for 
vaccine testing include: 
− test of vaccine identity
− freedom from contamination test
− vaccine efficacy test
− vaccine safety and stability tests .
The relevant Terrestrial Manual 2014 chapters 
that outline the requirements for the production of 
conventional vaccines before authorisation for use are 
included in the following chapters: 
− Chapter 1 .1 .7 . Tests for sterility and freedom from 
contamination of biological materials
− Chapter 1 .1 .8 . Minimum requirements for vaccine 
production facilities
− Chapter 1 .1 .9 . Quality control of vaccines (revision of 
the chapter is in progress) 
− Chapter 1 .1 .10 . International standards for vaccine 
banks .
The specific chapter dedicated to PPR is Chapter 
2 .7 .11 .: Peste des Petits Ruminants . 
3.3.2. Promoting the harmonisation of quality assurance for 
veterinary vaccine manufacture
AU-PANVAC will support AU Member States’ (AUMS) 
laboratories to ensure that all vaccine production 
procedures and techniques comply with standards and 
that the vaccines produced meet accepted international 
standards . AU-PANVAC will continue to support 
participation of vaccine production laboratories in 
both internal and external assessments to ensure the 
harmonisation of Quality Assurance for veterinary vaccine 
manufacture; and will ensure that they are accredited 
under ISO 9005 for production and ISO 17025 for 
internal quality control which covers sterility, safety, 
potency, identity and stability tests . AU-PANVAC will 
play a greater role in facilitating/negotiating a regional 
contract with certified calibration organisations on behalf 
of the AUMS laboratories for the maintenance and 
calibration of their laboratory equipment . 
3.3.3. AU-PANVAC to play a leading role in facilitating  
the harmonisation of veterinary vaccine registration  
on the African continent
Several African countries have in recent years, 
adopted veterinary medicinal products legislation, but 
only a few possess an effective regulatory system for 
licensing of biological products such as vaccines to 
ensure that that they are pure, safe and potent . In the 
few countries where regulations relating to vaccine 
quality standards and registration exist, these regulations 
vary from one country to the next . In third countries, 
veterinary medicinal products are licensed on the basis 
of the application submitted by the suppliers . These tend 
to be unreliable and do not comply with laboratory or 
field data from assessment by the National Authorities 
responsible for vaccine approval . 
To remedy this situation, AU-PANVAC was 
mandated by the Seminar for OIE National Focal 
Points on Veterinary Products held in Johannesburg in 
November 2010 to coordinate the harmonisation of 
veterinary vaccine registration in the Regional Economic 
Communities (RECs) with the support of Global Alliance 
for Livestock Veterinary medicine (GALVmed) and 
the OIE . Since then, several meetings and workshops 
have been organised by AU-PANVAC and GALVmed in 
support of this initiative . The harmonised dossier for the 
registration of veterinary vaccines and biological products 
in the East African Community (EAC) is already at the 
stage of implementation. Workshops on harmonising 
veterinary vaccine registrations have also been organised 
in the Economic Community of West Africa States 
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(ECOWAS) and the West Africa Economic and Monetary 
Union (WAEMU). AU-PANVAC will continue with this 
initiative within the scope of the Pan African Quality 
Control Strategy to ensure that registration procedures 
are harmonised between the RECs and gradually spread 
throughout the African continent .
3.3.4. Strengthening vaccine manufacturing  
capacity in Africa to meet national and regional  
vaccine supply needs
By implementing its mandate, AU-PANVAC has 
provided technical expertise to vaccine-producing 
laboratories to strengthen vaccine manufacturing capacity 
and improve their productivity to meet national and 
regional vaccine needs . Accordingly, AU-PANVAC recently 
organised training on PPR vaccine production and 
quality control within the framework of the OIE Sub-grant 
for Member States vaccine production laboratories . 
Furthermore, AU-PANVAC recently assessed the 
performance of PPR vaccine production laboratories using 
questionnaires and visits to all vaccine manufacturers in 
Africa with a view to improving the capacity and quality 
of the PPR vaccines produced . These crucial activities by 
AU-PANVAC will enable it to continue to play a leading 
role in supporting vaccine-producing laboratories in Africa 
through its laboratories network at continental level to 
ensure the production of good quality vaccines in Africa . 
This network will provide a forum for sharing expertise 
and make for the harmonisation of techniques, training 
and development of scientific and technical exchanges to 
resolve major vaccine production-related problems . 
3.3.5. AU-PANVAC to support vaccine delivery network by 
ensuring that transportation, storage and distribution are 
implemented through appropriate cold-chain, at national  
and regional levels
Vaccines must be stored properly from the time 
they are manufactured until they are administered to 
ensure that vaccines meet the requirements for quality 
assessment at AU-PANVAC or that they are delivered 
in good condition in the field . AU-PANVAC will provide 
support through its laboratory network to ensure that 
distribution of vaccine is made with minimal adverse 
impact on vaccine potency . All vaccine shipments from 
manufacturers to AU-PANVAC for quality control and 
to the field for use will be made in accordance with IATA4 
regulations . AU-PANVAC has produced guidelines describing 
the procedure to be followed for vaccine handling and 
shipment from the manufacturer to the field to contribute to 
ensuring the appropriate shipment of the vaccine from the 
manufacturer to the country or region, while the national 
veterinary authorities can proceed with vaccine delivery after 
shipment . These Guidelines provide the necessary facilities 
and procedures used in the transport, storage and handling 
of vaccines through a proper cold chain . AU-PANVAC 
will also encourage the use of data loggers for cold chain 
monitoring to be included in the vaccine parcels to ensure 
cold chain integrity .
 
3.3.6. Support for the implementation of post-vaccination 
monitoring by African Union Member States
AU-PANVAC will support vaccination campaigns by 
implementing vaccine quality control by random sampling 
in the field during vaccination campaigns . This will be 
performed as audit missions to monitor the quality of PPR 
vaccines used during vaccination campaigns in Africa . 
The audit will comprise:  
a) evaluating the vaccine quality in terms of potency by 
titration to ensure that vaccine potency is maintained at the 
time of administration;
b) supporting the sero-monitoring process at national 
level throughout Africa by ensuring that the relevant 
laboratory techniques for sero-monitoring are transferred  
(in collaboration with IAEA) and that data obtained from the 
field can be used for monitoring the vaccination campaign;
c) making the link between a) and b) to monitor vaccine 
performance;
d) making the information obtained from the random 
sampling of vaccines from the field available to the different 
target groups, especially the vaccine manufacturers and the 
Veterinary Services . 
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All these activities will be implemented in support of and in 
close cooperation with the National Laboratories and Veterinary 
Services to ensure that effective sero-monitoring is undertaken 
and the results obtained are processed on completion of the 
vaccination campaign .
4. Conclusion
The heavy economic and social losses caused by PPR, 
necessitated international intervention and the conclusion that 
global eradication was not only the viable option available to 
overcome the continuing spread and impact of the disease on 
food security and livelihoods of poor livestock farmers . Just like 
rinderpest, total eradication of PPR infection from the world 
is justified and technically feasible . Now, all conditions are in 
place for ensuring the availability of good quality PPR vaccines 
produced or imported to Africa . AU-PANVAC will support all 
global initiatives to control and eradicate PPR incorporating 
the lessons learned from the global rinderpest eradication 
campaign . Consequently, the overall objectives of the OIE 
Sub-grant Project which was to ensure the production and 
use of good quality PPR vaccines in Africa as a major tool 
of PPR control and eradication strategies and programmes, 
has been achieved and is ready for implementation at 
AU-PANVAC .
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Introduction 
Peste des petits ruminants (PPR) constitutes one of 
the major hurdles to the improvement of small-ruminant 
production directly affecting animal keepers . Its huge 
impact on small-ruminant production has led to the 
development of a global control and eradication strategy [8]. 
Vaccination is the key, acknowledged tool used to control 
and eradicate PPR . CIRAD has been greatly involved in the 
development of vaccines since the 1980s as exemplified 
by the achievement of the first PPR vaccine by attenuation 
of the Nigeria 75-1 isolate [7]. As with all members of the 
Paramyxoviridae family, PPRV is heat-sensitive requiring 
an effective cold chain in hot climates . The drawback of 
this thermosensitivity has been partly overcome by the use 
of stable freeze-drying formulations resulting in enhanced 
stability during manufacturing, shipping and storage [20] 
or the use of thermostable capripox vaccine backbone for 
inserting PPR transgenes by homologous recombination to 
prepare multivalent and thermotolerant vaccines [2, 3, 6]. 
Furthermore, CIRAD team is undertaking major efforts 
towards developing new generation vaccines against PPR 
that lead to DIVA and antiviral strategies expected for 
successful PPR control and eradication .
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Summary 
CIRAD, France, in collaboration with the Pirbright Institute, United Kingdom, 
was the first laboratory to develop a live attenuated vaccine against peste des 
petits ruminants (PPR). This vaccine available in the 1980s was shown to provide 
a life-long immunity after a single injection [5] and is now widely used in sheep 
and goats. New vaccines are in development, more specifically thermotolerant 
vaccines for use in tropical conditions and DIVA (differentiating infected from 
vaccinated animals) vaccines to gain virus-free status more easily and rapidly. 
This paper reviews most of the current and recently developed vaccines at CIRAD 
and emphasises their adequate delivery and utilisation in the field, for successfully 
decreasing the incidence of PPR.
Keywords
CIRAD – peste des petits ruminants (PPR) – DIVA vaccine – thermotolerant vaccine.
Conventional attenuated PPRV vaccines 
Effective live attenuated PPR virus vaccines are now widely 
available . One of the most currently produced vaccines is a 
live attenuated strain obtained at CIRAD in collaboration with 
the Pirbright Institute . The wild PPRV strain from which the 
vaccine is derived was isolated in Nigeria in 1975 [22] and 
attenuation obtained after 74 successive passages on Vero 
cell culture [7]. Soon after, field trials on nearly 100,000 
animals were implemented by CIRAD, to demonstrate the 
efficacy of this vaccine which is also devoid of residual side 
effects such as abortion in pregnant animals . The vaccine 
confers clinical protection against all PPRV lineages and also 
prevents transmission of the challenge virus to in-contact 
animals . Protective antibodies generated after a single injection 
persist for at least three years, which is most of the time the 
economic life of a small ruminant . These results demonstrated 
the potential of this vaccine if used globally for the eradication 
of PPR . Several vaccine manufacturing facilities worldwide 
(Table I) received the seed strain directly from CIRAD or 
through AU-PANVAC based in Debre Zeit, Ethiopia, in the case 
of African laboratories . All now have the capacity to produce 
and deliver millions of PPR vaccine doses . Strict quality 
controls on the seed stock delivered by CIRAD are undertaken 
on a regular basis, including the certification of absence of 
pestivirus and mycoplasma contamination . In addition, by 
massive parallel sequencing using next generation sequencing 
technology, the seed of this vaccine was recently shown to 
be free of adventitious pathogens . To ensure the quality of 
these veterinary vaccines for safe use during vaccination 
campaigns in Africa, AU-PANVAC has an outstanding role, not 
Table I
List of manufacturing facilities producing the peste des petits ruminants vaccine strain Nigeria 75-1
Country Laboratory City
Botswana Botswana Vaccine Institute Gaborone
Cameroon Laboratoire National Vétérinaire (LANAVET) Garoua
Chad Institut de Recherches en Élevage pour le Développement (IRED) Farcha N’Djamena
China (People’s Rep. of) Tiankang Biopharmacuetical Urumqi
Egypt Veterinary Serum and Vaccine Research Institute Cairo
Ethiopia National Veterinary Institute Debre Zeit
Iran Razi Institute Karaj
Iraq Al-Kindi Co. Baghdad
Israel Abic Beit Shemesh
Jordan Bio-Industries Center (JOVAC) Amman
Kenya Kenya Veterinary Vaccines Production Institute (KEVEVAPI) Nairobi
Mali Laboratoire Central Vétérinaire Bamako
Morocco Biopharma Rabat
Nepal Biological Products Division, Veterinary Complex Tripureshwor, Kathmandu
Niger Direction des Laboratoires Vétérinaires (LABOCEL) Niamey
Nigeria National Veterinary Research Institute Vom, Plateau State
Pakistan Intervac (PVT) Ltd. Lahore
Saudi Arabia Veterinary Vaccine Production Centre Riyadh
Senegal
Laboratoire National de l’Elevage et de Recherches Vétérinaires (LNERV), Institut 
Sénégalais de Recherches Agricoles (ISRA)
Dakar Hann
South Africa Onderstepoort Biological Products Ltd. Onderstepoort
Sudan Central Veterinary Research Laboratory Soba Kartoum
Turkey Central Veterinary Control and Research Etlik Ankara
Turkey Vetal Veterinary Vaccines Adiyaman
Turkey Dollvet Cadde Merkez Sanliurfa
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only on the quality assurance of PPR vaccines, but also in 
strengthening Africa’s capacity-building in veterinary vaccine 
development production . In addition to the PPR vaccine 
strain Nigeria 75-1, other live attenuated strains, such as 
Sungri 96, more recently developed by other laboratories –
particularly in India (e.g. MSD Animal Health [Merck], Indian 
Immunologicals Ltd ., Hester Biosciences Ltd .) –, Arasur 87 or 
Coimbatore 97 vaccines, successfully passed potency tests in 
sheep and goats according to the OIE guidelines [17].
Vaccines acceptable for a DIVA strategy
PPRV expresses two glycoproteins on its outer envelope, 
the haemagglutinin (H) and the fusion (F) proteins which 
are vital for cell attachment and penetration . These two 
proteins are also key antigens for inducing protective host 
immune response . The nucleoprotein (N) while unable to 
confer protective immunity, is a strong and early inducer of 
serum antibodies, and thus may serve as a negative mark in 
DIVA vaccines when combined with the serological diagnostic 
tests targeting this protein [13]. For better protection, 
a DIVA vaccine should be designed with at least H or F 
proteins . Such a DIVA vaccine should be linked to companion 
diagnostic tests capable of detecting both the marker and the 
specific glycoproteins to attest to induced immune response 
and therefore the guarantee of DIVA vaccination . DIVA 
vaccines and companion diagnostic tests would be ideal tools 
for emergency vaccination in case of the occurrence of an 
outbreak in a PPR-free country or zone and in the eradication 
phase of the disease since it would accelerate the process .
Different strategies are on-going for the development of 
DIVA vaccines, but they can be summarised as follows: the 
modification of the current attenuated vaccine by reverse 
genetics or the production of recombinant viruses expressing 
the H and/or F proteins. 
Using reverse genetics technology, the PPR vaccine 
strain Nigeria 75-1 was modified to express marker proteins 
in order to differentiate vaccinated from infected animals, 
whilst maintaining characteristics of the original vaccine . 
For the moment the ideal marker for a commercial vaccine 
is not yet available . However, recent prototype vaccines have 
been developed bearing a fluorescent protein [10, 15]. The 
advantage of the reverse genetics strategy lies in process 
scale-up for steep rise in the production of the resulting 
DIVA vaccine since it is not expected to require a different 
manufacturing scheme than the parental PPR vaccine .
In the second strategy, most studies have dealt 
with recombinant PPR-capripoxvirus vaccines using the 
KS1 strain [2, 6]. KS1 recombinant vaccines expressing 
either H- or F-PPRV demonstrated protective efficacy when 
administered in a single subcutaneous shot in previously 
unexposed animals . Doses as low as 0 .1 Particle Forming 
Units (KS1 expressing F-PPRV) proved to protect goats 
against challenges involving both virulent PPRV and 
capripoxvirus strains . More recently, a study demonstrated 
full protection against capripox challenge of animals with 
prior exposure to PPRV secondarily vaccinated with a 
recombinant KS1-PPR recombinant vaccine, demonstrating 
that pre-immunity against PPRV does not interfere with 
the immunogenicity of a recombinant PPR-capripoxvirus 
vaccine [3]. The same study showed partial protection 
against PPRV in animals with prior exposure to capripox virus 
secondarily vaccinated with a KS1-PPR recombinant vaccine . 
Researches are ongoing in order to develop new generation 
recombinants, integrating the DIVA strategy with an improved 
immunogenicity, safety and an increased efficacy in pre-
immune animals .
Combined vaccines for multiple  
disease protection 
CIRAD pioneered the use of combined vaccines against 
the viruses causing sheep pox, goat pox and PPR, the most 
obvious and simplest way of achieving protection against 
these diseases and particularly economically justifiable . 
Vaccines used in combination have been evaluated in sheep 
and goats [14] and proved to be safe and immunogenic as 
demonstrated by others [4, 9]. In addition, the vaccine strain 
was unable to spread from vaccinated animals to in-contact 
animals [7]. Different recombinant vaccines expressing a 
unique valence can be delivered in combination to confer 
protection against several different diseases . This implies 
that the vaccines, at least in small-scale experiments, do 
not interfere with the immunogenicity of the other . Broader 
studies performed in field conditions are now awaited to 
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confirm these results . The newly launched PPR eradication 
campaign is a great opportunity to target multiple 
diseases at the same time as previously undertaken, for 
example during the Pan-African Rinderpest Campaign by 
combining vaccines against rinderpest and contagious 
bovine pleuropneumonia (CBPP) . Regional specificities will 
define which diseases to tackle to maximise the impact 
of vaccination and applied laboratory and field studies 
should be undertaken to verify whether the sheep or goats 
could be inoculated with monovalent vaccines against 
two or three diseases at the same time or whether bi- or 
trivalent vaccines using conventional vaccine strains (such 
as the bivalent rinderpest-CBPP vaccine for cattle) could 
be developed . Alternative strategies are currently being 
developed to generate a recombinant capripoxvirus vaccine 
with multiple valences (e .g . PPR and Rift Valley fever) .
Thermotolerant vaccines 
Given the enormous challenges associated with the 
distribution of PPR vaccine for the global eradication 
of PPR that are faced by the majority of developing 
countries, the key issue is the thermal stability of the 
vaccines . The thermostable capripox-based vaccines 
may offer significant contribution to this objective . The 
main focus of conventional attenuated PPRV strains is to 
improve stability by extending the virus half-life at high 
temperatures compatible with tropical conditions in order 
to maintain a viral titre higher than the minimal requested 
vaccine dose . Improvements have been made in terms of 
lyophilisation formulations . Collaborative work between 
CIRAD and Instituto de Biologia Experimental e Tecnológica 
(IBET, Portugal), under the framework of a project carried 
out at National Veterinary Institute (NVI) in Ethiopia 
clearly demonstrated the ability to produce higher quality 
PPR vaccines by replacing Weybridge medium by a Tris/
Trehalose formulation [21]. Lyophilised vaccine half-life at 
37 and 45 °C could be extended by up to 2 .5 and 2 days, 
respectively . These results corresponded to previously 
published results [20] and demonstrated that improved 
formulation procedure could be rapidly and successfully 
transferred to a vaccine-producing laboratory . 
Vaccination strategy and vaccine delivery 
Mass vaccination of all animals in the target 
population is the only efficient vaccination strategy for 
PPR eradication . The target immunity threshold of 80% of 
small ruminants is generally considered appropriate in 
vaccination programmes to stop the spread of disease . 
But some field and experimental work has shown that it 
could be lower . More research should be carried out to 
achieve a better estimate of this threshold while allowing 
for the complex relationships between small-ruminant 
population dynamics, post-vaccination immunity coverage, 
and PPRV transmission (FAO/OIE). With this in mind, 
partial vaccination of the population, for example targeting 
small middle-aged stock [12] may reduce the virus load 
in circulation but comes with two major drawbacks: first, 
PPRV will continue circulating in the general population; 
second, the wild PPRV will have more opportunities to adapt 
and produce escape mutants . A similar situation probably 
occurred in the past with rinderpest virus, causing the 
emergence of so-called RPV lineage II and complicating the 
eradication process . Vaccination campaigns must also be 
coordinated at national and regional levels to ensure good 
vaccination coverage of all small ruminant populations . 
Practical implementation of vaccination campaigns is of 
great importance . This includes the acquisition of vaccine 
submitted to rigorous quality control, maintaining the cold 
chain (at least until a thermotolerant vaccine is made 
widely available), adequate means for the vaccination 
teams, as well as careful preparation of the campaigns . 
Successful mass vaccination in developing countries is a 
very challenging objective and calls for effective Veterinary 
Services, which involve public and private veterinarians . The 
effectiveness of delivery systems for animal health services 
particularly for vaccination is crucial and in this regard the 
participation of private veterinary para-professionals and 
representatives of producers’ and farmers’ communities 
(animal health workers) can be very effective in reaching 
small ruminants in difficult areas (e .g . remote or insecure 
areas) or when the animal population density is very low 
such as in smallholder village production systems in crop-
based humid zones . This partnership requires effective 
implementation of appropriate legislation and veterinary 
supervision . 
Treatment against PPR 
Preventive measures are the main strategies for reducing 
the impact of PPRV in the world . Today, despite constantly 
improving vaccine strategies, vaccination of small ruminants 
against the disease remains problematic and in practice, 
is not applied continually during inter-epidemic waves . 
In addition, given the necessary delay of several days to 
mount an efficient immune response to induce sufficient 
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protection, vaccine cannot be used to stop an outbreak 
immediately . Effective and rapid control of PPR is 
foreseeable using cheap antiviral compounds . Antivirals 
based on synthetic short interfering RNAs (siRNAs), a 
new class of molecules with a significant potential for 
therapeutic applications could be good candidates since 
they can be delivered in viral vectors and biologically 
synthesised in the treated animals . A breakthrough 
has occurred in the last decade for the design options 
of siRNA to prevent the in vitro selective degradation 
of viral RNA . Although siRNA as potential emergency 
tools against PPR are not yet available, efficient in vitro 
activity making for more than 90% inhibition of PPRV 
replication was reached when targeting the N gene 
[11, 18, 19]. Excellent knock-down of PPRV replication 
brings us closer to a therapeutic application for the 
future . Such antiviral therapeutics could complement 
vaccination to limit the clinical impact of PPR quickly in 
emergency situations in the context of new introduction 
into free zones or of re-emergence in endemic areas . 
New therapies to treat infection may therefore be of 
particular interest . 
Conclusion and outlook 
PPR control is a priority for poverty alleviation . 
Because of the fast turnover of small ruminant 
populations, and insufficient investment or political 
commitment for improving their health and productivity, 
PPR control will not be an easy task . Post-vaccination 
evaluation of PPR clinical incidence and immune status 
of target populations will be needed to monitor the 
progress of PPR control . The development of marker 
vaccines will certainly facilitate the final control phase 
by preserving the ability to monitor the epidemiological 
situation during vaccination campaigns while 
contributing to secure international trade in animals and 
animal products . Full and reliable genome sequence 
knowledge of the PPR vaccine strain Nigeria 75-1 
is the basis for the development of a DIVA vaccine . 
A double mark strategy, both recognised by small 
ruminants is ongoing at CIRAD to allow differentiation of 
vaccinated from infected and from vaccinated/infected 
animals . Multivalent capripox recombinant vaccines 
used differentially to protect ruminants against two or 
more diseases, depending on the local situation, is a 
strategy currently underway . In addition to the available 
PPR-capripox vaccine, recombinant capripoxvirus vaccines 
targeting bluetongue and Rift Valley fever have proved 
their efficacy [1, 16], a stepping stone toward second 
generation of tri- or quadri-valent recombinants . Ongoing 
trials with PPR-capripox vaccine will determine the duration 
of immunity in field conditions . Following the example 
of the work carried on the vaccinia virus, improvement 
of the capripox backbone is foreseen by subtracting 
neutralising epitopes and expanding the number of antigens 
expressed to comply with DIVA strategy and enhanced 
immunogenicity . Antiviral therapy still has an economically 
unbearable cost, but some cheap biological molecules could 
have an economic interest combined with vaccination in 
eradicating the disease . 
Such innovative concepts and developments have 
been achieved thanks to the continuing collaboration 
with Southern partners, notably African countries . This 
collaborative work for science-based and integrated control 
programmes against PPR will be supported by strengthening 
the capacity of the team working on that subject with, 
for example, the recruitment of technicians and experts, 
notably in virology and in epidemiology-modelling as well 
as the development of the collaborative projects with the 
socio-economists working on animal health at CIRAD and in 
partners’ institutions .
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Introduction
Prior to 2012, Burkina Faso’s Directorate-General 
of Veterinary Services sponsored and conducted several 
studies on the prevalence of peste des petits ruminants 
(PPR) in Burkina Faso . The results showed a prevalence of 
15-30%, revealing active virus circulation in the country’s 
sheep and goat population .
After discussions and negotiations, the Bill & Melinda 
Gates Foundation signed an agreement with the OIE in 
October 2012 to co-finance a pilot project on PPR control 
protocols1 . The funding agreement followed in October 
2013 . Field activities began immediately . The project, 
planned to last 18 months, ultimately focused on Burkina 
Faso and Ghana . 
The aim of the pilot project was to:
− control PPR by vaccinating 100% (at least 80%) of 
small ruminants in the project area; 
− contribute to the development of a comprehensive 
PPR control and eradication strategy .
The proposed scenarios had to take into account the:  
− eco-climatic zone and farming system
− level of external support to the national Veterinary 
Service
− number of vaccination campaigns per year
− private sector involvement .
Project 
Geographical location 
The project areas selected were in four administrative 
regions of Burkina Faso: Sahel; Nord; Centre-Nord and Boucle 
du Mouhoun (Fig . 1) . This area hosts 27% of the country’s 
sheep and goat population .  
 
Fig. 1
Project areas  
1 See the article on the regional project Vaccine Standards and Pilot 
Approach to Peste des Petits Ruminants Control in Africa (VSPA), pp. 56–60
2015 • 278
th
e 
O
IE
 a
n
d
 i
ts
 p
a
rt
n
er
s
Pilot project on protocols  
for PPR control
Lassina Ouattara (1), Joseph Savadogo (2), Daniel Bourzat (3),  
Joseph Domenech (3) & Renaud Lancelot (4)
(1) Delegate of Burkina Faso to the World Organisation for Animal Health (OIE), Directeur général des Services 
vétérinaires, Ministère des ressources animales et halieutiques, 09 BP 907, Ouagadougou 09, Burkina Faso
(2) Directeur de la santé animale, Direction générale des Services vétérinaires, Ministère des ressources 
animales et halieutiques, 09 BP 907, Ouagadougou 09, Burkina Faso
(3) World Organisation for Animal Health, Regional Representatio for Africa, Parc de Sotuba, BP 2954,  
Bamako, Mali
(4) Directeur adjoint, UMR CMAEE, Centre de coopération internationale en recherche agronomique  
pour le développement (CIRAD), Campus international de Baillarguet, F-34398 Montpellier, France
Keywords
Burkina Faso – peste des petits ruminants (PPR) – vaccination – VSPA.
Protocols
The various protocols tested were as follows:  
− P1: Control areas (no vaccination) .
− P2: Vaccination (vaccine alone) + farmer participation .
− P3: Vaccination + operating costs/vaccinator + farmer participation.
− P4: Vaccination + operating costs/vaccinator + farmer participation + farmer incentives (free 
deworming prior to vaccination) .
These four protocols were duplicated in the Boucle du Mouhoun region to test the parameter 
‘private operator versus public services’ . The field component is illustrated in Figure 2 .
 
Tools used
Tight deadlines prevented the implementation of a comprehensive serological survey of PPR 
prevalence across the area . It was decided instead to conduct a comprehensive survey of participatory 
PPR searching throughout the regions and departments concerned in order to ensure absence of 
bias linked with an uneven distribution of PPR outbreaks (Fig . 3) . Any outbreaks based on farmers’ 
accounts were confirmed by serological testing of herds that had been declared positive .
The effectiveness of the vaccination campaign was verified at two levels:
− The African Union Pan African Veterinary Vaccine Centre (AU-PANVAC) conducted a study of 
vaccine and diluent quality starting from the central cold room and ending with the vaccinator’s 
syringe . The titre of the vaccine and quality of the cold chain were extensively documented .
− The seroconversion of vaccinated animals was monitored by the Ouagadougou central veterinary 
laboratory based on more than 5,000 samples .  
Fig. 2
Pilot field component
Protocol 1
Protocol 2
Protocol 3
Protocol 4
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With the support of researchers from the French Agricultural Research Centre for 
International Development (CIRAD), sociologists conducted a survey of vaccination 
acceptance and perception by farmers, industry stakeholders and the Veterinary 
Services concerned, in accordance with a participatory survey protocol .
Meanwhile, CIRAD animal production specialists conducted a survey of pre-and 
post-vaccination productivity using the twelve-month method .
Results
Vaccination coverage
It was necessary to implement the field component and organise the campaign in 
great haste . This meant that very little awareness could be raised among stakeholders 
and local contact points . Nevertheless, the performance of all operators, at both 
central and field levels, was outstanding . By the end of 2014, a total of 1,430,000 of 
the estimated 1,782,700 small ruminants throughout the vaccination areas had 
been vaccinated: a vaccination coverage rate of 80 .20% . The protocols that provide 
the best vaccination coverage are P3, with external support from the Veterinary 
Service, and P4, with the addition of farmer incentives (anthelmintics coupled with 
vaccination) . However, the fact remains that the average coverage rate achieved was 
enough to block virus circulation in the vaccinated population . Figure 4 illustrates 
this .
Fig. 3
Distribution of peste des petits ruminants outbreaks in accordance with the various pre-vaccination protocols
Protocol 1
Protocol 2
Protocol 3
Protocol 4
No PPR outbreak
PPR outbreak
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Fig. 4
Distribution of peste des petits ruminants outbreaks in accordance with the various post-vaccination protocols 
N.B. The high incidence of outbreaks in the department of Pissila can be explained by a heavy bout of peste des petits ruminants just before the vaccination teams 
arrived, as the campaign had begun late in the season.
Prevalence and seroconversion
According to the PPR incidence rate graphs (Fig . 5), neither the agro-climatic zone nor the 
type of operator appear to significantly affect this marker .
The pre- and post-vaccination serological tests showed a significant increase in 
seroprevalence (Fig . 6) . These results, coupled with the significant decrease in the number of 
outbreaks, show that the vaccine is highly effective .
Productivity
The productivity surveys show that PPR has a very heavy impact on the numeric productivity 
of herds and that vaccination provides substantial productivity gains . The following graph, 
compiled from surveys conducted in Ghana (Fig . 7), is very telling .
Sociological surveys
Sociological surveys were organised around two themes:
1) The socio-technical network of sheep and goat production present in 263 villages  
in the project area
The main findings of this survey are that:
− ‘vaccination’ is considered to mean an ‘injection’, whether preventive or curative (it is 
usually associated with a visit by the veterinarian to the villages closest to the veterinary station);
Protocol 1
Protocol 2
Protocol 3
Protocol 4
No PPR outbreak
PPR outbreak
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Fig. 5
Incidence rate of peste des petits ruminants
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Fig. 6
Pre- and post-vaccination serological testing
100
90
80
70
60
50
40
30
20
10
0
Sahel region
Vaccination regions in the area covered by the project Vaccine Standards and Pilot Approach to Peste des Petits Ruminants Control in Africa (VSPA)
47
89
43
91
38
89 86
Se
ro
pr
ev
al
en
ce
 (%
)
Pre-vaccination 
serological testing
38
Post-vaccination 
serological testing
Nord region Centre-Nord region Boucle du Mouhoun 
region
Fig. 7
Impact of peste des petits ruminants on the numeric productivity of herds  
(example of Ghana)
− the veterinarian’s availability depends on the group 
to which the farmer belongs (veterinarians give preference 
to farmers with large herds);
− the work of community animal health workers 
is perceived as being that of ‘illegal workers’ and/or 
traditional healers;
− farmers are well aware of other projects underway in 
their area .
2) Perception of the vaccination campaign by farmers 
and industry stakeholders
This survey, conducted through 20 group interviews 
with 18 vaccinators and 549 farmers, plus 62 individual 
interviews with agro-pastoralists, reveals that:
− perceptions of the effectiveness of the 
communication tools used varied widely;
− communities attach great importance to the identity 
of the vaccinator and to the origin of the project;
− the perception was that neither the village 
counsellors nor the presidents of village associations had 
been informed; this was seen as a weakness of the project 
(‘We have received no information’);
− short notice was given for organising vaccination;
− numerous messages were received simultaneously: 
vaccination, date, animals concerned, price, etc .
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Main challenges facing farmers
The challenges
The following two figures illustrate the main challenges facing vaccinators and farmers .
Fig. 8
Main challenges facing vaccinators
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Main findings
The vaccination teams encountered many problems with 
implementing the PPR campaign, in particular: 
− far too little time was allocated to awareness-raising;
− the timeframe for implementing the campaign was so 
short that it was impossible to implement two vaccination 
rounds per village or to do a search;
− the vaccination period (March to April) was inappropriate 
because most of the animals were already free grazing (goats) 
or in transhumance;
− farmer mistrust of the first ever campaign organised 
specifically for small ruminants (with the result that some 
farmers refused to vaccinate their entire herd);
− door-to-door vaccination, which was the only option for 
this campaign owing to lack of enclosures in every village, was 
very demanding in terms of time and resources;
− few or no logistical resources (motorcycles), the 
defective condition of the motorcycles used by vaccinators and 
of some vehicles;
− packaging of the vaccine in 100-dose phials was a 
constraint because it led to considerable losses of unused 
vaccine .
Conclusions
General principles of vaccination
− Mass vaccination (all animals over the age of three 
months), in the Sudano-Sahelian region, in a single round early 
in the cold dry season, in view of the transhumant/nomadic 
nature of livestock farming and the impossibility of defining 
epidemiological units that can be studied throughout the 
control/eradication process.
− Any other type of vaccination (such as targeted 
vaccination, which is of doubtful efficacy in Africa) would 
require preliminary studies (incurring a high additional cost) 
to ascertain the epidemiological status of the disease in the 
country .
Organisation of the campaign
− Planning by the public services, which must be 
strengthened; awareness-raising among professional 
organisations; involvement of private veterinarians with an 
animal health accreditation mandate where possible .
− Organisation of the rounds, teams, cold chain and 
distribution of the vaccine, diluent and additional equipment 
to ensure fast and effective vaccination with high coverage 
(greater than 80%) .
− Laboratories that produce PPR vaccine should always 
supply it with the diluent and the AU PANVAC quality label .
Vaccine bank
− A vaccine bank ensures a fast and efficient supply of 
top-quality vaccine and diluent (VSPA showed that excellent 
seroconversion rates are essential) in support of the current 
insufficient capability of vaccine-producing laboratories .
− The cost price of the vaccine dose (vaccine + diluent) 
is the fairest in the market .
Epidemiological study and vaccine efficacy monitoring
− The national PPR control and eradication campaign 
provides a good opportunity to rehabilitate and revive 
national passive and active epidemiological surveillance 
networks . Serological testing, in accordance with a 
predefined sampling design, makes it possible to monitor 
vaccine efficacy and the population’s level of protection .
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activities of Reference Laboratories 
& Collaborating Centres
Table I
2014 OIE Reference Laboratory activities
Annual reports have been received from 190 out of 205 Reference Laboratories and from 39 out of 47 Collaborating Centres 
for terrestrial animal diseases or topics . 
The international activities relevant to the work of the OIE are summarised in the following tables:
Table II
2014 OIE Collaborating Centre activities
0% 20% 40% 60% 80% 100%
1. Activities within the sphere of competence
2. International harmonisation of regulations
3. Maintenance of a network in same specialty
4. Maintenance of a network in other disciplines
5. Provision of consultant expertise
6. Provision of scientific and technical training
7. Organisation of international scientific meetings
8. Coordination of scientific and technical studies
100%
90%
85%
77%
90%
87%
59%
92%
0% 20% 40% 60% 80% 100%
1. Tests in use
2a. Production of OIE-recognised standard reference reagents
2b. Supply of standard reference reagents
3. Production/supply of diagnostic reagents other than OIE-approved
4. Production of vaccines
5. Supply of vaccines
6. Development of new diagnostic methods
7. Development of new vaccines
8. Provision of diagnostic testing
9. Provision of expert advice in technical consultancy
10. Participation in international scientific collaborative studies
11. Collection of epizootiological data
12. Dissemination of epizootiological data
13. Method of dissemination of information
14. Provision of scientific and technical training
15. Maintenance of quality management system according to int'l standards
16. Accreditation by an international accreditation body
17. Maintenance of biosafety and biosecurity
18. Organisation of international scientific meetings
19. Participation in international scientific meetings
20. Exchange of information with other OIE labs
21. Proficiency testing with other OIE labs
22. Collaboration with other OIE laboratories for same disease
23. Proficiency testing labs other than OIE labs
24. Provision of consultant expertise 39%
53%
33%
40%
79%
64%
15%
92%
64%
78%
58%
92%
65%
69%
56%
69%
57%
4%
20%
4%
4%
2%
5%
95%
64%
Annual reports for 2014 of reference centres  
for terrestrial animal disease
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Activities of OIE Reference Laboratories  
for peste des petits ruminants
The Pirbright Institute
Ash Road, Pirbright, Woking, Surrey, GU24 0NF,  
United Kingdom
Designated reference expert: Dr Michael Baron
The Pirbright Institute 
(previously the Institute for 
Animal Health) not only houses 
an OIE Reference Laboratory 
for peste des petits ruminants 
(PPR) and rinderpest viruses, 
it also maintains an active 
research programme in the 
biology of the PPR virus, led 
by Dr Michael Baron . The Institute has developed standard 
and real-time polymerase chain reaction (PCR) tests for 
PPR virus, as well as developing and distributing both a 
serological test (cELISA) for PPR antibodies and the first 
pen-side test for PPR virus infection . The Institute provides 
primary and confirmatory diagnostic services to any OIE 
Member Country . It also provides training in diagnostic 
laboratory management as well as PPR diagnostics to other 
laboratories through the OIE twinning programme .
National Diagnostic Center for Exotic  
Animal Diseases (CEAD)
China Animal Health and Epidemiology Center (CAHEC)  
369 Nanjing Road, Qingdao 266032,  
People’s Republic of China
Designated reference expert: Dr Zhiliang Wang
The National Diagnostic Center for Exotic Animal 
Diseases (CEAD) of the China Animal Health and 
Epidemiology Center (CAHEC) was designated as the 
National Reference Laboratory for PPR in 2007 and 
accepted as an OIE Reference Laboratory at the 82nd 
OIE General Session in 2014 . CEAD applies multiple 
tools including both the traditional and the most 
advanced molecular techniques for PPR diagnosis . It 
also provides diagnostic reagents and laboratory training 
nationally and internationally . CEAD has been engaged in 
the prevention and control of PPR for many years, providing 
key technical support to policy-makers . It diagnosed the 
first outbreak of PPR in China in 2007 and has confirmed 
all of the outbreaks in 22 provinces, 119 cities and 
257 counties since the disease was reintroduced into China 
in December 2013 . CEAD also drafted the first national 
PPR contingency plan, surveillance plan and diagnostic 
standard, and updates them periodically .
In May 2014, invited by FAO, Dr Zhiliang Wang, the 
designated OIE reference expert, presented the current 
status and control strategies of PPR in China at FAO 
Headquarters in Rome . 
In November 2014, the OIE Reference Laboratory 
organised an International Symposium on Newcastle 
Disease and PPR in Qingdao, and Dr Zhiliang Wang 
delivered a keynote lecture on PPR diagnosis and control . 
Participants from the OIE Regional Representation, the 
FAO Beijing office, the Pirbright Institute and countries in 
the region, such as Cambodia, Indonesia, Mongolia, Nepal, 
Thailand and Timor-Leste, shared their knowledge and 
experiences in PPR prevention and control .
Dr Zhiliang Wang at the Symposium in Qingdao 
in November 2014
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In addition, more than 2,000 veterinary field staff from 
various provinces received training from the Reference 
Laboratory in 2014, and optimal and rapid diagnostic kits for 
PPR (400,000 ELISAs and 20,000 PCR tests) were produced 
and delivered to provincial laboratories for surveillance and 
screening .
Based on its contribution, CEAD was honoured with the 
titles of ‘Advanced Team’ of the Ministry of Agriculture and 
‘National Innovative Team’ of the Ministry of Science and 
Technology .
CEAD is now drafting the national PPR eradication plan, 
based on FAO/OIE precepts, and preparing to contribute to the 
final eradication of this disease from the world .
CIRAD-BIOS
Control of Exotic and Emerging Animal Diseases
Programme Santé animale
Campus International de Baillarguet TA A-15/G,  
34398 Montpellier Cedex 5, France
Designated reference expert: Dr Geneviève Libeau
The OIE reference laboratory for PPR – Biological Systems 
Department (BIOS) – is hosted by the French Agricultural 
Research Centre for International Development (CIRAD) 
in Montpellier . Ever since it was established, and later as 
part of its reference activities, the laboratory has developed 
diagnostic and surveillance tools and vaccines against PPR, 
which now makes it feasible to eradicate the disease . The 
reference laboratory also builds capacity in epidemiology and 
animal health economics to support strategic decision-making 
on disease control . The laboratory is involved in training, 
technology transfer and research through its network of partner 
national laboratories and experts, especially in Africa and the 
Middle East . In partnership with national Veterinary Services, 
it also develops laboratory twinning programmes, including the 
reinforcement of epidemiological surveillance, inter-laboratory 
tests and implementation of an ISO/IEC 17025 quality 
management system to build confidence in diagnoses and, more 
broadly, in research into PPR and other major transboundary 
animal diseases .
International Symposium on Newcastle Disease and PPR in Qingdao in November 2014
Dr Libeau in front of CIRAD-BIOS (in the middle, dressed in a beige jacket)
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Ms Ghizlane Sebbar at work in the serology laboratory at Biopharma
OIE twinning of the Biopharma Laboratory (Morocco)  
with CIRAD (France) for peste des petits ruminants
Since it was first described in Côte d’Ivoire in 1942, 
peste des petits ruminants (PPR) has spread steadily 
throughout Africa, the Middle East and Asia . As a result of 
illegal cross-border trade in animals, in July 2008 the disease 
occurred in Morocco for the very first time and went on to 
spread rapidly across almost the entire country . Investigations 
by the Moroccan Veterinary Services found that sheep farming 
and trade played a dominant role in the spread of the virus .
With exemplary responsiveness, Morocco’s Veterinary 
Services met the challenge by implementing immediate PPR 
control measures based on mass vaccination of the country’s 
domestic sheep and goat population, which enabled the disease 
to be successfully contained1 . Biopharma, Morocco’s national 
vaccine production and diagnostic laboratory, played a crucial 
role in this process by confirming PPR and producing the 
required vaccine doses within just three months of receiving 
the vaccine strain from the OIE Reference Laboratory for PPR, 
the French Agricultural Research Centre for International 
Development (CIRAD, see page 88) . Biopharma produced 
25 million doses between 1 September and 15 October 2008 
and a total of over 20 million animals were vaccinated .
This initial collaboration between CIRAD, Biopharma and 
the Moroccan Veterinary Services led to the submission of a 
twinning project in 2013 to build regional PPR expertise and 
capacity by reinforcing the Biopharma laboratory’s diagnostic 
capability and boosting synergy with national epidemiological 
surveillance networks, in line with the regional strategy 
drawn up by the Mediterranean Animal Health Network 
for North Africa (REMESA) . Nevertheless, the risk of PPR 
being reintroduced into Morocco remains high because of its 
confirmed presence throughout the Maghreb region .
The project was launched in December 2013 by two days 
of meetings devoted to presenting the teams and their twinning 
activities, as well as to drafting the future programme . One 
or more annual meetings, depending on the activity, are held 
to promote the Biopharma PPR diagnostic platform, quality 
system and accreditation project and to further the debate on 
implementing a PPR control strategy geared specifically to 
the region . The CIRAD and Biopharma teams have known and 
worked together since the PPR incursion into Morocco, which 
1 In parallel, the Veterinary Services implemented a major communication effort to halt the disease ahead of the Eid-al-Adha Muslim festival of sacrifice. Around 5 million 
sheep are traded and slaughtered each year during this period. In 2008 it took place in early December.
makes dialogue much easier . In addition, Montpellier in France 
and Rabat in Morocco are emblematic of North-South links in 
that they are both large Mediterranean cities with a relaxed pace 
of life, which has helped to establish close relations between 
the two teams during exchange visits .
The twinning project actually began when a young Moroccan 
veterinarian from Morocco’s National Office for Food Safety 
(ONSSA) enrolled, in 2013–2014, in a Master’s degree in 
epidemiological surveillance of human and animal diseases 
at France’s Alfort Veterinary School (ENVA) and Paris-Sud 
University . The veterinarian completed his degree with a 
six-month work placement in Morocco on the subject of PPR, 
under the supervision of two epidemiologists from CIRAD and 
the ONSSA epidemiological and health monitoring service . The 
following year, the epidemiologists and ONSSA experts used 
these initial results to set up an information system on animal 
movements, which was extended nationwide, and to define 
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Working session between members of Biopharma and CIRAD virology team and epidemiologists 
from CIRAD and from the ONSSA Department of Epidemiology and Health Surveillance during 
the mid-term meeting from 3 to 6 November 2014 at Biopharma
epidemiological indicators to strengthen surveillance in areas 
deemed to be at greatest risk . A training course on these 
aspects for ONSSA managers was designed and scheduled 
for June 2015 (to familiarise managers with the various 
information processing tools and enable them to build on the 
tools independently: data collection systems; social network 
analysis methods; geographic information system mapping; 
proposals for improving surveillance on the basis of results; 
and training course design) .
year one also saw the first technical workshop on PPR 
diagnosis at CIRAD and the implementation and start-up by 
CIRAD of an inter-laboratory test involving the Biopharma 
laboratory and 21 other laboratories located in five Maghreb 
countries and four more African and Middle Eastern 
countries . The inter-laboratory test involved both serological 
and virological tests, in which all the laboratories proved to 
be fully proficient .
The diagnostic training curriculum delivered in Montpellier covers: 
− setting up PPR serological analysis
− use of controls and internal reference materials
− implementing real-time PCR methods (QPCR)
− introduction to pipette calibration
− introduction to sequencing
− introduction to phylogenetics
− a review of International Air Transport Association (IATA) procedures.
 
Virologists and quality experts from the two laboratories have 
worked together in Rabat on several occasions, either for audit 
meetings or mid-term meetings to analyse the situation, assess 
progress and take stock of the training courses based on the 
progress made . 
Region-wide inter-laboratory PPR diagnostic tests are being 
planned by the Biopharma laboratory and may be extended in 
the future to cement the legitimacy of Biopharma’s application 
to become an OIE reference laboratory . The existing quality 
management system was reviewed and proposals were made 
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Members of the Biopharma scientific team involved in the twinning project
From left to right, Ms Ghizlane Sebbar, Ms Amina Aqari, Dr Safa El Azhari and Dr Khali Zro
for upgrading it to meet all the requirements of standard ISO/
IEC 17025 . Appropriate quality management system indicators 
were defined and discussed (maintaining customer satisfaction, 
maintaining staff competence, continuing to implement 
and enhance the quality management system and preparing 
accreditation of the enzyme-linked immunosorbent assay [ELISA] 
for PPR) . The fact that everyone was involved helped to build the 
mutual trust needed for effective collaboration .
The quality management system is based on standard ISO/IEC 17025. The 
Biopharma personnel concerned underwent training on this standard 
and on metrology, and will soon undergo training on the validation of the 
ELISA method. This will help them to understand the requirements for 
implementing a quality system and defining an action plan to include the 
ELISA PPR test within the scope of accreditation. Assistance is provided 
to help Biopharma to organise PPR inter-laboratory tests.
 
Although the progress described above was of direct 
benefit to the candidate laboratory, the advantages for the 
parent laboratory should not be overlooked . Generally speaking, 
twinning improves the parent laboratory’s knowledge 
of a disease by enabling it to take specific local and 
regional circumstances into consideration, whether 
they be epidemiological (assessing health risks 
more accurately and adapting control strategies) or 
microbiological, paving the way for studies on such 
matters as identification, genetic evolution, pathogenicity 
or improved diagnosis, to meet the needs of the country 
and the region . Twinning also enables the personnel 
involved to show their skills and expertise, work with 
others from different disciplines, interact and/or take part 
in international expert groups .
Although the twinning process is not yet complete, 
Biopharma and CIRAD, as partners, welcome the results 
achieved so far and the opportunity to take part in such 
projects, which ultimately improve disease surveillance 
and control . First and foremost, this twinning has led to 
better communication and stronger links between the two 
teams, has created trust and transparency and has given 
them an opportunity to extend their collaboration beyond 
the twinning project .
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news from Member 
Countries
Following up on three cases of 
lethal encephalitis among breeders 
of variegated squirrels (Sciurus 
variegatoides) in Germany between 
2011 and 2013, the Bernhard Nocht 
Institute for Tropical Medicine (BNITM)1 
investigated a possible infectious origin. 
Variegated squirrels are an exotic species 
in Germany, where they are kept as zoo 
and companion animals. 
Initially, no clues for the cause 
of the disease could be found, until 
the Friedrich Loeffler Institute (FLI)2 
investigated samples from a variegated 
squirrel belonging to one of the deceased 
breeders. By using a metagenomic 
approach with a comprehensive 
deep-sequencing strategy, the presence 
of high loads of the RNA of a novel 
bornavirus could be detected in samples 
from the squirrel. 
Subsequent molecular biological 
and immunohistological tests confirmed 
the presence of the virus in the brain 
samples of the three breeders who had 
died. Phylogenetic analysis demonstrated 
that this novel virus, tentatively named 
variegated squirrel bornavirus 1 
(VSBV-1), formed a separate lineage 
from that of the known species, 
with a sequence identity of less than 
75% similarity with other mammalian 
bornaviruses. Investigations of further 
samples from different squirrel holdings 
in Germany identified more animals 
which tested positive for the virus, and 
serological studies revealed the presence 
of high bornavirus-specific antibody 
titres in both the squirrels that tested 
positive by polymerase chain reaction 
(PCR) and one of the dead patients.
From the available data and due to 
the epidemiological links, it seems likely 
that the disease affecting these three 
patients was caused by the transmission 
of this novel bornavirus from infected 
squirrels. However, at present, it is not 
known whether these are isolated cases, 
or how the infection occurred. Bites and 
scratches appear to be possible means of 
acquiring the infection.
Test methods for the detection 
of the new virus were developed and 
validated at the FLI and are available on 
request. Preliminary screening results of 
variegated squirrels on different holdings 
showed a high correlation between the 
PCR test results of oral swab samples 
and brain tissue.
The BNITM in Hamburg, the FLI on 
the Isle of Riems and the Robert Koch 
Institute3 in Berlin are cooperating with 
veterinary and health authorities at 
federal and state levels to further clarify 
the situation. The FLI is carrying out 
tests on the occurrence of this virus in 
animals. In addition, people who keep 
variegated squirrels are being screened to 
identify possible cases of infection. The 
BNITM is conducting analogous analyses 
of the spinal fluids of patients with 
encephalitis of unknown origin.
Until further data become available, 
the scientists working on this issue 
advise avoiding direct contact with 
variegated squirrels as a preventive 
measure. If a variegated squirrel 
develops a disease or dies from unknown 
causes, the owner should inform their 
veterinarian who can initiate further 
investigations. In the context of the FLI’s 
and BNITM’s discovery of this new and 
probably zoonotic bornavirus, we still 
need to clarify whether the virus was 
imported into Germany with infected 
squirrels or whether the squirrels were 
infected by another animal species.
German scientists discover new bornavirus in variegated squirrels. 
Potential link to fatal human infections
1 Bernhard-Nocht-Institut für Tropenmedizin (BNITM), Bernhard-Nocht-Straße 74, 20359 Hamburg, Germany 
2 Friedrich-Loeffler-Institut (FLI), Federal Research Institute for Animal Health and OIE Collaborating Center, Südufer 10, 17493 Greifswald-Insel Riems, Germany
3 Robert Koch-Institut (RKI), Postfach 65 02 61, 13302 Berlin, Germany
Information received on 31 March 2015 from Dr Karin Schwabenbauer, Delegate of Germany to the OIE, Director of Animal Health and Animal 
Welfare, Federal Ministry of Food and Agriculture, Bonn
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Other than for African horse sickness, bovine spongiform 
encephalopathy, classical swine fever, contagious bovine 
pleuropneumonia, foot and mouth disease and peste des petits ruminants, 
for which the OIE currently has a procedure of official recognition of 
status, the self-declaration of freedom of a country or a territory from 
a given OIE-listed disease is under the responsibility of the Member 
concerned. The OIE is not responsible for inaccuracies in the publication 
of self-declarations concerning the status of a country or zone with 
regard to a disease.
Self-declaration
Self-declaration by Lithuania  
of freedom from rabies
Notification
Rabies was enzootic in Lithuania and it is compulsory to notify any occurrence of 
this disease . Statistical information about rabies outbreaks in Lithuania is available 
back to 1960 . Since 1992, in accordance with the Act on Veterinary Activities, every 
suspicion of rabies must be notified to the Veterinary Authorities .
Epidemiological background
Rabies was widespread in the whole territory of Lithuania. Wildlife rabies was 
enzootic whereas urban rabies has been eradicated . Carnivorous wild animals are 
the main reservoir of this disease, in addition to sporadic cases of rabies in domestic 
animals . Since 1960, 11 people have died of rabies: two infected by dogs; four 
infected by foxes; two by raccoon dogs; one by a badger; one by a cat and one case of 
unknown origin .
The main reservoir species for the rabies virus, and the animals which principally 
distributed the disease, were red foxes (Vulpes vulpes) and raccoon dogs (Nyctereutes 
procyonoides) . 
Rabies was more widespread in wooded areas but wild predators have also moved 
into areas of human settlement . For instance, foxes and raccoon dogs have become a 
common sight in urban areas . Under such conditions, reports of rabies cases in dogs, 
cats and foxes in the cities and villages have increased . 
submitted to the OIE on 9 March 2015 by Dr Jonas Milius, Delegate of Lithuania to the OIE, Director, 
State Food and Veterinary Service, Ministry of Agriculture, Vilnius
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Eradication measures
The movements of companion (pet) 
animals are controlled at border entry points 
and vaccination against rabies is required, 
as are appropriate animal identification and 
veterinary certificate for the commercial 
movement of companion animals and 
approved passport or veterinary certificate for 
the non-commercial movement of animals . 
Since October 2004, all dogs and cats 
must be identified by tattoo or microchip for 
international movement . They should also 
be vaccinated against rabies with live or 
inactivated vaccine of at least one antigenic 
dose and an authorised veterinarian should 
carry out the vaccination . Pet passports should 
be used for the movement of animals between 
Member States of the European Union . All 
identified pet animals should be registered on 
a computerised database that is accessible to 
all relevant Competent Authorities .
In Lithuania, oral vaccination trials started 
as far back as 1983, using Russian vaccine-
bait systems (employing an adapted ERA 
vaccine strain derivative in fish or meat baits) . 
A 25% to 50% reduction in animal rabies 
cases was reported .
In the era of independence, the oral 
vaccination of wildlife was initiated in 1995, 
in accordance with the Lithuanian National 
Rabies Prevention Programme . 
The first oral vaccinations of wild animals 
were conducted in 1995, over an area of 
430 km2, in the Panevežys, Pakruojis and 
Joniškis districts . The Virbac-made vaccine 
SAG1 with a tetracycline biomarker was used .
In 1996, a spring vaccination campaign 
was organised over an area of 4,000 km2 
in 13 districts of northern Lithuania . Some 
100,000 doses were used (approximately 
25 baits per km2) . The task was carried out 
manually, by placing the baits in forests and 
bushes, by animal dens . In one district (Biržai), 
a plane was used to complete the task .
In 1997, two vaccination campaigns, one 
in spring (May) and one in autumn (October–
November), were carried out, over an area 
of 5,349 km2 . A total of 250,000 baits were 
distributed in 22 districts .
In 1998, a vaccination campaign was 
conducted over an area of 6,375 to 7,000 km2 
in 26 districts of northern and western Lithuania . 
A new type of vaccine, Lysvulpen, manufactured 
by Bioveta in the Czech Republic, was used and 
200,000 baits were distributed .
Over the five-year duration of the programme 
(1995–2000), a range of vaccines has been used 
and various geographic areas covered . In total, 
oral vaccination has been carried out over more 
than 8,000 km2, with 820,000 baits distributed 
at various stages of the programme . Delivery 
methods have included distribution by hand 
(predominantly by hunters) and aerial distribution 
using fixed-wing aircraft in a few limited areas . The 
vaccines used have included SAG1 (1995–1997, 
1999), Lysvulpen (1998) and Rabifox (2000), 
all incorporating tetracycline biomarkers . These 
campaigns have followed a twice-yearly delivery 
strategy, with baits distributed in March–April and 
October–November . The distribution of baits relied 
mainly on manual distribution through hunting 
clubs . 
From 2006, the oral rabies vaccination 
campaign (for red foxes and raccoon dogs) was 
conducted by airplane .
The total oral vaccination area is 65,000 km2 
(the entire territory of Lithuania) . A total 
of 1 .3 million baits are used per campaign 
(i .e . 2 .6 million vaccine baits per year) . The 
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baits are distributed by four Cessna-type small 
aircraft at a density of approximately no fewer 
than 20 baits km2 . The aircraft flying lines were 
separated by 1,000 metres but, near the border 
with Belarus, the flying lines were 500 metres 
apart .
According to the Act on the Welfare and 
Protection of Animals in Lithuania, Municipal 
Administrations must organise activities to reduce 
the number of stray pets in a municipality, provide 
temporary care for homeless and stray animals 
and return stray animals to their owners, as well 
as establish pet cemeteries and organise the 
maintenance of these . In accordance with the 
procedure set out by the Head of the Municipal 
Administration, the Municipal Administration 
must, within its remit, participate in implementing 
stray cat neutering programmes drafted by animal 
care organisations .
The prevalence of stray dogs is negligible .
In accordance with requirements set forth 
by legal acts, animal owners or keepers must 
ensure that cats, dogs, ferrets and other animals 
susceptible to rabies are vaccinated against the 
disease .
Additionally, free-of-charge vaccination 
campaigns are organised several times per year 
by the municipalities in association with private 
veterinarians, i.e. on 28 September (World Rabies 
Day) and 4 October (World Animal Day).
According to the Act on the Welfare and 
Protection of Animals the requirement to 
identify all cats, dogs and ferrets in the country 
by microchip and to record the data in the 
Pet Animal Register shall enter into force on 
1 January 2016 .
Legislation on rabies
Legislation on rabies in Lithuania includes the 
following:
− Order of the Director of the State Food 
and Veterinary Service No . B1-366 of 18 August 
2009, ‘On the requirements for notification of 
contagious diseases’, implementing EU Directive 
82/894/EEC
− Order of the Director of the State Food and 
Veterinary Service No . B1-463 of 11 May 2007,  
‘On the approval of requirements for rabies 
control’
− Order of the Director of the State Food and 
Veterinary Service No . B1-281 of 12 April 2006,  
‘On the approval of the programme for animal 
contagious disease control’
− Order of the Minister of Health and of the 
Director of the State Food and Veterinary Service 
No. V-146/B1-140 of 28 February 2002, ‘On 
the approval of the form of an information notice 
about suspected/confirmed cases of rabies in 
animals’
− Law on Welfare and Protection of Animals 
of the Republic of Lithuania No . VIII-500 of 
6 November 1997 (as last amended) .
Surveillance and monitoring
Passive surveillance of rabies in Lithuania is 
based upon a network of authorised veterinarians 
and veterinary officials . All rabies-suspected 
cases should be notified to the State Food and 
Veterinary Service, relevant samples should 
be collected from suspected cases and further 
samples collected for rabies surveillance and the 
monitoring of oral rabies vaccination campaigns . 
These samples should be submitted to the 
National Food and Veterinary Risk Assessment 
Institute, which is the National Reference 
Laboratory for rabies in Lithuania . The costs of 
rabies investigations are covered from the State 
Budget .
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The long-term strategy for the eradication 
of rabies in Lithuania began in 2006 and 
contains the following elements:
− the oral vaccination of wild animals 
should cover the entire territory of Lithuania
− the oral vaccination of wild animals, 
especially red foxes and raccoon dogs, should 
be conducted with a vaccine which creates 
sufficient immunity
− all Baltic states and Poland should start 
this campaign at almost the same time and 
coordinate their activities
− to ensure the complete eradication of 
rabies and avoid re-infection from neighbouring 
countries, cross-border oral vaccination was 
performed with the Kaliningrad region of 
Russia and Belarus .
The rabies eradication campaign should 
continue for two years after the last registration 
of a rabies case and include:
− the compulsory vaccination of dogs  
and cats
− the implementation of an identification 
and registration system for dogs and cats
− control of the population of stray dogs  
and cats .
In addition to the investigations of 
suspected rabies in wild and domestic animals 
mentioned above, and under the framework 
of monitoring the efficacy of the oral rabies 
vaccination programme which began in 
2006, brain samples were collected from 
8 foxes/raccoon dogs per 100 km2 for virus 
investigation . In 2011 the sample size was 
reduced to 4 target animals per 100 km2, as 
recommended by the WHO Expert Consultation 
on Rabies (First Report, 2005) . Samples 
for monitoring the oral rabies vaccination 
programme are collected by authorised 
veterinarians in close collaboration with 
hunting associations . 
To detect the virus, the preferred target 
groups are indicator animals (foxes and/or 
raccoon dogs showing abnormal behaviour 
suggestive of rabies, animals found dead and 
road-kill) .
Importation procedures
In the European Union, conditions for the 
non-commercial movement of pet animals have 
been harmonised, as laid down in Regulation 
(EC) No. 998/2003 of the European 
Parliament and of the Council of 26 May 2003 
on the animal health requirements applicable 
to the non-commercial movement of pet 
animals into a Member State from another 
Member State or from third countries . 
For the commercial movement of pet 
animals, Council Directive 92/65/EEC of 
13 July 1992 lays down animal health 
requirements governing trade in and imports 
into the Community of animals, semen, ova 
and embryos not subject to animal health 
requirements laid down in specific Community 
rules referred to in Annex A (I) to Directive 
90/425/EEC.
At the time of pet movement from non-
European Union countries, the owner or person 
responsible for the companion animal must 
be able to present to the relevant Authority 
responsible for animal health checks a pet 
passport or certificate certifying that the animal 
meets the requirements laid down for such 
movements . 
Where such checks reveal that the 
animal does not meet the requirements, the 
Competent Authorities shall decide: 
a) to return the animal to its country of 
origin 
b) to isolate the animal under official 
control for the time necessary for it to meet 
the health requirements, at the expense of the 
owner or the person responsible for it, or 
c) as a last resort, to put the animal down, 
without financial compensation, where its 
return or isolation in quarantine cannot be 
envisaged . 
The measures are withdrawn when negative 
results are obtained from sample investigation 
or when, after 14 days of surveillance of the 
quarantined animal, rabies is excluded .LI
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Fig. 1
Number of positive cases of rabies in wild and domestic animals from 2005 to 2014
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Conclusions
Through its use of oral rabies vaccination 
of wildlife with aircraft over the entire country, 
beginning in 2006, Lithuania has succeeded in 
eradicating rabies within seven years . 
The last case of rabies in a dog was detected 
on 15 January 2013 in the Varena region, close to 
the border with neighbouring Belarus .
No cases in wildlife have been detected since 
2012; therefore it can be considered that the 
State Food and Veterinary Service has succeeded 
in eliminating terrestrial rabies in the territory of 
Lithuania .
The last (imported) human rabies case was 
reported in 2007 .
An adequate system of laboratory-based rabies 
surveillance and oral rabies vaccination monitoring 
has been put in place and the investigation results 
obtained confirm the positive outcome of the 
programme .
Efforts will continue to maintain awareness and 
educate the public about the risk of re-introducing 
rabies via the illegal importation of pets or natural 
migration of infected wildlife .
Lithuania complies with the conditions to be 
considered a rabies-free country in accordance 
with Article 8 .12 .3 . of the Terrestrial Animal 
Health Code (2014) .
Therefore, 
− considering the information above, 
− considering the fact that more than two years have 
elapsed since the last case of rabies was detected 
on 15 January 2013 and resolved on the same day,
− and in accordance with Article 8.12.3. of 
Chapter 8.12. of the Terrestrial Animal  
Health Code (2014),
the Delegate of Lithuania to the OIE declares on 
9 March 2015 that his country is free from rabies.
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Self-declaration  
by the Dominican Republic of  
country freedom from avian influenza
Overview of animal health services
The Directorate-General for Livestock (DIGEGA), which comes under 
the Ministry of Agriculture, is responsible for protecting and promoting the 
development of the Dominican Republic’s livestock industry .
Through its Animal Health Directorate, DIGEGA designs, manages, evaluates 
and supervises national animal health programmes . It also organises and 
implements training, skills development and the development and distribution of 
educational material to strengthen animal health programmes . It is responsible 
for custody, surveillance and quarantine control at ports, airports, post offices 
and land borders, by monitoring and regulating products, by-products, medicinal 
products, raw materials and live animals introduced into the country, in 
accordance with the health regulations established in the Dominican Republic’s 
agricultural legislation .
The Central Veterinary Laboratory (LAVECEN) is the national reference 
laboratory . As the official diagnostic entity, it supports national policy on animal 
health, food security and safety and the production of biologicals . 
Legal framework
− The Dominican Republic’s Law 4030 of 15 January 1955 declares it in 
the public interest to safeguard livestock health, control and eradicate epizootics, 
and prevent animal diseases transmissible to humans .
− Law 8 of 8 September 1965 specifies that the functions of the Secretariat 
of State for Agriculture (now the Ministry of Agriculture) should include 
organising and managing the country’s livestock industry and promoting livestock 
production .
− Ministerial Decision 29-2013 of 25 March 2013 established the executive 
committee for avian influenza surveillance and Newcastle disease control .
Background to avian influenza in the Dominican Republic
In May 2006, an avian influenza surveillance plan was implemented 
throughout the country’s poultry population and the national contingency plan for 
avian influenza emergencies was developed .
As part of avian influenza surveillance of birds for export, on 10 December 
2007 the LAVECEN laboratory detected specific antibodies against avian 
influenza virus type A in a fighting cock .
The virus was identified as low pathogenicity subtype H5N2 and was 
95 .5% compatible with the strain that has been circulating in the United 
States of America since 1994 . The diagnosis was confirmed by the international 
submitted to the OIE on 27 January 2015 by Dr Nimia Lissette Gómez Rodríguez,  
Delegate of the Dominican Republic to the OIE, Director, Animal Health Directorate,  
Directorate-General for Livestock, Ministry of Agriculture, Santo Domingo
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reference laboratory, National Veterinary Services Laboratories (NVSL) in Ames, Iowa, 
United States of America . This case triggered the warning system and nationwide 
surveillance was intensified .
The case was closed in February 2009 . Since then no further occurrence of either low 
pathogenicity or highly pathogenic avian influenza virus has been detected .
Overview of poultry production
Poultry farming is one of the Dominican Republic’s most important agricultural 
sub-sectors . It continues to grow steadily and is contributing an increasing share to the 
national economy . It has a significant social impact because it creates jobs throughout the 
chain of poultry production and marketing and provides high-protein foods accessible to 
the neediest families .
From a total of 386 organised poultry producers, data are presented on the 
commercial and backyard poultry populations (Table I), drawn from the records of 
the Dominican Poultry Association (ADA), National Council for Livestock Production 
(CONAPROPE) and DIGEGA .
Table I
Breakdown of the poultry population in the Dominican Republic (December 2014)
Description by category Number
Layers 6,000,000
Broiler breeders 1,640,000
Layer breeders 58,000
Grandparent stock 36,000
Backyard poultry/fighting cocks* 2,256,000
Total 9,990,000
Sources: Dominican Poultry Association (ADA)/National Council for Livestock Production 
(CONAPROPE)/*Directorate-General for Livestock (DIGEGA)
The country produces 16 million broilers every month but there is no significant 
production of other avian species, such as turkeys or ducks .
There are poultry establishments throughout the Dominican Republic, 75% of 
which are in the Cibao region and produce chicks, hatching eggs, commercial eggs or 
grandparent stock, or are hatcheries or slaughterhouses . The remaining 25% are located 
around the province of Santo Domingo and in other parts of the country .
Another production system of great economic importance, especially for low-income 
households, is backyard poultry . The breeding of fighting cocks has also grown 
significantly in recent years . Both backyard poultry and fighting cocks are therefore 
included in animal health programmes .
There are wild and migratory birds in the country, which are concentrated in greater 
numbers around wetland areas, lakes and lagoons .
Prevention and control measures
DIGEGA issues guides to biosafety procedures, in accordance with which it performs 
inspections for the health accreditation of poultry establishments .
The system for the control of bird movements is being implemented through the guide 
to the movement of birds, bird products and by-products .
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Epidemiological surveillance
Since 2006, the Dominican Republic has had a continuous surveillance 
system, based on compulsory reporting, for the early detection of avian influenza, 
an animal health emergency response system and diagnostic capacity for 
identifying the influenza virus .
For these activities, DIGEGA has veterinarians (46) and veterinary assistants 
(50) trained to collect and transporting samples .
Following the occurrence of the case of low pathogenicity avian influenza 
H5N2 in December 2007, active surveillance was initiated to investigate virus 
circulation on organised farms and among poultry and fighting, wild, migratory 
and ornamental birds . This was accompanied by geo-referencing of poultry 
establishments . 
For the 2010–2012 period, a programme of ongoing technical visits was 
established to collect samples from organised farms, fighting cock breeding farms 
and bird sales outlets throughout the country .
Ten geographical locations of epidemiological risk were identified across the 
country, in which surveillance and monitoring of migratory and wild birds is carried 
out jointly with Ministry of Environment staff .
There is an ongoing system of passive surveillance, based on the immediate 
notification of clinical suspicion of avian influenza, and of active surveillance, 
based on sampling to confirm the absence of virus circulation . 
During the 2006–2013 period, a total of 75,214 avian samples were collected 
and processed . Apart from the asymptomatic cases that had tested positive in the 
laboratory, which were reported to the OIE in 2007, all the remaining samples 
processed have given negative results . In 2014, a total of 8,337 samples were 
analysed from 256 producers nationwide, all of which gave negative results 
(Table II) .
Table  II
Breakdown of samples processed by the Central Veterinary Laboratory (LAVECEN)  
for the diagnosis of avian influenza (2006–2014)
Year Number of samples
2006 5,293
2007 6,664
2008 32,211
2009 3,681
2010 8,850
2011 2,357
2012 3,636
2013 4,185
2014 8,337
Total 75,214
Source: Avian Diseases Division, Animal Health Directorate, Directorate-General for Livestock 
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Diagnosis 
LAVECEN is the official laboratory for the diagnosis of avian influenza . The tests 
used are: agar gel immunodiffusion (AGID), enzyme-linked immunosorbent assay 
(ELISA) and virus isolation .
Whenever results are inconclusive, the samples are sent to the international 
reference laboratory (NVSL) in Ames, Iowa, United States .
Public–private cooperation agreements
Through DIGEGA, the official sector has developed activities to prevent the 
introduction of the causal agent of avian influenza and to demonstrate the absence 
of virus circulation . All this work has been developed in close coordination and 
cooperation with the committee appointed for avian influenza surveillance, which 
covers the Dominican Poultry Association and the official Veterinary Service . These 
combined efforts have made possible this self-declaration of country freedom from 
avian influenza .
Therefore,
− in view of the above information,
− given that more than 70 months have elapsed since the last case was closed (26 February 2009), 
and
− in accordance with Chapter 10.4 of the OIE Terrestrial Animal Health Code (2014 edition),
the Delegate of the Dominican Republic to the OIE declares the country to be free from avian 
influenza as from 26 February 2015.
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The OIE and the International Veterinary Students’ 
Association (IVSA) signed a Cooperation Agreement 
in May 2014 (see Bulletin, no. 2014–4, pp. 48–49). 
IVSA is the largest veterinary student association in 
the world, representing around 30,000 students in 
more than 40 countries on all continents. It is a non-
profit organisation managed by volunteer veterinary 
students from across the globe, which aims to 
improve veterinary education through the exchange 
of knowledge, ideas and culture by encouraging 
worldwide collaboration among students, to enrich 
their experiences and improve their skills as future 
veterinarians. 
The two organisations committed themselves 
to active collaboration in the field of veterinary 
education, to improve animal health and animal welfare 
worldwide. High-quality veterinary education is a 
major pillar of good governance to ensure the quality 
of national Veterinary Services. The backbone for 
this collaboration is the set of OIE Recommendations 
on the competencies of graduating veterinarians 
(‘Day 1 graduates’) to assure National Veterinary Services 
of quality1 and the companion OIE Guidelines on the 
Veterinary Education Core Curriculum2.
As a first step towards the implementation of this 
recently signed Agreement, the President of IVSA 
invited the OIE to the 63rd IVSA Winter Symposium 
and General Assembly, held from 13 to 17 December 
2014 in Edinburgh, United Kingdom. More than 
80 veterinary students from 22 IVSA Member Countries 
across the world attended the event. The IVSA General 
Strengthening collaboration  
with veterinary students worldwide
news from
partners
An auditorium of the Royal (Dick) School of Veterinary Studies in Edinburgh, 
where the IVSA General Assembly took place
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1 Available at: www.oie.int/fileadmin/Home/eng/Support_to_OIE_Members/Vet_Edu_AHG/DAY_1/DAYONE-B-ang-vC.pdf
2 Available at: www.oie.int/Veterinary_Education_Core_Curriculum.pdf
Assembly provided an excellent opportunity to raise 
awareness of the OIE’s mandate, objectives and activities. 
Particular attention was given to the OIE PVS Pathway 
as a means of improving national institutional capacity 
and expertise in veterinary education, notably using 
the OIE Veterinary Education Establishment Twinning 
Programme.
To further put the agreement into action, the OIE 
will take part in the 64th IVSA Summer Congress, 
scheduled for 28 July 2015 in Cluj-Napoca, Romania, 
as well as the first IVSA Animal Welfare Conference, 
planned for 29 April – 1 May 2016 in London. The 
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Dr S. Ralchev, OIE Sub-Regional Representation, Brussels, introduces 
the aims of the OIE at the IVSA General Assembly in Edinburgh
©
 IV
SA
IVSA website: 
www .ivsa .org
OIE-IVSA cooperation agreement: 
www.oie.int/fileadmin/Home/eng/About_us/docs/pdf/
accords/A_IVSA.pdf
OIE portal on veterinary education:  
www.oie.int/en/support-to-oie-members/veterinary-
education/
special 
events
The Third OIE Global Conference on Aquatic Animal 
Health was held in Ho Chi Minh City, Vietnam, from 20 to 
22 January 2015 . This conference was one of a series of 
global conferences that began in 2006 aimed at raising 
awareness of the importance of aquatic animal health, and 
building a global framework for improving the management, 
prevention and control of aquatic animal diseases . 
The conference brought together over 250 key players 
in the aquaculture sector from nearly 100 countries, 
including representatives of national Veterinary Services 
and Aquatic Animal Health Services, international experts 
from OIE Reference Centres, representatives of national, 
regional and international organisations, private sector 
representatives, and representatives of other Competent 
Authorities . 
The conference served as a reminder of the crucial 
importance of implementing OIE standards, both to 
safeguard aquatic animal health and to facilitate safe 
trade . In order to implement these standards, both the 
Veterinary Services and the Aquatic Animal Health Services 
must have the appropriate competency and capacity . 
However, with most aquaculture production originating 
in developing and emerging countries, there is also a 
3rd OIE Global Conference  
on Aquatic Animal Health
Ho Chi Minh City, Vietnam, 20–22 January 2015
conference is expected to gather together more 
than 200 international veterinary students. In 
addition to being a key speaker, the OIE plans to 
organise a competition for veterinary students and 
the winners will be awarded with sponsorship to 
attend the conference.
international
news
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RECOMMENDATIONS
of the 3rd OIE Global Conference on Aquatic Animal Health
CONSIDERING THAT:
1 .   Aquaculture is one of the world’s fastest-growing food-
producing sectors and food derived from aquatic animals is 
an important source of high-quality nutrition; aquaculture 
representing close to 50% of aquatic animal global 
consumption;
2 .   Aquatic animal diseases continue to cause significant losses 
in aquaculture production throughout the world and are 
having a major detrimental impact on national economies in 
some countries and regions;
3 .   Approximately 500 different aquatic animal species are 
farmed globally, with several new species brought to 
aquaculture every year;
4 .   Aquaculture production is very diverse worldwide, ranging 
from family farms to intensive integrated production 
systems, and from locally consumed to internationally traded 
production;
5 .   Countries need effective aquatic animal health programmes to 
secure potential investment and to increase the production of 
aquatic animals in an environmentally sustainable way and to 
participate in international trade;
6 .   Veterinarians and other aquatic animal health professionals 
play a key role in the establishment and implementation of 
aquatic animal health programmes;
7 .   Aquatic Animal Health Services, whether part of the 
Veterinary Services or not, frequently lack human and 
financial resources and infrastructure, including legislation, to 
implement efficient aquatic animal health programmes;
8 .   One of the objectives of the OIE is to improve aquatic animal 
health worldwide and the welfare of farmed fish, and to 
facilitate safe international trade;
9 .   The need for all OIE Member Countries to meet their OIE 
membership obligations, and to implement the OIE standards 
for disease prevention and control, and trade in aquatic 
animals in line with the WTO Agreement on the Application of 
Sanitary and Phytosanitary Measures (as appropriate);
10 .  The need to clarify and develop the concept and application 
of compartmentalisation in aquaculture;
11 .  Private–public partnerships are an essential component to 
ensuring the effective implementation of OIE standards;
12 .  OIE Reference Centres are of crucial importance to help the 
OIE to fulfil its mandate relevant to diagnostic capacities 
and the setting of science-based standards, guidelines and 
recommendations on aquatic animal health; and noting that 
there are only two OIE Collaborating Centres for aquatic 
animal topics;
continuing need to strengthen the capacity 
of all Member Countries in this respect . 
The OIE provides Member Countries with 
appropriate support, notably through its PVS 
Pathway for evaluating the performance of 
Veterinary Services and/or Aquatic Animal 
Health Services .
The conference discussions achieved 
a greater awareness of the need for good 
governance of Veterinary Services and 
Aquatic Animal Health Services, including 
their public- and private-sector components, 
and encouraged veterinarians, aquatic 
animal health professionals and other 
partners to play their part in ensuring 
effective animal and veterinary public 
health risk management throughout 
the aquaculture production 
chain . The importance of 
partnerships between the 
public sector and the 
various private sector 
stakeholders was also 
highlighted .
One of the key 
objectives of the conference 
was to set priorities for the 
future work of the Aquatic Animal 
Health Standards Commission . The priority 
issues raised regarding surveillance, zoning 
and compartmentalisation will be considered 
in the formulation of the new Commission’s 
work plan at its next meeting in September 
2015 .
Conference presentations and abstracts:
www.oie.int/fr/A_AAHRWF2015/
presentations .htm
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13 .  The ongoing work of the OIE 
in reinforcing the capacity of 
Veterinary Services and Aquatic 
Animal Health Services, using the 
OIE PVS Pathway and the OIE 
standards published in the Aquatic 
Animal Health Code and Manual 
of Diagnostic Tests for Aquatic 
Animals;
14 .  One hundred and sixty-eight (168) 
OIE Member Countries have already 
nominated a National Focal Point 
for Aquatic Animals, under the 
responsibility of the National OIE 
Delegate; the OIE is providing 
ongoing capacity-building regional 
seminars for National Focal Points 
for Aquatic Animals to assist them 
to meet their responsibilities;
15 .  The successful global initiative for 
twinning of OIE Reference Centres;
16 .  The OIE has developed 
recommendations on the 
Competencies of graduating 
veterinarians (‘Day 1 graduates’) to 
assure National Veterinary Services 
of quality in both aquatic and 
terrestrial animals;
17 .  A number of important and relevant 
topics and issues were identified at 
the Second OIE Global Conference 
on Aquatic Animal Health, held 
in Panama in 2011, including 
the need for Member Countries to 
develop national aquatic animal 
health strategies .
OIE MEMBER COUNTRIES ARE 
REQUESTED TO:
 1 . Consider requesting an aquatic 
animal OIE PVS evaluation of their 
Veterinary Service and/or Aquatic 
Animal Health Service,  
if not yet done, with the objective 
of improving competencies and 
general compliance with OIE 
standards for aquatic animals, 
where aquaculture is an important 
or potentially growing sector;
 2 . Take steps to improve compliance 
with OIE standards, notably 
surveillance and early detection, 
notification to the OIE of aquatic 
animal diseases; and the control 
of pathogenic agents in aquatic 
animals and preventing their 
spread via trade, while avoiding 
unjustified sanitary barriers to 
trade; 
 3 . Support participation of 
nominated Focal Points in 
OIE regional capacity-building 
seminars and other relevant 
activities while those Member 
Countries who have not yet done 
so should nominate National 
Focal Points for Aquatic Animals 
under the responsibility of the OIE 
Delegate;
 4 . Promote the development of 
public–private partnerships 
to ensure the effective 
implementation of OIE standards;
 5 . Ensure that the OIE standards 
and guidelines including the 
responsible and prudent use of 
antimicrobial agents are respected 
in their country; 
 6 . Encourage veterinary education 
establishments to address the 
competence of graduating 
veterinarians (‘Day 1 graduates’) 
in aquatic animal health, as 
appropriate to the importance of 
the aquaculture sector in their 
country, using the OIE ‘Guidelines 
for a Model Core Veterinary 
Curriculum’;
 7 . Ensure that veterinarians 
accredited by the Veterinary 
Services to perform regulatory 
functions in aquatic animal 
health programmes receive 
appropriate training;
 8 . Encourage potential centres of 
expertise to apply to become 
an OIE Collaborating Centre 
or Reference Laboratory for an 
aquatic topic in order to expand 
the network of Reference Centres 
for aquatic animals;
 9 . Consider participation, if 
appropriate, in OIE twinning 
programmes for Reference 
Centres; and
 10 . As appropriate, comply with 
their WTO SPS obligations with 
respect to aquatic animal health 
certification for international 
trade .
THE OIE IS REQUESTED TO:
 1 . Continue to revise and develop 
OIE standards for aquatic 
animal health, notably standards 
on surveillance, zoning and 
compartmentalisation, diagnostic 
tools and vaccines, and 
responsible and prudent use of 
antimicrobials, in accordance 
with priorities set by the World 
Assembly of Delegates;
 2 . Provide more guidance in the 
OIE standards on the concept 
of compartmentalisation and 
its application and review 
the critical competency for 
compartmentalisation in the PVS 
Tool: Aquatic;
 3 . Assist Member Countries in 
strengthening their Veterinary 
Services and other Competent 
Authorities to promote good 
governance practices, including 
national legislation and regulatory 
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frameworks for import, marketing 
authorisation, production, 
distribution and use of quality 
antimicrobial agents in aquatic 
animals worldwide using, if 
needed, the OIE PVS Pathway;
 4 . Encourage veterinary education 
establishments to address the 
competence of graduating 
veterinarians (‘Day 1 graduates’) 
in aquatic animal health, as 
appropriate to the importance 
of the aquaculture sector in the 
country or region, using the OIE 
‘Guidelines for a Model Core 
Veterinary Curriculum’;
 5 . Cooperate with governments and 
with relevant international and 
regional organisations to increase 
awareness of the need for aquatic 
animal health programmes; 
improve disease reporting and 
foster cooperation between 
veterinary and other relevant 
authorities at the national, 
regional and international level;
 6 . Continue to strengthen 
collaboration with donors and 
with regional and international 
organisations, such as FAO, 
to advocate for the key role of 
veterinarians and aquatic animal 
health professionals in the 
prevention and control of aquatic 
animal disease and to encourage 
governments and donors to invest 
in Veterinary Services and/or 
Aquatic Animal Health Services 
as a global public good, as well as 
in aquaculture and health control 
programmes;
 7 . Continue to encourage 
governments, relevant regional 
and international organisations 
and donors to provide resources 
for applied research in vaccines 
and alternative therapeutics to 
reduce the use of antimicrobial 
agents in aquatic animals;
 8. Work closely with donors and 
international and regional 
organisations, and continue to 
provide appropriate technical 
support to Member Countries, 
especially developing countries, 
to meet the OIE standards for 
quality Veterinary Services and/or 
Aquatic Animal Health Services 
through the OIE PVS Pathway;
 9 . Develop its capacity-building 
activities including through 
negotiation with donors, to 
assist Delegates, supported 
by nominated Focal Points, to 
comply with the obligations 
and responsibilities of OIE 
membership, including 
participation in the standard-
setting process and capacity-
building activities;
 10 . Promote the role and 
responsibility of the Veterinary 
Services and/or Aquatic Animal 
Health Services (including public- 
and private-sector veterinarians 
and experts) in aquatic animal 
health;
 11 . Promote the development of 
public–private partnerships 
to ensure the effective 
implementation of OIE standards;
 12 . Collaborate with donors and 
governments, and continue to 
promote the use of twinning 
programmes for OIE Reference 
Centres;
 13 . Ensure that OIE Reference 
Laboratories apply OIE standards 
and guidelines for the validation 
of diagnostic tests so as to ensure 
confidence in and the reliability 
of diagnostic tests in the 
improvement of disease control 
programmes; and to achieve or 
maintain accreditation to the 
ISO 17025 or equivalent quality 
management system in diagnostic 
laboratories;
 14 . Request the Aquatic Animal 
Health Standards Commission 
to consider the development of 
recommendations for the use of 
serosurveillance for fish and for 
the concept of disease freedom at 
the supranational level; 
 15. Work together with FAO and WHO 
using the tripartite ‘One Health’ 
approach to reduce the impacts 
of zoonotic diseases on aquatic 
animals .
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The FAO/OIE International Conference for the 
Control and Eradication of Peste des Petits Ruminants 
(PPR), held in Abidjan from 31 March to 2 April 2015, 
was organised by the OIE, FAO and the government 
of Côte d’Ivoire. The overall objective was to present 
the Global Strategy for the Control and Eradication 
of PPR (hereinafter ‘the Global Strategy’), prepared by 
the FAO/OIE Global Framework for the Progressive 
Control of Transboundary Animal Diseases (GF-TADs) 
Working Group on PPR. Adoption of the Global 
Strategy by Conference participants was expected to 
lay the foundations for launching a global control and 
eradication programme for PPR.
Preparation of the Global Strategy and the 
organisation of the Conference were in line with the 
recommendation adopted by the GF-TADs Global 
Steering Committee in Paris in October 2012, 
the Resolution of the World Assembly of national 
Delegates of the OIE adopted in May 2014, and the 
recommendations of the 24th Session of the FAO 
Committee on Agriculture (COAG, October 2014), 
subsequently endorsed at the 150th Session of the FAO 
Council (December 2014).
The Global Strategy was prepared by OIE and FAO 
experts in collaboration with representatives of regional 
and international organisations, key countries and 
specialised research and development bodies, as well as 
other, private sector stakeholders.
The Conference in Abidjan was attended by over 
400 participants, representing 76 countries, including 
most of the countries and regions or sub-regions 
infected with PPR virus in Africa, the Middle East, 
Central Asia/Western Eurasia, including Turkey, South 
Asia and the People’s Republic of China.
Numerous personalities were present, including 
11 Ministers and 10 senior officials representing their 
respective Ministers, the Directors General of the OIE 
and FAO, the Delegates to the OIE / Chief Veterinary 
Officers of 41 countries, representatives of regional 
and international bodies, national and international 
development agencies and donors, research bodies, the 
private sector and non-governmental organisations.
FAO/OIE International Conference for the Control  
and Eradication of PPR
Abidjan, Côte d’Ivoire, 31 March – 2 April 2015
The Conference agenda included an opening session 
followed by five scientific and technical sessions, during 
which the following topics were presented in turn:
− global issues relating to small ruminant production
− the PPR situation worldwide
− tools already available for PPR control
− specific tools developed to support the implementation 
of the Global Strategy and research issues
− experiences and programmes underway in various 
affected or free regions (presentations made by the 
representatives of 11 regions or sub-regions) 
− socio-economic aspects.  
This scientific and technical part concluded with a 
presentation of the Global Strategy and an evaluation of its 
cost. 
A panel discussion introduced and led by panellists 
from seven key countries (Burkina Faso, China,  
Côte d’Ivoire, Ethiopia, India, Morocco, and Tunisia) 
concluded the second day.
During the second part of the Conference, entitled 
‘High-level meeting on commitment and support’, speeches 
by the Prime Minister of Côte d’Ivoire, the Directors 
General of the OIE and FAO, the Minister of Livestock 
and Fishery Resources of Côte d’Ivoire, the Mayor of 
the municipality of Cocody, and the Director of AU-
IBAR representing the African Union were followed by 
statements by Ministers and High Authorities representing 
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21 countries (Bangladesh, Cameroon, Chad, China, 
Comoros, Dem. Rep. of the Congo, Côte d’Ivoire, 
Equatorial Guinea, Guinea, Kenya, Mali, Mauritania, 
Nepal, Niger, Nigeria, Uganda, Rwanda, Senegal,  
Sierra Leone, Somalia and Sudan), and the 
representatives of three donors (European Union, 
World Bank, French Development Agency), who 
presented their views and expressed strong support for 
implementation of the Global Strategy for the Control 
and Eradication of PPR. 
The Director General of the OIE and the Assistant 
Director General of the FAO for Africa gave a 
presentation on ‘Global control and eradication of 
PPR: Investing in veterinary systems, food security and 
poverty alleviation’.
The Conference concluded with a reading of the 
recommendations and a motion of thanks to the 
authorities of Côte d’Ivoire.
Throughout the presentations and the debates that 
followed, the devastating effects of PPR on the economy 
of affected countries, its impact on the incomes of 
livestock farmers and especially on the livelihoods of 
the poorest smallholders and on food security were 
acknowledged, as was the consequent need to control 
the disease. The objectives of global eradication, along 
the lines of that achieved for rinderpest in 2011, were 
approved and the many high-level representatives 
who spoke indicated their political and financial 
commitment to support this vision.
The principles and the various components and 
activities of this control strategy were presented and 
were approved, along with the accompanying tools 
specifically developed for this purpose.
Emphasis was placed on the importance of 
strengthening the effectiveness of the Veterinary 
Services with regard to their public- and private-sector 
components, and on compliance with OIE standards 
for the Veterinary Services and for the various technical 
aspects (vaccines, surveillance systems, laboratories, 
etc.) and the regulations and legislation in force in the 
countries involved.
The recommendations of the Conference can be 
found on pages 111–114 of this issue of the Bulletin. 
The main points on which they are based and that 
were discussed during the sessions are itemised in the 
first part of the introduction to the recommendations 
(entitled ‘Considering that’) and emphasise:
− The importance of livestock for nutrition and food 
security, income generation, agriculture production 
and soil fertilisation, and the livelihoods of pastoralists 
and smallholders, and for the alleviation of hunger and 
poverty;
− The impact of infectious diseases of small 
ruminants, and in particular PPR, given that they can 
severely affect and disrupt community livelihoods and 
regional and international trade in live animals and 
their products; 
− The need, in view of the increasing movement of 
animals and animal products that increases the risk of 
major pathogens spreading from one country or region 
to another, to consider the control of these diseases as 
a Global Public Good;
− The crucial role of animal health systems, including 
effective Veterinary Services complying with OIE 
standards on quality and supported by the public/
private partnerships needed to obtain the support of 
animal owners and private sector veterinarians for the 
implementation of control strategies;
− The importance of using the lessons learned from 
rinderpest eradication, as well as those from national 
and regional PPR control projects (such as those 
implemented by FAO in Somalia and other countries, 
and by the OIE notably in Burkina Faso and Ghana 
supported by the Bill & Melinda Gates Foundation), 
including regional (particularly in Africa under 
AU-IBAR leadership) and international cooperation 
and coordination, with the support of the OIE and 
FAO;
− The need for socio-economic studies to justify 
investing in the eradication of PPR and other high 
impact animal diseases; 
− The quality of the presented Global Strategy and 
accompanying tools (specific PPR Monitoring and 
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Assessment Tool [PMAT], Post-Vaccination Evaluation 
tool [PVE], PPR Global Research and Expertise Network 
[PPR-GREN]), with its three integrated components 
(control and eradication of PPR; strengthening of 
Veterinary Services; simultaneous prevention and 
control of other priority diseases of small ruminants), 
the organisation and governance of Global Strategy 
implementation following FAO/OIE GF-TADs principles 
and practices;
− The requirement that the vaccines used comply with 
OIE standards and are certified by independent bodies, 
such as the African Union Pan African Veterinary 
Vaccine Centre (AU-PANVAC) in the case of Africa;
− The need to strengthen diagnostic laboratories and 
epidemiology teams, working together within regional 
networks, and animal health delivery systems;
− The possibility of using the articles of the Terrestrial 
Animal Health Code adopted in 2013 establishing official 
disease status recognition for PPR and providing for 
official endorsement of national control programmes, 
which are seen as strong incentives for the countries 
concerned to engage in PPR control and eradication 
programmes;
− The demand for national and regional vaccine banks 
capable of meeting the needs of vaccination and control 
programmes and responding to emergencies;
− The need to continue research in the fields of 
epidemiology and vaccines and in socio-economics.  
The recommendations adopted by the participants 
are preceded by a Declaration supported by the 
Ministers, donors and the High-Level Authorities 
present in Abidjan. The Declaration states that the 
control and eradication of PPR worldwide is officially 
and solemnly launched, with the vision of a world 
free of PPR by 2030; the FAO/OIE Global Control and 
Eradication Strategy (GCES) is officially endorsed along 
with its aforementioned three components; the national 
competent authorities, the international community, 
the veterinary profession and all stakeholders are 
encouraged as a whole to commit to its implementation 
and thereby take the necessary political, technical and 
financial means to ensure its success.
The recommendations directed at countries relate to 
the following key points:
− PPR should be considered as a priority disease, and 
agricultural development programmes at both regional and 
national level should include a component on the control 
of this disease and of other important diseases of small 
ruminants; 
− The national Veterinary Services should be 
concomitantly strengthened so that PPR-specific activities 
are successfully implemented; 
− The key principles based on rinderpest eradication 
lessons and PPR country experiences should be used and 
adapted to local situations, in compliance with the rules 
governing regional and international cooperation, with the 
active participation of regional organisations, for instance 
AU-IBAR in Africa;
− Vaccines must be compliant with OIE international 
standards and be used as recommended in the Global 
Strategy, and combined vaccinations with other small 
ruminant diseases should be encouraged; 
− Delivery systems for animal health activities, including 
vaccinations, should be adapted to local conditions and 
situations;
− Diagnostic laboratories, surveillance teams and 
surveillance plans must be strengthened and support 
given to the establishment or strengthening of regional 
epidemiology, laboratory and socio-economic networks;
− The development of public-private partnerships between 
official Veterinary Service must be promoted; 
− Regional meetings on the PPR control programmes will 
be organised under the GF-TADs umbrella and countries 
will attend them regularly to ensure the continuous 
evaluation and monitoring of the PPR situation and of the 
implementation of the Global Strategy, notably through the 
use of the PMAT and PVE tools;
− Countries will be encouraged to carry out a census of 
their small ruminant populations.  
With regard to the OIE and FAO and other 
international and regional organisations, the Conference 
recommended that:
− FAO and the OIE put in place GF-TADs governance 
for the implementation of the Global Strategy and the 
subsequent Global Control and Eradication Programme 
(GCEP). This will include a joint FAO/OIE Global 
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Secretariat, joint fund-raising agreements, as well as 
strong collaborations with regional and sub-regional 
organisations; 
− The GCEP be aligned with the Global Strategy and 
integrate the lessons learned from rinderpest eradication 
programmes, including major participation of regional 
bodies, such as AU-IBAR in Africa, and that it use north-
south and south-south cooperation and OIE and FAO 
multilateral trust funds;
− Regional vaccine quality certifying bodies should be 
supported, as for example AU-IBAR in Africa;
− Regional PPR vaccine banks should be established, 
drawing on successful OIE experiences in this field, and 
appropriate mechanisms should be established to reduce 
the unit cost of vaccines purchased by countries or 
livestock owners;
− FAO and the OIE call for an expert meeting to 
discuss the cost of the Global Strategy, including the 
cost-effectiveness of bringing the Veterinary Services 
into compliance with OIE standards on quality, and that 
the results from expert groups should be made available 
immediately;
− FAO and the OIE provide annual reports on the 
implementation of the Global Strategy and the GCEP and 
that a mid-term review be conducted after the first five 
years (2020);
Conference website (rationale, objectives and programme for the Conference):
www.oie.int/eng/PPR2015/background.html
Presentations by Conference speakers:
www.oie.int/eng/PPR2015/presentation.html
Book of abstracts, Global Strategy (document with annexes) and Advocacy document:
www.oie.int/eng/PPR2015/Document.html
The Organising Committee teams at the OIE and FAO and at the Ministry of Livestock and Fishery Resources of 
Côte d’Ivoire are to be thanked for their excellent work, as are the members of the FAO/OIE GF-TADs Working Group, 
which was designated as the Scientific Committee for the Conference.
− A second International Conference on PPR be organised 
after the first five years;
− The OIE and FAO assist their member countries in 
implementing the Global Strategy and in strengthening 
their Veterinary Services and that the OIE PVS Pathway be 
used, where appropriate and on a voluntary basis;
− Socio-economic surveys and cost-benefit analyses be 
conducted, for the purpose of additional advocacy, and that 
the impact of control measures on the environment and 
biodiversity be part of these cost-benefit analyses, which 
should also take into account the benefit of increasing the 
availability of small ruminant meat to allow substitution of 
‘bush meat’;
− Stakeholders should support the PPR Global Research 
and Expertise Network (PPR-GREN) and that FAO the 
OIE, the International Atomic Energy Agency (IAEA) and 
centres of excellence in scientific research – such as the 
OIE and FAO reference laboratories and the centres of the 
Consultative Group for International Agricultural Research 
(CGIAR) – should contribute to and support research and 
technology transfer (e.g. on vaccines, diagnostic assays, 
epidemiology and socio-economics).
The Conference proceedings will be published in the 
near future but participants and other interested parties 
can already access various Conference documents via the 
internet.
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CONSIDERING THAT  
−  Livestock are an important 
component in nutrition and food 
security, income generation, 
agriculture production and soil 
fertilisation, the livelihoods of 
pastoralists and smallholders and 
in the alleviation of hunger and 
poverty . In subsistence livestock 
production systems and their 
associated value chains, millions 
of people, especially women and 
their families, depend on small 
ruminants to generate nutrition 
for their families and revenue for 
their daily life;
−  Infectious diseases of small 
ruminants can severely affect and 
disrupt community livelihoods 
and regional and international 
trade in live animals and their 
products, causing significant 
financial damage . In developing 
countries, these diseases 
undermine access to quality 
nutritional products, food security 
and economic development at the 
level of village smallholders and 
the entire production chain;
−  Following its first identification 
in Côte d’Ivoire in 1942, peste 
des petits ruminants (PPR) has 
spread to around 70 countries 
today in Africa, the Near and 
Middle East and Asia that are 
home to over 80% of the world’s 
sheep and goats, and to more 
than 330 million of the world’s 
poorest people who depend on 
them for their livelihoods . The 
economic losses caused by PPR, 
and the ever-increasing threat of 
its spread to non-infected areas, 
RECOMMENDATIONS
of the FAO/OIE International Conference for the Control and Eradication of Peste des Petits Ruminants
further cripple already vulnerable 
livelihoods as well as national 
and regional livestock production 
opportunities;
−  The globalisation of trade, with 
rapid and long-distance movements 
of animals and animal products, 
increases the risk of major 
pathogens spreading from one 
country or region to another;
−  Controlling transboundary animal 
diseases (TADs), such as PPR, at 
their source is a shared interest 
between infected and uninfected 
countries and should be considered 
as a ‘global public good’;
−  In response to a resolution passed 
by the World Assembly of Delegates 
of the OIE and recommendations 
of FAO’s Committee on Agriculture 
(COAG) and the Council of FAO, the 
GF-TADs Working Group on PPR 
has developed a PPR Global Control 
and Eradication Strategy (GCES), 
which was presented at the FAO and 
OIE International Conference for 
the Control and Eradication of PPR 
held in Abidjan, Côte d’Ivoire, from 
31 March to 2 April 2015; 
−  The control of PPR and other 
TADs cannot be sustained if good 
governance of animal health 
systems, including effective 
Veterinary Services complying with 
OIE standards on quality and the 
required and updated appropriate 
legislation, is not in place in many 
countries and further supported 
by efficient public–private 
partnerships;
−  The Global Strategy is not presented 
as a ‘stand-alone’ activity but 
rather as a combination of three 
interrelated components, namely 
the control and eradication 
of PPR, the strengthening of 
Veterinary Services and the parallel 
prevention and control of other 
major diseases of small ruminants . 
The overall aim of the PPR Global 
Strategy is to eradicate PPR and 
this should be used as an entry 
point to achieve sustainable 
progress in the performance of 
Veterinary Services which, in turn, 
will improve animal health status 
in regard to other small ruminant 
diseases . The organisation and 
governance required to implement 
the Global Strategy is through 
the PPR Global Control and 
Eradication Programme (GCEP), 
which will follow the FAO/OIE 
GF-TADs principles and practices;
−  Many countries in Africa, the 
Near and Middle East and parts 
of Asia are committed to the 
prevention and control of PPR, but 
more support and investment are 
needed;
−  FAO and OIE worked on new 
agreements for a joint fundraising 
mechanism to support the 
PPR Control and Eradication 
Programme in the improvement 
of small ruminant production, the 
health of these animals and the 
communities that rely on them;
−  Additional socio-economic studies, 
including cost–benefit analyses, 
are needed to justify investment in 
the eradication of PPR and other 
high-impact animal diseases in 
national animal health systems, 
including Veterinary Services and 
those services provided by  other 
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Competent Authorities, professional 
education, extension services, and 
access to animal health goods and 
services;
−  The key principles of control 
strategies, and lessons learned from 
the rinderpest eradication campaign, 
such as international and regional 
cooperation and coordination 
(particularly in Africa under AU-
IBAR leadership), will be adapted 
in the PPR Control and Eradication 
Programme; as demonstrated 
during the rinderpest eradication 
programme,  in which regional and 
sub-regional organisations had a 
pivotal role, with technical support 
from the OIE and FAO;
−  Note should be taken of the lessons 
learned from country projects, such 
as those implemented by FAO and 
OIE;
−  PPR situations and socio-economic 
contexts can be different in each 
region and country and control and 
eradication programmes have to 
reflect these differences;
−  The eradication of PPR is achievable 
since there are several favourable 
factors, such as the fact that the 
disease is caused by only one 
serotype, that there is neither a 
carrier state nor a sustainable 
reservoir outside domestic small 
ruminants, and that effective 
diagnostic tools and vaccines are 
available;
−  Vaccines must be quality certified in 
compliance with OIE standards and 
independent regional certification 
bodies should be encouraged (such 
as the African Union–Pan African 
Veterinary Vaccine Centre,  
AU–PANVAC, for Africa); 
−  Diagnostic laboratories and 
epidemiology teams are major 
tools for the prevention, detection, 
control and eradication of PPR 
and national/regional collaboration 
between them is crucial . However, 
several gaps and challenges have 
been highlighted with regard to 
quality assurance in diagnostic 
laboratories and their proficiencies, 
or epidemiological understanding 
of seasonal movement patterns or 
climatic influences for potential 
disease spread, which have to be 
addressed;
−  There is a need to develop 
animal health delivery systems, 
particularly for the delivery of 
quality-assured, safe vaccines that 
can, in amplitude and frequency, 
reach all production systems, 
including those in remote and 
insecure areas, to create effective 
flock immunity;
−  A specific PPR Monitoring and 
Assessment Tool (PMAT) and a 
Post-Vaccination Evaluation (PVE) 
tool have been developed for this 
Global Strategy and a PPR Global 
Research and Expertise Network 
(PPR-GREN) is being established;
−  The OIE Terrestrial Animal Health 
Code articles adopted in 2013 
establish PPR as a disease 
with official status recognition 
and the possibility of official 
national control programmes 
being endorsed by the OIE World 
Assembly as important steps and 
incentives that encourage countries 
to engage in PPR control and 
eradication programmes;
−  Despite country specificities 
with regard to PPR and other 
small ruminant diseases, regional 
approaches are needed in order 
to harmonise and coordinate 
national programmes and to 
share experience and information 
on the PPR situation and the 
implementation of prevention 
and control programmes; these 
approaches must be aligned with 
the Global Strategy;
−  There is value in having national 
and regional vaccine banks 
to respond to vaccination and 
control programmes as well as 
to emergencies, to ensure the 
availability of quality-assured 
vaccines that comply with OIE 
standards and have been selected 
by a panel including independent 
experts from OIE and FAO 
Reference Laboratories/Centres. 
Their demographic and strategic 
positioning should be a regional or 
global decision;
−  Regional epidemiology and 
diagnostic laboratory networks are 
needed to harmonise surveillance 
and diagnostic methods, to 
undertake quality assurance, 
to support regional/national 
laboratory proficiency and training 
programmes, and to share and 
transfer technologies and expertise;
−  Capacity-building at the technical 
(both at the laboratory and field 
levels) and managerial levels 
as well as regular and effective 
communication to build public–
private partnerships and to gain 
the support of animal owners and 
private-sector veterinarians are 
crucial for any control strategy;
−  Additional research is important 
to understand the possible role 
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of wildlife in PPR dynamics, to 
develop new vaccines that allow us 
to differentiate infected animals 
from vaccinated animals (DIVA: 
differentiation between infected 
and vaccinated animals) when 
used with a companion test, to 
find such companion diagnostic 
assays that can differentiate 
serologically infected animals 
from vaccinated animals, and to 
investigate the possible use of 
multivalent vaccines, value chains 
in connection with socio-economic 
analyses .
THE CONFERENCE AND IN 
PARTICULAR THE HONOURABLE 
MINISTERS, DONORS AND 
NATIONAL AND INTERNATIONAL 
HIGH-LEVEL PARTICIPANTS 
DECLARE THAT 
−  the control and eradication of 
PPR worldwide is officially and 
solemnly launched during the 
‘Abidjan Conference’ with the 
vision of a world free of PPR by 
2030 . PPR is expected to be the 
second animal disease eradicated 
from the globe after the success of 
rinderpest eradication in 2011;
−  as a consequence, they officially 
endorse the FAO/OIE GCES 
with its three components and 
encourage all national Competent 
Authorities, the international 
community, the veterinary 
profession and all stakeholders 
as a whole to commit to its 
implementation and thereby take 
the necessary political, technical 
and financial steps to ensure that 
this vision is accomplished in a 
timely manner;   
AND RECOMMEND: 
A. To the countries, that: 
 1 . PPR be considered as a top-
priority disease in the next two 
decades in the global context 
of improving nutrition and food 
security, income generation and 
smallholders’ livelihoods, and in the 
alleviation of poverty and hunger; 
and that agricultural development 
programmes, both at the regional 
and national level, systematically 
include a component on PPR (and 
other small ruminant diseases, 
whenever feasible) prevention, 
diagnosis, control and eradication 
in line with the GCES and tailored 
to the local context and needs; 
 2 . National Veterinary Services – 
including their public and private 
components and by extension 
the Veterinary Statutory Bodies 
– and their good governance be 
concomitantly strengthened so that 
PPR-specific activities are properly 
and sustainably implemented; 
in doing so, that the countries 
take steps to improve compliance 
with OIE standards, notably 
those related to surveillance, 
early detection, animal disease 
notification to the OIE, and the 
quality of their Veterinary Services, 
including updated veterinary 
legislation;
 3 . Key principles, based on rinderpest 
eradication lessons and PPR 
country experiences, such as 
national control programmes 
adapted to local situations 
and regional and international 
cooperation and coordination of 
control methods and protocols, be 
respected; 
 4 . The countries use vaccines 
compliant with OIE international 
standards and comply with the 
guidance provided in the GCES, 
including in terms of PVE; and 
that combined vaccinations with 
other small ruminant diseases 
be encouraged, provided the 
vaccination protocols are 
compatible;
 5 . Delivery systems be adapted to 
local conditions and situations to 
be able to reach all susceptible 
animals in national herds . These 
systems should aim at delivering 
a safe vaccine to create effective 
flock immunity, particularly in 
regard to the cold chain;
 6 . Countries strengthen their national 
diagnostic laboratory systems, 
quality assurance (ring trials/
proficiency testing), transfer of 
technologies, capacity-building 
and staff training, and address 
any gaps that may have been 
identified in their capacity to 
support the implementation of the 
GCES;
 7 . Countries design and implement 
robust surveillance plans to 
ensure that the global surveillance 
system for PPR in all susceptible 
species, and for other small 
ruminant diseases, obtains a good 
understanding of PPR variants 
circulating (or the lack thereof) 
and their worldwide distribution;
 8 . Countries promote the 
development of public–private 
partnerships between official 
Veterinary Services, livestock 
owners, private veterinarians 
and other partners to ensure 
the acceptance and effective 
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implementation of the GCES, 
particularly for the delivery of 
vaccination campaigns and other 
animal health goods and services; 
and that special attention be paid 
to women whose role in small 
ruminant husbandry is crucial;
 9 . Countries regularly attend the 
regional PPR road map meetings 
under the GF-TADs umbrella, to 
ensure continuous evaluation and 
monitoring of the PPR situation 
and the implementation of the 
GCES worldwide; that countries 
use the PMAT and PVE specifically 
developed for this purpose;
10 .  The establishment or 
strengthening of regional 
epidemiology, laboratory and 
socio-economic networks is 
supported to provide relevant 
technical assistance to countries 
in the region;
11 .  Communication strategies are 
developed at both the national 
and regional level;
12 .  Countries put in place robust 
data management systems to 
collect PPR data with a view to 
conducting cost–benefit analyses . 
Countries are also encouraged 
to carry out a small ruminant 
population census;
B. To the FAO and OIE and other 
international and regional 
organisations, that:  
13 . The FAO and OIE put in place 
the proper GF-TADs governance 
for the implementation of the 
GCES and the subsequent GCEP, 
including a joint FAO–OIE PPR 
Global Secretariat and joint 
fundraising agreements, as well as 
strong collaborations with regional 
and sub-regional organisations;
14 .  The OIE and FAO develop a 
fully fledged GCEP aligned 
with the GCES, to learn from 
the experiences of the Global 
Rinderpest Eradication Programme 
(GREP), the Pan African 
Rinderpest Campaign (PARC) 
and the Pan African Control of 
Epizootics (PACE) programme, 
these last under AU-IBAR 
leadership, using North-South and 
South-South cooperation and OIE 
and FAO multilateral trust funds to 
implement the Global Strategy;
15 .  The establishment of regional 
vaccine quality-certifying bodies 
should be encouraged where 
possible or advisable, and that 
AU-PANVAC be supported in 
Africa; 
16 .  Appropriate mechanisms be 
established to reduce the unit 
cost of produced vaccines, or 
a mechanism implemented by 
which livestock owners’ costs 
could be subsidised . In order 
to respond to emergencies, 
regional vaccine bank(s) could 
be established or strengthened . 
Regional PPR vaccine banks 
should be established, using the 
experience of the OIE to respond 
to emergencies and improve 
quality-controlled vaccine delivery 
in countries and employing a 
competitive basis in regard to 
quality and prices; 
17 .  The FAO and OIE call for an expert 
meeting to discuss the cost of 
the Global Strategy, including the 
cost-effectiveness of Veterinary 
Services’ compliance with OIE 
standards on quality and the 
prevention and control of other 
small ruminant diseases; that 
results from expert groups be made 
available urgently; 
18 .  The FAO and OIE provide annual 
reports on the implementation 
of the GCES and GCEP to their 
Member Countries . A mid-term 
review should be conducted 
after the first five years of 
implementation of the GCES 
(2020), as well as examining 
whether the vision can be achieved 
by the proposed timelines, with 
‘corrective action’, if needed . 
A second International PPR 
Conference should be organised 
after five years to maintain the 
mobilisation of Member Countries 
towards the eradication vision;
19 .  The FAO and OIE assist Member 
Countries in implementing the 
GCES and in strengthening 
their Veterinary Services and 
other Competent Authorities 
to promote good governance 
practices, including appropriate 
national legislation complying with 
intergovernmental standards and 
regulatory frameworks for PPR 
control and eradication, using, 
when pertinent and on a voluntary 
basis, the OIE PVS Pathway;
20 .  The FAO and OIE conduct 
additional socio-economic surveys 
and cost–benefit analyses on 
PPR (and other small ruminant 
diseases) for the purpose of 
additional advocacy and the 
preparation of national control and 
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By decision of the President of the French Republic, Mr François Hollande, 
the Director General of the OIE, Dr Bernard Vallat, has been promoted to the 
rank of Commander of the National Order of the Legion of Honour1. He received 
the insignia from the President of the Senate, Mr Gérard Larcher, the second 
most important person in France, during a ceremony at the OIE Headquarters 
on 5 February 2015.
Mr Larcher applauded ‘the merits of a Frenchman who has carried high the 
colours [of his country] throughout the world’. He then presented a long and 
eloquent portrait of Dr Vallat’s career, from his years of overseas veterinary 
cooperation spent in Africa, working in Chad, Cameroon, Zaire, Mauritius and 
Central African Republic, until his management of crises such as those involving 
‘mad cow disease’, foot and mouth disease and avian influenza, at the Ministry 
of Agriculture and then at the OIE, where he has been the Director General for 
the past fifteen years. ‘I will summarise your achievements by saying that you have 
placed the OIE at the forefront of the leading international institutions’, also said 
Mr Larcher.
In his speech, Dr Vallat underlined the importance of the work of the OIE 
in addressing the many challenges in terms of risks related to animal health, 
placing particular emphasis on the need for capacity building in areas such 
as the national Veterinary Services, prevention of antimicrobial resistance, 
control of diseases, including zoonoses, at their source in animals, transparency 
of animal health information, animal welfare and prevention of natural or 
intentional biological hazards. 
The award bestowed on Dr Vallat is thus one of the highest decorations in 
France. Founded in 1802, the Legion of Honour has always been awarded in 
recognition of eminent military or civilian services to the French nation.
Mr Gérard Larcher, President of the Senate, France, and Dr Vallat, Director General of the OIE
The Legion of Honour (in French):
www.legiondhonneur.fr/fr/rubriques/la-legion-dhonneur/79/1
1 By decree of the President of the French Republic dated 11 July 2014
eradication strategies; that the 
impact of control measures on 
the environment and biodiversity 
be part of those cost–benefit 
analyses, as well as the benefits 
of increasing small ruminant 
meat availability to substitute for 
bushmeat; 
21 .  All stakeholders are requested to 
support the PPR-GREN and that 
the FAO and OIE establish the 
PPR-GREN with a strong research 
component/expert group; 
22 .  The OIE, FAO, International 
Atomic Energy Agency (IAEA) 
and centres of excellence in 
scientific research, including 
those of the Consultative 
Group for International 
Agricultural Research (CGIAR) 
(International Livestock Institute 
ILRI, International Centre for 
Agricultural Research in the Dry 
Areas ICARDA, International 
Food Policy Research Institute 
IFPRI), contribute to and support 
PPR research and technology-
transfer through the PPR-GREN, 
with regard to, e .g . vaccines 
(DIVA vaccines and companion 
diagnostic tools, thermotolerant 
vaccines, combined vaccines 
against several diseases…), 
diagnostic assays, epidemiology 
(the role of other domestic 
animals and wild animals), value 
chains, socio-economics and other 
aspects that may contribute to the 
effective control and eradication 
of the disease by 2030 . 
Dr Bernard Vallat, promoted to the rank  
of Commander of the National Order  
of the Legion of Honour
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publications
Manual of poultry diseases
J. Brugère-Picoux, J.-P. Vaillancourt, H.L. Shivaprasad,  
D. Venne & M. Bouzouaia
A completely revised and augmented edition of an avian 
pathology textbook originally published in 1992 by ‘Chaire de 
pathologie médicale du bétail et des animaux de basse-cour’, 
Maisons-Alfort, France, is now available . The main objective of 
this new edition is to provide a comprehensive update on practical 
information related to avian diseases to assist in the diagnosis 
of diseases affecting all species of domestic poultry (chickens, 
turkeys, ducks, guinea fowl, quail, pheasants, partridges, pigeons, 
ratites) . This new edition also focuses on the control of these 
diseases . Indeed, several chapters have been added on biosecurity, 
water sanitation, antibiotherapy, epidemiology, etc . Since disease 
diagnosis is largely based on post-mortem and histological 
examinations, special attention has been given to including 
hig-quality photographic images, as well as illustrations, for a total 
of 2,700 figures .
This manual is the culmination of a long and fruitful 
collaboration with authors from around the world, whose diverse 
areas of expertise have contributed to the uniqueness of this 
publication . It has been simultaneously published in four different 
language editions (English, Spanish, French and Chinese) .
Given that the main goal was to disseminate this manual 
at the lowest cost, the project was carried out without the help 
of a professional publisher . The French Association for the 
Advancement of Science (AFAS), a non-profit organisation, 
has taken up the role of publisher .
The manual can be ordered through AFAS (afas@orange .fr) or 
www .vetbooks .fr
Peste des petits ruminants disease  
in Turkana, Kenya
Risk factors, socio-economic impacts  
and disease control
Simon Kihu, George Chege Gitao & Lily Caroline Bebora
Clinical cases of peste des petits ruminants (PPR) have 
been reported in arid and semi-arid pastoral areas of northern 
Kenya since 2006 . The Turkana community’s knowledge of 
PPR is analysed and validated with laboratory tests that provide 
information on the pathology, molecular epidemiology and 
seroepidemiology of PPR viral infection .
Using participatory epidemiology methods, the book analyses 
the PPR disease risk factors and the social and economic impact 
of the disease on the pastoral economy . This analysis is aimed 
at providing an impetus to develop an effective surveillance and 
control strategy for PPR in Kenya and the region .
Information: www .lap-publishing .com
This book is published in four different 
language editions: English, French, 
Spanish and Chinese
2015
720 pages; approx . 2,700 figures
EAN 9782908014020
Includes a CD that encompasses 
all four language editions (English, 
French, Spanish and Chinese)
In English
2015
320 pages
ISBN 978-3-659-69752-4
Published by Lambert Academic 
Publishing
2015 • 2116
Annual meeting of OIE Regional 
and Sub-Regional Representatives 
20–23 October
OIE Headquarters, Paris, France
Workshop on rabies surveillance 
and control
27 October – 7 November
Pasteur Institute, Phnom Penh, 
Cambodia
http://predemics.biomedtrain.eu
November
13th Conference of the OIE 
Regional Commission for the 
Middle East
10-13 November
Beirut, Lebanon
Regional Seminar for OIE National 
Focal Points on Veterinary 
Laboratories
23–27 November
December
Linking health and environment:  
a forum on the background
9–11 December
Pierrefite-sur-Seine, France
http://ahpne.fr/spip.php?article313
WHO/OIE Conference on rabies
with the collaboration of FAO  
and the support of GARC
10–11 December
WHO Headquarters, Geneva, 
Switzerland
2
0
1
5
August
Training course on Viral 
Bioinformatics and Genomics 
10–14 August 
Glasgow, United Kingdom
www.bioinformatics.cvr.ac.uk
September
Regional Seminar for OIE National 
Focal Points for Animal Production 
Food Safety
8–10 September
Aguascalientes, Mexico
32nd World Veterinary Congress
13–17 September
Istanbul, Turkey
www.wvcistanbul2015.com
29th Conference of the OIE 
Regional Commission for Asia,  
the Far East and Oceania
14–18 September
Ulaanbaatar, Mongolia
October
3rd GRF One Health Summit 2015
4–7 October
Davos, Switzerland
http://onehealth.grforum.org/
Global Training Seminar on the OIE 
World Animal Health Information 
System (WAHIS)
6–8 October
OIE Headquarters, Paris, France
May
84th General Session of the OIE 
World Assembly of Delegates
22–27 May
Paris, France
June
Conference on veterinary education
22–24 June
Thailand
September
27th Conference of the OIE Regional 
Commission for Europe
(dates to be confirmed)
Porto, Portugal
November
23rd Conference of the OIE Regional 
Commission for the Americas
14-18 November
Bolivia
Conference on animal welfare
30 November – 2 December
Mexico
agenda
2
0
1
6
2
0
1
7
February
22nd Conference of the OIE Regional 
Commission for Africa
(dates to be confirmed)
Swakopmund, Namibia
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It is with great sadness that the OIE 
learned that David Bayvel has passed away 
at the age of 70.
David was a recognised authority 
on animal welfare. He believed that the 
veterinary profession should take the 
leadership role as advocates for animals in 
society.
David had a long and distinguished 
veterinary career, from traditional 
practice to working for the New Zealand 
Government. After his retirement from 
the New Zealand Ministry for Primary 
Industries in 2012, David continued his 
contribution to animal welfare through his 
appointment as Chief Veterinary Adviser 
for World Animal Protection.
David was also very much involved 
with the OIE, playing a crucial role in 
adding animal welfare to the issues of 
animal disease and public health as 
core pillars of the OIE’s mission with 
its 180 Member Countries. He was 
instrumental in the adoption of animal 
welfare as a strategic theme of the OIE 
and was the inaugural chair of the OIE’s 
permanent Working Group on Animal 
tributes
Welfare, which was established in 2002 to 
coordinate and manage the animal welfare 
activities of the OIE.
David was actively involved in the OIE’s 
Animal Welfare Global Conferences in 2004, 
2008 and 2012 and he was still involved in 
the development of OIE standards through 
the Ad hoc Group on Animal Welfare of 
Working Equids, which he chaired.
David Bayvel co-edited two issues of the 
OIE Scientific and Technical Review, providing 
a contemporary and global perspective on 
animal welfare: ‘Animal welfare: global issues, 
trends and challenges’, in 2005, and ‘Animal 
welfare: focusing on the future’, in 2014.
David’s enormous contribution to the OIE 
and animal welfare was recognised when he 
received the OIE Meritorious Service Award 
on 28 May 2010 during the 78th General 
Session (see photo).
David will be truly missed by his many 
colleagues and friends around the world.
David 
Bayvel
Passed away on 7 April 2015
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It was with great sadness that we learned 
of the death, at age 68, of our colleague, 
Paul-Pierre Pastoret. 
Emeritus Professor of the University 
of Liege (Belgium), Paul-Pierre Pastoret 
was passionate about his chosen fields 
of virology, immunology, vaccinology, 
epidemiology and biotechnology, as 
witnessed by his many publications and 
numerous distinctions.
In particular, Paul-Pierre Pastoret was 
involved, towards the end of the 1970s, 
in the development of the rabies vaccine, 
a recombinant vaccine made up of the 
rabies and vaccinia viruses, administered 
orally to wildlife, and so he became a major 
participant in the elimination of sylvatic 
rabies from several countries in Western 
Europe. From 1995 to 2002, he chaired 
the Immunological Working Group within 
the Committee for Veterinary Medicines 
at the European Agency for the Evaluation 
of Medicinal Products (EMEA). He also 
managed the Belgian Veterinary Medicines 
Agency. From 2002 to 2005 he directed the 
Institute for Animal Health (IAH), based in 
Compton, Pirbright and Edinburgh (United 
Kingdom).
In recognition of his dedicated service 
to animal health, the OIE awarded him its 
Meritorious Service Award in 2005. Paul-Pierre 
had been active in the OIE from 1997, as a 
member of the Editorial Committee of the 
Scientific and Technical Review. He led the 
OIE Publications Department from 2006 to 
2009, then continued to work as its scientific 
adviser. As a result of his expertise, he made a 
significant contribution to the high scientific 
quality of OIE publications, he was the co-
ordinating editor of several, and he also took 
part in scientific meetings and missions in 
various countries.
On 19 April 2015, the OIE lost an 
incomparable personality, an extraordinary 
colleague, cheerful and full of humour, and 
a passionate supporter of the veterinary 
community, who was well known all over the 
world. 
Paul-Pierre 
Pastoret
Passed away on 19 April 2015
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Part One: An overview
Scientific and Technical Review, Vol. 34 (1)
S. Zientara, D. Verwoerd & P.-P. Pastoret, eds.
The first part of volume 34 of the Scientific and 
Technical Review focuses on the most important arthropod 
vectors (insects and ticks) and describes their taxonomy, 
biology, competence and development. It begins by 
defining ‘vector’, ‘vector-borne disease’ and ‘emerging 
disease’ and provides explanations that are in line with 
OIE standards. The zoonotic risks of infections transmitted 
by arthropod vectors are also discussed, as is the genetic 
resistance of certain vertebrate hosts to infection. In 
addition, this issue considers the influence of climatic and 
anthropogenic changes on the distribution of vectors and 
the infections they transmit. The last part of this issue 
focuses on surveillance and control methods for these 
infections.
Part Two: Important diseases  
for veterinarians
Scientific and Technical Review, Vol. 34 (2)
S. Zientara, D. Verwoerd & P.-P. Pastoret, eds.
The second part of Volume 34 of the Scientific and 
Technical Review principally looks at viral diseases, but 
also considers bacterial diseases and, finally, parasitic 
diseases. The description of each disease has been updated 
in accordance with the most recent scientific research, 
focusing on epidemiology and control. Particular emphasis 
is placed on emerging diseases (such as infection with the 
Schmallenberg virus) and diseases that have a zoonotic 
component (such as West Nile fever). Diseases that have 
experienced a recent geographic expansion (bluetongue, 
fever due to the Chikungunya virus) are also discussed. In 
total, twenty-nine diseases are covered.
New developments  
in major vector-borne diseases
NEW!
ORDER ONLINE NOW! www.oie.int/boutique
12, rue de Prony • 75017 Paris • France • tel. 33 (0)1 44 15 18 88 • fax 33 (0)1 42 67 09 87 • www.oie.int • oie@oie.int
